Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,intracellular ligand-gated ion channel activity (GO:0005217),-0.7917039325292609,-2.052767064911583,0.0,0.04453126702057356,0.036,5/11,9.90%,ITPR1;RYR2;ITPR3;RASA3;MCOLN1
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",-0.8097532305024142,-2.0476643053988357,0.0,0.024386170035076,0.04,6/11,13.20%,ITPR1;TRPC3;ITPR3;TRPC6;ITPR2;TRPC4
prerank,L-glutamate transmembrane transporter activity (GO:0005313),-0.7265529422156792,-1.967794303620064,0.003703703703703704,0.048772340070152,0.116,6/14,9.02%,SLC7A11;SLC1A3;SLC25A13;SLC1A1;SLC1A2;SLC38A7
prerank,solute:sodium symporter activity (GO:0015370),0.8019312824043783,1.924832992710666,0.0,0.009850008765604129,0.009,5/27,3.52%,SLC4A10;SLC4A4;SLC5A6;SLC5A2;SLC4A8
prerank,calcium-release channel activity (GO:0015278),-0.6644538402070752,-1.8965398620963283,0.004545454545454545,0.08614679631956196,0.251,6/17,10.40%,ITPR1;RYR2;ITPR3;RASA3;MCOLN1;ITPR2
prerank,retinoid binding (GO:0005501),-0.6012038006934846,-1.8640058474593608,0.0,0.09648441187790939,0.335,5/22,2.50%,ALDH1A2;NR2F2;PTGDS;RBP4;CYP26B1
prerank,chloride transmembrane transporter activity (GO:0015108),0.8236065176893489,1.8473597762531586,0.00130718954248366,0.045310040321779,0.083,4/16,3.52%,SLC26A7;SLC26A2;SLC26A6;SLC4A8
prerank,monocarboxylate:sodium symporter activity (GO:0140161),-0.725094911252494,-1.8125957294268173,0.01607717041800643,0.13324037830758914,0.487,3/10,2.06%,SLC6A13;SLC6A1;SLC6A12
prerank,platelet-derived growth factor binding (GO:0048407),0.8818755851335169,1.8124924716031487,0.0014084507042253522,0.07321839849099071,0.179,4/11,1.32%,COL6A1;COL3A1;COL1A2;COL1A1
prerank,ligand-gated calcium channel activity (GO:0099604),-0.5900757447895549,-1.8082412358225035,0.008928571428571428,0.11890151228282396,0.508,7/19,10.01%,ITPR1;RYR2;ITPR3;GRIN2B;RASA3;MCOLN1;GRIN2A
prerank,metalloendopeptidase activity (GO:0004222),0.6544193696807566,1.8043329208607393,0.0,0.0679650604826685,0.217,13/76,6.79%,ADAMTSL3;ADAMTS3;ADAMTS17;ADAMTS2;TRABD2B;ADAM9;ADAMTSL1;ECE1;ADAMTS10;MMP28;ADAM10;SPG7;MMP14
prerank,cAMP binding (GO:0030552),-0.7053076475964123,-1.79231856305475,0.006600660066006601,0.1204729813145874,0.554,5/11,10.27%,RAPGEF4;PDE4D;RAPGEF2;PDE2A;PDE4B
prerank,intracellular calcium activated chloride channel activity (GO:0005229),-0.6261871332885203,-1.7794066592213167,0.0,0.10825338959048954,0.593,8/16,16.27%,ANO4;ANO1;ANO3;TTYH2;ANO10;ANO6;ANO2;TTYH3
prerank,intracellular chloride channel activity (GO:0061778),-0.6261871332885203,-1.7794066592213167,0.0,0.10825338959048954,0.593,8/16,16.27%,ANO4;ANO1;ANO3;TTYH2;ANO10;ANO6;ANO2;TTYH3
prerank,MAP kinase phosphatase activity (GO:0033549),-0.6605513231290587,-1.7343283372325358,0.0037735849056603774,0.14236511123243972,0.729,4/12,11.79%,DUSP16;DUSP10;DUSP3;DUSP6
prerank,bicarbonate transmembrane transporter activity (GO:0015106),0.7888039252242828,1.7276232310086954,0.002635046113306983,0.2379762117769958,0.64,5/15,5.65%,SLC26A7;SLC26A2;SLC26A6;SLC4A8;SLC4A11
prerank,sulfate transmembrane transporter activity (GO:0015116),0.7962926483897218,1.726415690291663,0.004,0.20208934650764476,0.647,3/14,2.98%,SLC26A7;SLC26A2;SLC26A6
prerank,metallopeptidase activity (GO:0008237),0.6040853322637099,1.7177123045965839,0.0,0.1968594609011454,0.701,17/113,6.79%,ADAMTSL3;ADAMTS3;ADAMTS17;ADAMTS2;TRABD2B;BMP1;ADAM9;ADAMTSL1;ECE1;ADAM30;PAPPA;PSMD7;ADAMTS10;MMP28;ADAM10;SPG7;MMP14
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),0.6798441242985469,1.6945365576184863,0.00234192037470726,0.24674271957838345,0.805,9/32,9.00%,SLC38A2;SLC38A1;SLC38A6;SLC1A5;SFXN3;SLC7A10;SLC38A3;SLC43A1;SLC6A7
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),-0.6213583277326202,-1.6912127685313025,0.01056338028169014,0.17989218185295194,0.829,6/15,11.01%,ALDH1A2;ALDH1A1;ALDH4A1;ALDH1L1;ALDH2;ALDH9A1
prerank,anion:anion antiporter activity (GO:0015301),0.7600033211588477,1.6863429752202723,0.007692307692307693,0.24789188726770395,0.834,7/17,15.61%,SLC26A7;SLC26A2;SLC26A6;SLC4A2;SLC26A4;SLC4A3;SLC26A11
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),-0.6251930825676038,-1.644315257151139,0.016891891891891893,0.2371738543879632,0.916,6/13,11.01%,ALDH1A2;ALDH1A1;ALDH4A1;ALDH1L1;ALDH2;ALDH9A1
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),0.7359659882708158,1.6304204057646106,0.010680907877169559,0.46462491347354684,0.969,4/15,14.42%,PLA2G4F;PLA2G4A;PLA2G5;PLA2G12A
prerank,carbohydrate:cation symporter activity (GO:0005402),0.7987593703834422,1.625261822552283,0.01422475106685633,0.44844403543768624,0.972,3/11,2.03%,SLC23A1;SLC23A2;SLC5A2
prerank,chemorepellent activity (GO:0045499),-0.5075951747891303,-1.6159247504823375,0.05025125628140704,0.268247870385836,0.952,7/25,3.42%,SEMA6A;DPP4;EPHA7;SEMA3D;SEMA7A;NRG3;SEMA5A
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.6031986936920039,1.6038786335488964,0.005592841163310962,0.536579227506285,0.992,10/55,7.05%,SLC38A2;SLC38A1;SLC23A1;SLC23A2;SLC16A9;SLC16A1;SLC38A6;ABCC1;SLC25A32;SLC38A3
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",-0.5588797538329853,-1.600144042334796,0.04149377593360996,0.27538701001929305,0.96,7/18,11.01%,ALDH1A2;ALDH1A1;FAR2;ALDH6A1;HSD17B12;ALDH2;ALDH9A1
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",-0.6303156748007973,-1.5969320955706392,0.031578947368421054,0.26334412967226095,0.962,8/12,14.78%,PDE8B;PDE7B;PDE4D;PDE2A;PDE4B;PDE8A;PDE1B;PDE4C
prerank,R-SMAD binding (GO:0070412),0.6975085888183135,1.5830786092082123,0.018666666666666668,0.6300974838058765,1.0,5/18,6.32%,PMEPA1;DDX5;SMAD6;LDLRAD4;SMAD4
prerank,ankyrin binding (GO:0030506),-0.5198525773054978,-1.5779760741104885,0.02252252252252252,0.280721614649302,0.976,5/19,9.30%,SLC8A1;CACNA1D;CDH1;KCNQ2;FLNC
prerank,symporter activity (GO:0015293),0.7980215276252153,1.5739624969756916,0.011594202898550725,0.6476380763384716,1.0,3/10,7.53%,SLC4A4;SLC5A6;SLC28A2
prerank,organic anion transmembrane transporter activity (GO:0008514),0.5431469492710159,1.5691240356483478,0.0,0.6349315650308421,1.0,18/134,5.92%,SLC38A2;SLC38A1;SLC26A7;SLC26A2;SLC23A1;SLC23A2;SLC5A6;SLCO3A1;SLCO2A1;SLC16A1;SLC26A6;SLC38A6;SLC4A8;SLC1A5;ABCC1;SFXN3;SLC4A11;SLC25A32
prerank,chemoattractant activity (GO:0042056),0.6517698420590506,1.5669453162252416,0.019801980198019802,0.6090999170430454,1.0,6/26,9.70%,PGF;VEGFA;FGF2;CCL15;HMGB1;BMP4
prerank,gated channel activity (GO:0022836),0.7219792340129225,1.5587584828726428,0.02631578947368421,0.6224626127581481,1.0,3/14,7.37%,PIEZO2;TMEM266;TMC8
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),0.6366604358321949,1.5554609105142023,0.02418379685610641,0.6061038727101741,1.0,4/29,3.80%,SLC26A7;SLC26A2;SLC26A6;SLC1A5
prerank,potassium ion transmembrane transporter activity (GO:0015079),0.6182956014324509,1.547951823901857,0.022727272727272728,0.616299495818431,1.0,3/31,1.20%,KCNK5;SLC12A7;SLC12A2
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.6739349938821119,1.5430231852135292,0.032679738562091505,0.6133107957903412,1.0,9/20,18.25%,DLG2;MAGI3;AK3;AK6;DLG1;DTYMK;AK1;LRGUK;MPP1
prerank,glutamate receptor activity (GO:0008066),-0.5063080959579552,-1.5418291727346811,0.04032258064516129,0.33151054337538094,0.989,9/19,7.75%,GRM7;GRM5;GRM3;GRIA1;GRM8;GRID2;GRM1;GRIK2;GRIA4
prerank,amino acid transmembrane transporter activity (GO:0015171),0.598583423889553,1.541322910653227,0.010262257696693273,0.5941900525841577,1.0,8/47,7.47%,SLC47A1;SLC38A2;SLC38A1;SLC38A6;SLC1A5;SLC7A10;SLC38A3;SLC43A1
prerank,diacylglycerol kinase activity (GO:0004143),-0.6147386288331071,-1.5389786093789233,0.050156739811912224,0.318024675125625,0.989,7/11,14.58%,DGKB;DGKD;DGKG;DGKH;DGKE;DGKZ;DGKA
prerank,inorganic anion transmembrane transporter activity (GO:0015103),0.6271349345015043,1.530726083770987,0.023086269744835967,0.6281619226428452,1.0,5/27,5.65%,SLC26A7;SLC26A2;SLC39A14;SLC26A6;SLC4A11
prerank,mechanosensitive ion channel activity (GO:0008381),0.7281161736529687,1.5251983828392286,0.044534412955465584,0.6330129546278028,1.0,2/12,7.37%,PIEZO2;TMC8
prerank,aspartic-type peptidase activity (GO:0070001),0.7511447977824104,1.5194233527036658,0.03429355281207133,0.6393066105908981,1.0,4/10,17.79%,BACE2;DDI2;BACE1;NAPSA
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),-0.6115936309829295,-1.5155296291724056,0.05755395683453238,0.32691604757167103,0.996,3/10,11.79%,DUSP16;DUSP10;DUSP6
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),-0.6115936309829295,-1.5155296291724056,0.05755395683453238,0.32691604757167103,0.996,3/10,11.79%,DUSP16;DUSP10;DUSP6
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.5693648336935104,1.5056579346419738,0.01675977653631285,0.6962380195879623,1.0,9/53,9.00%,SLC47A1;SLC38A2;SLC38A1;SLC38A6;SLC1A5;SLC7A10;SLC38A3;SLC43A1;SLC6A7
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.7085303404561248,1.5050905975395719,0.04993252361673414,0.6726040600943681,1.0,5/12,12.68%,CRYZ;AKR1C1;CBR4;DHRS4;NDUFS7
prerank,BMP binding (GO:0036122),-0.6024165432641955,-1.5008735321696978,0.07191780821917808,0.3411172164195018,0.997,3/11,9.15%,ENG;GREM2;BMPR2
prerank,solute:anion antiporter activity (GO:0140323),0.6857407459759763,1.4900167993956648,0.06702412868632708,0.7374373229182292,1.0,7/14,15.61%,SLC26A7;SLC26A2;SLC26A6;SLC4A2;SLC26A4;SLC4A3;SLC26A11
prerank,endopeptidase activity (GO:0004175),0.5031860160235088,1.4837609633077071,0.0,0.7495856670624743,1.0,76/257,24.21%,ADAMTSL3;ADAMTS3;ADAMTS17;HTRA3;ADAMTS2;TRABD2B;PCSK5;F3;HTRA4;ADAM9;ADAMTSL1;ECE1;PRSS38;PRSS12;FAP;USP24;ADAMTS10;USP2;PSMA8;PRSS53;MMP28;ADAM10;SPG7;MMP14;BACE2;TASP1;CLPP;MBTPS1;DDI2;BACE1;PSMA4;USP40;PDIA3;RHBDL3;ADAMTS6;USP48;ADAMTS20;USP34;USP11;PSMA6;MMP16;USP7;CASP1;USP33;USP36;NLN;USP13;PSEN2;HGF;USP35;IDE;PRSS36;PCSK7;NAPSA;TPP2;USP10;USP46;USP1;RHBDD3;CTSZ;PSMA3;UCHL1;USP5;CTSB;PSMB1;SENP1;USP47;CTSK;CTSO;MMP2;PSMA5;AFG3L2;PSMA7;USP49;PHEX;USP14
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.5769065863311876,1.4694785913895443,0.032073310423825885,0.8146976215578644,1.0,19/40,24.79%,PRMT8;PEMT;TPMT;LRTOMT;TARBP1;NNMT;LCMT1;HNMT;CARNMT1;THUMPD3;GNMT;PCMT1;ARMT1;SUV39H1;FBL;ASMT;METTL8;METTL9;DNMT1
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",0.7121420730034598,1.4600297870740628,0.05386740331491713,0.851566091149029,1.0,4/10,7.56%,DSE;GALE;FUOM;GFUS
prerank,inorganic cation transmembrane transporter activity (GO:0022890),0.5542646531805707,1.4559270529671948,0.0362400906002265,0.8510725315700214,1.0,12/48,13.38%,PIEZO2;SLC12A7;SLC12A2;SLC4A11;CALHM6;CALHM5;SLC12A4;TRPM7;TRPM4;TMEM165;TRPM6;ATP6V1B2
prerank,lysine-acetylated histone binding (GO:0070577),0.6239903821405784,1.4539955174637902,0.07343124165554073,0.8125660261395189,1.0,15/20,25.53%,BAZ2A;BRD4;BRD3;CARM1;PHIP;BRD2;BRD9;MLLT3;THAP7;ATAD2B;BRDT;KMT2A;TAF1;SMARCA4;ZMYND8
prerank,acetylation-dependent protein binding (GO:0140033),0.6239903821405784,1.4539955174637902,0.07343124165554073,0.8125660261395189,1.0,15/20,25.53%,BAZ2A;BRD4;BRD3;CARM1;PHIP;BRD2;BRD9;MLLT3;THAP7;ATAD2B;BRDT;KMT2A;TAF1;SMARCA4;ZMYND8
prerank,outward rectifier potassium channel activity (GO:0015271),-0.5898167886744772,-1.450858556017467,0.11513157894736842,0.4316674786549181,1.0,4/11,5.34%,KCNK2;KCND3;KCND2;KCNT1
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),0.6673867801303162,1.448828216775476,0.07539682539682539,0.8211141130691701,1.0,3/14,6.98%,KCNJ2;KCNE5;KCNIP2
prerank,histone methyltransferase activity (GO:0042054),0.5824096890464219,1.4451998690310766,0.05589307411907655,0.8209560162898231,1.0,19/32,30.72%,PRMT8;KMT5A;KMT2C;EHMT1;CARM1;SETDB1;MEN1;NTMT1;SUV39H1;FBL;SETD2;PRMT1;SMYD2;EHMT2;SETD7;PRMT5;NSD3;TTLL12;SUZ12
prerank,cation transmembrane transporter activity (GO:0008324),0.5488590047445681,1.4449965591964669,0.04591265397536394,0.799109322245095,1.0,7/48,9.00%,SLC38A2;SLC38A1;SLC38A6;SLC1A5;SFXN3;SLC38A3;SLC6A7
prerank,ion gated channel activity (GO:0022839),-0.45399036474721977,-1.4422025261079907,0.03398058252427184,0.4327661624340661,1.0,7/24,8.49%,ANO4;ANO1;KCNT1;ANO3;TTYH2;ANO10;ANO6
prerank,O-acyltransferase activity (GO:0008374),0.5979342405711802,1.4400739413301393,0.05357142857142857,0.8076474754889138,1.0,8/30,10.44%,PLA2G4A;SOAT1;PIGW;LPCAT1;MBOAT2;LPCAT4;GPAT4;LPCAT3
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.6628901581941945,1.4392337627936986,0.07493188010899182,0.7919666258302711,1.0,6/14,22.74%,CAPN5;CAPN10;CAPN2;CAPN15;CAPNS1;CAPN6
prerank,vascular endothelial growth factor receptor binding (GO:0005172),0.6909555567886155,1.4375442502599856,0.07452574525745258,0.7814087723051953,1.0,2/12,0.78%,PGF;VEGFA
prerank,SUMO transferase activity (GO:0019789),0.6523679355609726,1.4372707000675424,0.06772908366533864,0.7635480544877181,1.0,5/16,14.16%,HDAC4;TOPORS;TRIM28;RANBP2;PIAS4
prerank,RNA polymerase II complex binding (GO:0000993),0.5765802617749302,1.436588477797791,0.0524390243902439,0.748888959125395,1.0,18/32,25.44%,ELOF1;BRD4;CCAR2;ERCC5;SCAF1;ESRRB;URI1;AGO1;AGO2;PCF11;RPRD1A;ELP4;RTRAF;PAF1;HNRNPU;SMYD2;RECQL5;UVSSA
prerank,hyaluronic acid binding (GO:0005540),-0.5830895223231098,-1.428774519751827,0.09868421052631579,0.44539749166672726,1.0,4/10,16.30%,CEMIP;LAYN;HYAL2;CD44
prerank,semaphorin receptor binding (GO:0030215),-0.4577179132544912,-1.4281520773144698,0.07281553398058252,0.42944942581837015,1.0,13/23,21.24%,SEMA6A;SEMA3D;SEMA7A;SEMA5A;SEMA4D;SEMA3G;RIT2;SEMA4A;PLXNB1;SEMA4G;SEMA5B;SEMA6D;SEMA3B
prerank,RNA cap binding (GO:0000339),0.6372704700726806,1.4185785115182754,0.07579787234042554,0.8368051494417166,1.0,12/16,28.60%,CYFIP1;EIF4E3;EIF4A1;SNUPN;AGO2;NCBP3;EIF3D;NCBP1;NCBP2;CYFIP2;EIF4E;LARP1
prerank,store-operated calcium channel activity (GO:0015279),-0.5645285740136405,-1.4128311692073963,0.09931506849315068,0.44641220766303374,1.0,5/10,13.20%,TRPC3;TRPC6;ORAI1;ORAI2;TRPC4
prerank,ATPase binding (GO:0051117),0.5125804056713797,1.4102429452446033,0.04628632938643703,0.8682439121923101,1.0,17/71,14.53%,ESR1;EGFR;ATP1B1;SLC2A13;PTPN3;RDX;TCIRG1;ATP6V0A1;ANK2;CLPP;SNTA1;SYVN1;TMEM106B;EZR;S100A1;ABCA1;ATP6V1E1
prerank,cation:chloride symporter activity (GO:0015377),0.6939882845900788,1.4021035142742782,0.10564399421128799,0.8979626172861656,1.0,3/10,7.64%,SLC12A7;SLC12A2;SLC12A4
prerank,sodium ion transmembrane transporter activity (GO:0015081),0.5816243808684616,1.4018190272488813,0.07654320987654321,0.8795838938600808,1.0,7/27,6.93%,SLC23A1;SLC9B2;SLC4A8;SLC9A8;SLC4A11;SLC9A4;SLC9A1
prerank,sulfuric ester hydrolase activity (GO:0008484),0.6788545090252316,1.4009583794813727,0.10112359550561797,0.8655159876211281,1.0,9/12,27.08%,ARSJ;ARSB;SULF1;ARSA;ARSI;SULF2;GNS;ARSG;SGSH
prerank,frizzled binding (GO:0005109),0.5555394663349652,1.3958557826337683,0.07919621749408984,0.8766507801387676,1.0,5/34,6.69%,MYOC;LRP6;WNT9A;DVL1;FZD7
prerank,protein tyrosine kinase activator activity (GO:0030296),0.6078728804192343,1.3944226114580158,0.09266409266409266,0.8673958760694187,1.0,6/19,9.52%,EFNA5;GAS6;ABI1;DGKQ;ANGPT4;PAK2
prerank,Wnt-activated receptor activity (GO:0042813),0.6423487849184412,1.39226571123812,0.07313829787234043,0.8622577061057624,1.0,5/15,9.47%,PKD1;LRP5;FZD7;FZD5;ROR1
prerank,manganese ion binding (GO:0030145),0.5267283775050248,1.390775432326632,0.06292906178489703,0.8540942600655341,1.0,17/48,23.64%,ME1;ADCY2;B4GALT1;XPNPEP1;PPM1M;WRN;HMGCL;ABL1;GALNT1;GALNT3;MPPED2;XYLT2;NEK4;GALNT2;B4GALT7;PRIMPOL;ARG2
prerank,ubiquitin-specific protease binding (GO:1990381),0.6103998331156619,1.3896633322731295,0.0873015873015873,0.8438174175867539,1.0,12/19,32.05%,VCP;SYVN1;CHMP3;CLTC;SUMO1;LCOR;DERL1;AMFR;SELENOS;PRKN;SPATA2;SART3
prerank,insulin-like growth factor I binding (GO:0031994),-0.5307204541376239,-1.389398627063849,0.0959409594095941,0.481626858192751,1.0,6/13,4.96%,IGF1R;INSR;IGFBP2;ITGA6;IGFBP3;ITGB4
prerank,tropomyosin binding (GO:0005523),-0.5026686378810089,-1.3889867344426896,0.1087866108786611,0.46567713303862523,1.0,5/16,10.02%,NEBL;TMOD3;TMOD1;LMOD1;S100A6
prerank,I-SMAD binding (GO:0070411),0.6514306600649561,1.3885999655073824,0.08819345661450925,0.8336327610874465,1.0,7/13,12.60%,SMAD9;SMAD6;SMAD4;AXIN1;SMAD7;TGFB1I1;TGFBR1
prerank,cysteine-type endopeptidase activity (GO:0004197),0.49540962679014405,1.38366463677286,0.05422993492407809,0.8453166013108269,1.0,32/78,24.21%,CAPN5;USP24;USP2;GPAA1;CAPN10;CAPN2;USP40;PDIA3;USP48;USP34;USP11;USP7;CASP1;USP33;USP36;USP13;USP35;CAPN15;USP10;USP46;USP1;CTSZ;UCHL1;USP5;CTSB;CAPNS1;USP47;CTSK;CTSO;CAPN6;USP49;USP14
prerank,pre-mRNA binding (GO:0036002),0.5679711198674792,1.3836322671204404,0.09316770186335403,0.8299179607730681,1.0,15/28,24.31%,SRSF6;DDX5;CELF4;CELF3;HNRNPL;U2AF1;ZRSR2;PTBP1;RBM4;U2AF2;RBM22;TRA2B;HNRNPA1;HNRNPU;RBM24
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),-0.5640502920287214,-1.3830754321839263,0.1282051282051282,0.46319586156479137,1.0,4/10,7.50%,PRKAG2;PRKAR2B;PRKAR1B;PKIG
prerank,protein phosphorylated amino acid binding (GO:0045309),0.5401021258976231,1.3826270490576076,0.07783018867924528,0.819825184114655,1.0,5/42,3.29%,IRS1;NEDD4;PTPN3;VAV2;SHC1
prerank,inward rectifier potassium channel activity (GO:0005242),0.5860688886179464,1.3743766718033659,0.08531994981179424,0.850126113677105,1.0,3/24,4.11%,KCNJ2;KCNJ15;KCNN1
prerank,sodium:proton antiporter activity (GO:0015385),0.6559113959968778,1.3737042094133183,0.1301859799713877,0.8384085531242378,1.0,4/11,6.93%,SLC9B2;SLC9A8;SLC9A4;SLC9A1
prerank,insulin-like growth factor receptor binding (GO:0005159),0.6507411590929191,1.373453265505752,0.11592178770949721,0.8252609068202882,1.0,4/12,8.51%,GNAS;IRS1;SHC1;SOCS2
prerank,serine-type peptidase activity (GO:0008236),0.489096535843789,1.3686353800801025,0.03657262277951933,0.8359318455975668,1.0,10/96,7.85%,HTRA3;PCSK5;F3;HTRA1;PRSS38;PRSS12;FAP;PRSS53;CLPP;MBTPS1
prerank,metal ion:proton antiporter activity (GO:0051139),0.635303543737553,1.3669691422504868,0.12236286919831224,0.8308974894225365,1.0,10/13,29.53%,SLC9B2;SLC9A8;SLC9A4;SLC9A1;LETM1;SLC11A1;SLC9A5;SLC9A7;SLC9A6;SLC9A9
prerank,aspartic-type endopeptidase activity (GO:0004190),0.6492014675068646,1.3644331795603095,0.116,0.8311954118188075,1.0,6/12,23.62%,HM13;BACE2;DDI2;BACE1;NAPSA;SPPL2A
prerank,transcription corepressor binding (GO:0001222),0.5583454857097783,1.3635561944420667,0.10669975186104218,0.8222215381533486,1.0,10/27,17.70%,ESR1;PHF1;PER3;EHMT1;RORA;USP11;PER1;HDAC6;LCOR;THAP7
prerank,protease binding (GO:0002020),0.4780792092080628,1.362921651602242,0.038662486938349006,0.8122661196677234,1.0,22/99,14.08%,F3;COL3A1;SLC2A13;COL1A2;COL1A1;TIMP2;TIMP3;COMP;NOL3;FAP;ANXA2;CRADD;CARD16;VCP;SYVN1;CST3;STIM1;ITGAV;ATP9A;SERPINB9;CHMP3;CLTC
prerank,MAP kinase kinase kinase activity (GO:0004709),0.6760760383191976,1.361920332853259,0.1144927536231884,0.8050535289237826,1.0,2/11,3.77%,EGFR;MAP3K5
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.5370620832729613,1.361620751763624,0.09918319719953325,0.7943653222968746,1.0,16/37,25.81%,VARS1;VARS2;WARS2;HARS2;YARS1;DARS2;YARS2;NARS2;EPRS1;SARS1;SARS2;DARS1;CARS2;TARS2;QARS1;CARS1
prerank,RNA polymerase core enzyme binding (GO:0043175),0.5436448538455206,1.360656691881749,0.08732057416267942,0.7871201701617082,1.0,18/33,25.44%,ELOF1;CCAR2;ERCC5;ESRRB;URI1;AGO1;SPTY2D1;AGO2;PCF11;ERBB2;RPRD1A;ELP4;RTRAF;PAF1;HNRNPU;SMYD2;RECQL5;UVSSA
prerank,C2H2 zinc finger domain binding (GO:0070742),-0.5419814827689745,-1.3602552978019942,0.12915129151291513,0.49887331855766975,1.0,3/11,6.85%,LEF1;MBD2;GATA2
prerank,ionotropic glutamate receptor binding (GO:0035255),0.6714645281676643,1.3593304705597817,0.10829817158931083,0.7820465914721071,1.0,5/10,14.32%,GNAS;DLG4;NSF;SHANK1;SQSTM1
prerank,transcription coactivator binding (GO:0001223),0.58384653452881,1.3548054445196567,0.12388250319284802,0.792476661113877,1.0,7/20,11.84%,ESR1;CIT;SMAD4;RORA;CCNT2;TERT;MED25
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.5416833853984606,1.354590385985218,0.08160779537149818,0.7821192467390132,1.0,24/33,35.34%,ELOF1;CCAR2;ERCC5;ESRRB;URI1;AGO1;AGO2;PCF11;RPRD1A;ELP4;RTRAF;PAF1;TBP;HNRNPU;SMYD2;RECQL5;UVSSA;ZNF326;ELP2;RPRD2;WAC;LLPH;DHX9;SUPT4H1
prerank,monovalent cation:proton antiporter activity (GO:0005451),0.6313488515008816,1.3491906490012275,0.15220483641536273,0.7970204949894051,1.0,9/12,29.53%,SLC9B2;SLC9A8;SLC9A4;SLC9A1;LETM1;SLC9A5;SLC9A7;SLC9A6;SLC9A9
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.5522315184629084,1.3478750830083146,0.10513447432762836,0.7915383804528784,1.0,14/30,25.12%,GAS6;NOL3;CARD16;CST3;CD27;SERPINB9;PRDX3;BIRC6;BIRC5;CAST;BIRC3;DPEP1;UBE2Z;XIAP
prerank,nuclear import signal receptor activity (GO:0061608),0.6152134982483489,1.3466219969829876,0.11497326203208556,0.7861811857402397,1.0,9/15,19.35%,IPO5;IPO4;HIKESHI;KPNA2;TNPO2;KPNA3;IPO9;TNPO1;KPNA4
prerank,myosin binding (GO:0017022),0.5041637064712587,1.3377628965849484,0.07658157602663707,0.8174697685689872,1.0,13/55,15.83%,MYOC;GSN;DMD;RAB8A;LLGL1;GIPC1;RHOA;RAB3D;STXBP5;KIRREL1;RAB11B;RAB3B;CXCR4
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.6086786959507549,1.3376772301645656,0.12258953168044077,0.8067689611936032,1.0,8/15,22.60%,KMT2C;WDR5;KMT2D;SETD4;KMT2B;WDR82;SETD1A;KMT2A
prerank,RNA 7-methylguanosine cap binding (GO:0000340),0.6249459157116048,1.335213785193938,0.14722222222222223,0.8077138521245595,1.0,10/12,31.77%,CYFIP1;EIF4E3;AGO2;NCBP3;NCBP1;NCBP2;CYFIP2;EIF4E;LARP1;DCPS
prerank,histone acetyltransferase activity (GO:0004402),0.5436836456909203,1.3317235236424254,0.0954653937947494,0.8136496056524496,1.0,17/30,29.38%,NAA60;NAA40;TADA2A;KAT14;KAT6B;KAT2A;ARRB1;CREBBP;ATF2;KAT7;KAT8;KAT2B;TAF1;SRCAP;TAF10;USP22;TADA3
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),-0.5108557532901251,-1.3308307212693904,0.13138686131386862,0.551637696893995,1.0,3/12,1.02%,TGFBR3;ENG;LTBP1
prerank,histone demethylase activity (GO:0032452),0.5535105677876273,1.329530587051105,0.13399503722084366,0.8142375427785306,1.0,10/27,16.74%,JMJD1C;RIOX2;KDM2A;PHF8;KDM5B;KDM4A;FBXL19;HR;KDM5C;KDM6B
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),-0.44170804577910616,-1.3274806633214518,0.09615384615384616,0.5427930916634702,1.0,7/22,12.05%,CPEB2;RBMS3;ELAVL4;ELAVL1;EXOSC8;ZC3H12A;ZFP36
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),-0.48828322044166916,-1.3257882574151139,0.12648221343873517,0.5157144828287377,1.0,5/16,6.90%,PTPRG;PTPRB;PTPRD;PTPRO;PTPRK
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),-0.48828322044166916,-1.3257882574151139,0.12648221343873517,0.5157144828287377,1.0,5/16,6.90%,PTPRG;PTPRB;PTPRD;PTPRO;PTPRK
prerank,LRR domain binding (GO:0030275),-0.5002544094719723,-1.325631057179384,0.12878787878787878,0.5018014070744262,1.0,3/14,2.99%,ROBO1;PAWR;LRRFIP2
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.5454073796656037,1.323750289408282,0.13016270337922403,0.8323636253426475,1.0,4/25,8.80%,FMO1;MICAL2;MTRR;AKR1C1
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),-0.5052586176939659,-1.323094880612509,0.14652014652014653,0.49414232207385483,1.0,3/13,2.28%,CDH5;BMP6;BMP7
prerank,nuclear export signal receptor activity (GO:0005049),0.6393858195390282,1.322671075062566,0.15406976744186046,0.8274880148694295,1.0,3/11,11.20%,XPO1;XPO6;XPO4
prerank,3'-5' DNA helicase activity (GO:0043138),0.5917246093358114,1.3226328805725152,0.14188267394270124,0.8173660398807877,1.0,4/16,12.11%,NAV2;MCM2;WRN;ERCC3
prerank,protein-arginine N-methyltransferase activity (GO:0016274),0.6325519991213331,1.3202168892504034,0.15517241379310345,0.8190464696169568,1.0,7/11,29.58%,PRMT8;CARM1;PRMT1;FBXO11;PRMT9;PRMT5;PRMT3
prerank,endonuclease activity (GO:0004519),0.5019170338158142,1.317087792485382,0.12641083521444696,0.8236649403033044,1.0,16/49,19.53%,N4BP2;ERN2;SMG6;ERCC5;ZC3H12D;ERCC4;OGG1;AGO1;ZC3H12C;AGO2;YBEY;LACTB2;SND1;DIS3;KHNYN;NOB1
prerank,wide pore channel activity (GO:0022829),-0.4351623645567005,-1.3162219189032431,0.12206572769953052,0.4957870198549948,1.0,4/23,4.91%,GJB6;GJB2;GJC1;GJD3
prerank,GTPase inhibitor activity (GO:0005095),0.6130219855236793,1.3150805692238106,0.1523545706371191,0.8230928409108502,1.0,8/13,20.88%,SLIT2;IPO5;GPS1;PDE6D;ARL2;IQGAP1;RTKN;GPS2
prerank,gap junction channel activity (GO:0005243),-0.4400836429097656,-1.3144959235225173,0.12217194570135746,0.4866903188048277,1.0,4/22,4.91%,GJB6;GJB2;GJC1;GJD3
prerank,amino acid:sodium symporter activity (GO:0005283),0.6419599199614424,1.3142224141950982,0.1673758865248227,0.817069953307774,1.0,2/11,0.11%,SLC38A2;SLC38A1
prerank,phosphotyrosine residue binding (GO:0001784),0.5223131709835359,1.3124423717120706,0.13253012048192772,0.8155111963183824,1.0,4/37,3.29%,IRS1;PTPN3;VAV2;SHC1
prerank,fibroblast growth factor binding (GO:0017134),0.562112264020384,1.3117588769983317,0.14030612244897958,0.809418743564237,1.0,5/21,13.26%,THBS1;FGFR1;FGFR2;ITGAV;GLG1
prerank,transferrin receptor binding (GO:1990459),0.6554438822281123,1.3103447480259032,0.17352941176470588,0.8067270397521341,1.0,4/10,12.48%,SNX2;SNX1;CHUK;RGMA
prerank,protein kinase inhibitor activity (GO:0004860),0.5043199791965475,1.3088411016846166,0.10889929742388758,0.8044099203964845,1.0,19/42,27.05%,CIT;SPRED2;GMFB;PARVA;HEXIM1;CAMK2N1;GSKIP;CDKN1C;DUSP19;RPTOR;TAOK3;SMCR8;YWHAB;IBTK;MAPK8IP1;QARS1;SOCS1;NCK1;SH3BP5
prerank,ligand-gated cation channel activity (GO:0099094),0.4782593957380651,1.3075929505472206,0.08917197452229299,0.8011377354109956,1.0,9/75,9.13%,KCNJ2;KCNJ15;GRIK4;GRIN3A;KCNN1;CHRNB2;CHRNA5;TRPM4;KCNK6
prerank,BMP receptor binding (GO:0070700),-0.5052600324780336,-1.306804293838361,0.14840989399293286,0.4924946078822957,1.0,3/12,2.28%,CDH5;BMP6;BMP7
prerank,small GTPase binding (GO:0031267),0.4488898601962821,1.3060588937439832,0.05589430894308943,0.7994704892331673,1.0,82/170,28.55%,SGSM2;PLCE1;SRGAP2;YBX3;DOCK4;EXOC4;EHD1;ANKRD27;UNC13B;DOCK7;FGD6;GOLGA5;RAB34;ERC1;RABGEF1;RILP;RAB3GAP1;CDC42EP2;RIC1;GGA2;RAB8A;IFT20;PEX5;RAF1;GOLGA4;NDRG1;PDE6D;CYFIP1;PPP6R1;LZTR1;PAK2;RGP1;ARFIP2;RCC1;SOD1;RCC2;EVI5L;TRIP11;CDC42EP5;OCRL;LSM2;STK19;ABCA1;USP33;RANBP2;CCDC186;HPS4;TMEM127;AKAP13;IQGAP1;GGA1;DAPK3;BIRC5;MYCBP2;RAB3GAP2;EVI5;MAPKAP1;RTKN;OPTN;ABI2;LRRK2;KCTD13;MLPH;TSC2;RAPGEF6;RABGAP1;RAB11FIP4;AFDN;NUTF2;TBC1D20;ARHGDIB;CYRIB;RABGGTB;WAS;GCC2;XPO5;MYO5A;GGA3;NOX1;SPHK2;ULK1;MTSS2
prerank,miRNA binding (GO:0035198),0.5246492202237094,1.3022988965650288,0.1406060606060606,0.8085450052451618,1.0,13/30,23.77%,ZC3H7A;PUM1;MATR3;HNRNPA2B1;RBM10;AGO1;AGO2;RBM4;ZC3H10;TUT7;ZNF346;HNRNPA1;YBX1
prerank,ribonuclease activity (GO:0004540),0.4885680432302175,1.3008073768035757,0.10165745856353592,0.8066300656528426,1.0,20/56,19.53%,RNASE7;ERN2;PPP1R8;RNASE3;SMG6;ZC3H12D;RNASE6;AGO1;DIS3L2;ZC3H12C;AGO2;YBEY;LACTB2;SND1;EXOSC4;RPP40;N4BP1;ELAC2;KHNYN;NOB1
prerank,methyltransferase activity (GO:0008168),0.501485750751806,1.3001305013648252,0.10783200908059024,0.8008057126436158,1.0,21/46,29.58%,PRMT8;LRTOMT;EEF1AKMT3;EHMT1;NNMT;LCMT1;EEF1AKMT2;CARNMT1;GCSH;ARMT1;NTMT1;SUV39H1;ASMT;PRMT1;BUD23;DNMT1;NSUN3;METTL27;MEPCE;PRMT5;PRMT3
prerank,enoyl-CoA hydratase activity (GO:0004300),0.6324418832814019,1.2999141723253456,0.19225037257824143,0.793344854940307,1.0,5/10,22.45%,EHHADH;ECHDC2;AUH;ECHDC1;HADHA
prerank,mannose binding (GO:0005537),0.6203363505374844,1.299161774204664,0.17266187050359713,0.7881458592722446,1.0,4/12,21.82%,COLEC11;LMAN2L;LMAN2;LMAN1
prerank,clathrin adaptor activity (GO:0035615),0.5893871941175322,1.2974250465471187,0.1742627345844504,0.7875389820874428,1.0,6/15,16.45%,STON2;AP2A1;STON1;AP2A2;DAB2;HIP1
prerank,ferrous iron binding (GO:0008198),0.5532810640809573,1.2958330103768458,0.15106117353308365,0.7861627099219651,1.0,9/21,23.68%,FTO;FXN;ALKBH1;FECH;DNAJC24;TET2;PHYH;ISCU;ALKBH3
prerank,signal sequence binding (GO:0005048),0.5098449223147912,1.2951551579504679,0.14385150812064965,0.7808343173198857,1.0,17/35,19.72%,KDELR3;SEC61A1;IPO5;IPO4;KCNIP2;PEX5;KDELR1;KDELR2;KPNA2;TNPO2;CAT;TOMM70;KPNA3;POM121;TNPO1;KPNA4;NFKBIA
prerank,alkali metal ion binding (GO:0031420),-0.49226658228360354,-1.2946910880374525,0.1443661971830986,0.5078684976870176,1.0,1/13,0.01%,ATP1A2
prerank,cation channel activity (GO:0005261),0.4580245422505373,1.294121973087204,0.08517350157728706,0.7771557421023623,1.0,13/94,8.86%,PIEZO2;KCNK5;PKD1;SLC24A3;SEC61A1;TRPV3;ANXA2;SLC4A11;MCU;CALHM6;CALHM5;TRPM7;TRPM4
prerank,NAD binding (GO:0051287),0.5461896068857819,1.2940509395535003,0.1460122699386503,0.7696107348829475,1.0,9/26,17.46%,ME1;SORD;SIRT5;CRYZ;NNT;BDH2;SIRT2;CRYL1;HSD17B8
prerank,acylglycerol lipase activity (GO:0047372),0.6253899367013289,1.2937354637836773,0.18544935805991442,0.7632488970432777,1.0,1/11,0.40%,MGLL
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.5758501096981296,1.2923207438555624,0.17969821673525377,0.7615698443939594,1.0,5/17,14.33%,AK5;AK3;DTYMK;CLP1;AK1
prerank,UDP-glycosyltransferase activity (GO:0008194),0.47119649185292145,1.2923048035161708,0.11468381564844587,0.7542715935626161,1.0,17/70,19.98%,EXT1;GXYLT2;CHPF2;POGLUT3;B3GNT7;POGLUT1;B4GALT1;OGT;MGAT4B;HEXA;B3GNT9;B4GAT1;B3GNT6;GXYLT1;EXT2;GCNT7;B4GALNT3
prerank,androgen receptor binding (GO:0050681),0.5238651584715258,1.291557110218874,0.16687737041719342,0.750116052149853,1.0,5/25,12.50%,FOXP1;DDX5;NSD1;RNF14;TGFB1I1
prerank,histone deacetylase binding (GO:0042826),0.4542269948436536,1.2896791470794493,0.1006423982869379,0.7505800488997639,1.0,36/88,25.75%,NCOR2;HDAC9;HDAC4;DACT1;ANKRA2;MEF2B;IKZF3;BEX4;PKN2;MAPK8;MIER2;KPNA2;SFPQ;KAT2A;HDAC1;MEF2D;MEF2A;YWHAE;NACC1;SIRT2;HDAC6;NIPBL;MTA3;LCOR;THAP7;AKAP8;MIER1;KAT2B;GLI3;TP53;CHD4;PHF6;YWHAB;NCOR1;HDAC2;SUDS3
prerank,poly(A) binding (GO:0008143),-0.4288204723723088,-1.2874674850990369,0.14224137931034483,0.5123620155609756,1.0,5/21,5.11%,RBPMS;RBMS1;RBMS3;ELAVL4;DDX3X
prerank,sodium channel activity (GO:0005272),0.5100959578888643,1.281575696868869,0.15456674473067916,0.7766267288623876,1.0,5/37,6.62%,CACNA1G;GRIK4;HCN4;SLC4A11;SCN11A
prerank,cyclic nucleotide binding (GO:0030551),-0.42161189025539353,-1.2809067987453362,0.125,0.5146492830860527,1.0,6/21,10.27%,RAPGEF4;PDE4D;RAPGEF2;KCNH1;PDE2A;PDE4B
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.5995159299282191,1.2797748175465204,0.182328190743338,0.7767974669794143,1.0,1/13,1.04%,EHHADH
prerank,calcium channel inhibitor activity (GO:0019855),-0.5031344728974154,-1.2790273470968723,0.16720257234726688,0.5070732964902216,1.0,4/11,14.45%,ITPR1;PACSIN3;SLC30A1;MCUB
prerank,lysophospholipase activity (GO:0004622),0.5463865339387897,1.2774386738368606,0.17191601049868765,0.7793728231999402,1.0,2/20,1.79%,MGLL;PLA2G4A
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.4925022868502945,1.2765117717884187,0.14485981308411214,0.7762529843719218,1.0,23/44,26.50%,KMT5A;KMT2C;KMT5C;EHMT1;NSD1;ASH1L;SETD5;WDR5;KMT2D;SETDB1;SETD4;KMT2B;MEN1;WDR82;SUV39H2;SETD1A;SUV39H1;SETD2;KMT2A;SETDB2;SMYD2;EHMT2;SETD7
prerank,GTPase binding (GO:0051020),0.4354317581883133,1.270519674124961,0.07164480322906155,0.79436738873228,1.0,90/195,28.55%,SGSM2;PLCE1;SRGAP2;YBX3;DOCK4;EXOC4;EHD1;ANKRD27;UNC13B;DOCK7;FGD6;GOLGA5;RAB34;ERC1;RABGEF1;RILP;RAB3GAP1;CDC42EP2;LAMTOR1;RIC1;GGA2;RAB8A;IFT20;PEX5;RAF1;GOLGA4;NDRG1;PDE6D;CYFIP1;PPP6R1;LZTR1;PAK2;RGP1;ARFIP2;RCC1;SOD1;RCC2;EVI5L;TRIP11;CDC42EP5;OCRL;LSM2;STK19;ABCA1;USP33;RANBP2;CCDC186;HPS4;TMEM127;AKAP13;IQGAP1;GGA1;SPTBN1;EPRS1;DAPK3;BIRC5;MYCBP2;RAB3GAP2;EVI5;MAPKAP1;RTKN;GNB1;OPTN;ATG16L1;ABI2;LRRK2;KCTD13;MLPH;TSC2;RAPGEF6;STOML2;RABGAP1;YBX1;RAB11FIP4;AFDN;NUTF2;TBC1D20;ARHGDIB;CYRIB;RABGGTB;WAS;GCC2;AMBRA1;XPO5;MYO5A;GGA3;NOX1;SPHK2;ULK1;MTSS2
prerank,thiol-dependent deubiquitinase (GO:0004843),0.4525783093412475,1.2672647924236975,0.11727078891257996,0.8011961634415317,1.0,48/83,30.64%,USP24;USP2;OTUB1;USP50;USP40;UCHL3;USP48;USP45;OTUB2;USP34;USP11;TANK;USP7;USP33;USP36;USP13;USP19;USP35;PSMD14;OTUD5;OTULIN;YOD1;USP32;USP10;USP46;USP1;UCHL5;ZRANB1;MPND;OTUD6B;UCHL1;BRCC3;USP5;USP47;DESI2;CYLD;USP4;USP49;USP14;MYSM1;USP21;USP16;USP22;USP37;USP30;OTUD3;USP26;COPS5
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),0.6079227721314819,1.2659703042396953,0.2066957787481805,0.7997591492122703,1.0,8/11,30.04%,UBR5;STUB1;UBE4A;UBOX5;AMFR;UBE4B;RBX1;ANAPC11
prerank,protein kinase C binding (GO:0005080),0.48658298575641945,1.2645573195819069,0.1456876456876457,0.7985219053015024,1.0,11/43,14.32%,IRS1;ADAM9;HDAC9;DACT1;PRKCSH;DACT3;ITGAV;ABL1;NELL1;PICK1;SQSTM1
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),-0.40290713875215334,-1.2643921085565328,0.14220183486238533,0.5284848250113571,1.0,13/24,28.06%,ZDHHC14;GLUL;ZDHHC18;ZDHHC3;ZDHHC2;ZDHHC23;ZDHHC12;ZDHHC21;ZDHHC7;ZDHHC6;GOLGA7B;ZDHHC24;ZDHHC22
prerank,methylation-dependent protein binding (GO:0140034),0.47515156954576165,1.2618514395362976,0.12884834663625996,0.8017129502930793,1.0,24/57,25.67%,MORC3;PHF1;ING3;SGF29;MBTD1;PYGO1;ING5;PHF8;CBX2;KDM4A;WDR5;L3MBTL2;ING4;CBX5;THAP7;ZMYND11;CHD8;CDYL;BPTF;MPHOSPH8;KAT8;ZCWPW2;ZMYND8;CHD1
prerank,kinase inhibitor activity (GO:0019210),0.5069304110680461,1.261124674907664,0.17064439140811455,0.7978678404639618,1.0,16/33,28.77%,LRP6;GMFB;PARVA;HEXIM1;GSKIP;CDKN1C;DUSP19;TAOK3;SMCR8;YWHAB;MAPK8IP1;QARS1;SOCS1;NCK1;SH3BP5;WARS1
prerank,transforming growth factor beta binding (GO:0050431),0.5331457560061813,1.2605700108755766,0.18125,0.7932568697189416,1.0,7/23,9.72%,THBS1;LTBP3;TGFB3;ACVR1;TGFBR2;TSKU;ITGAV
prerank,ubiquitin binding (GO:0043130),0.4531104512854636,1.2587841022969473,0.14984059511158343,0.7937423302894775,1.0,28/73,21.03%,NEDD4;MVB12B;RAE1;TOM1L1;OTUB1;NBR1;FAF2;DDI2;SHARPIN;UCHL3;WDR48;OTUB2;USP33;MARK4;SQSTM1;UBAP1;USP13;UBE2L6;SIRT2;CXCR4;N4BP1;USPL1;NPLOC4;CKS1B;UCHL1;UBAP1L;NUP62;USP5
prerank,CARD domain binding (GO:0050700),0.579966442730374,1.258204526961828,0.2096551724137931,0.7891192615657804,1.0,4/14,13.71%,CARD14;CARD16;MAVS;CASP1
prerank,calcium channel regulator activity (GO:0005246),-0.372214962619277,-1.256832840995126,0.11428571428571428,0.5335684783950608,1.0,11/37,15.11%,ITPR1;PRKG1;NRXN1;CACNG7;CACNG8;REM1;PACSIN3;CACNG4;SLC30A1;MCUB;INAFM1
prerank,glucuronosyltransferase activity (GO:0015020),0.5454417986419233,1.2565306647638894,0.2033898305084746,0.7895899463600917,1.0,4/19,18.85%,EXT1;B4GAT1;B3GAT2;EXT2
prerank,tRNA binding (GO:0000049),0.4712763505573158,1.2565292329954858,0.16953035509736541,0.7830100301404244,1.0,17/43,22.93%,SSB;ELP5;TRNAU1AP;TERT;DALRD3;DARS2;ALKBH1;ELP1;YARS2;XPOT;ALKBH8;SARS1;SARS2;EIF2AK4;EIF2A;NSUN6;PUS1
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),0.6066274867204504,1.2562449729167617,0.19529085872576177,0.7776459812897779,1.0,3/12,3.29%,IRS1;GAB2;SHC1
prerank,receptor antagonist activity (GO:0048019),0.5647513423391952,1.2556604048467495,0.20052083333333334,0.7734840489855794,1.0,2/17,3.94%,DKK3;LRPAP1
prerank,cell adhesion mediator activity (GO:0098631),-0.39784887304873345,-1.253902606577966,0.17391304347826086,0.5284873315557126,1.0,10/24,10.11%,BSG;ESAM;LRRC4C;BCAM;NTNG1;CNTN6;DSCAML1;CNTN4;ROBO4;NEXN
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",0.5971938439568737,1.253573986508584,0.20583941605839415,0.7749954864228499,1.0,4/12,13.29%,AOX1;XDH;FXN;ISCA2
prerank,damaged DNA binding (GO:0003684),0.4851814215936081,1.2529988972676818,0.1676168757126568,0.7709141134621897,1.0,25/44,33.38%,MPG;HMGB1;ERCC5;RBBP8;ERCC4;RAD1;OGG1;TDG;SDE2;ERCC3;ERCC2;DCLRE1B;CREBBP;FANCG;CRY2;POLD1;SMC6;XPA;PNKP;DDB1;XRCC1;ERCC1;POLQ;RPA3;CUL4B
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.4578628385094673,1.2522589337664027,0.14842903575297942,0.7677569632332608,1.0,19/75,18.75%,ME1;EHHADH;LDHC;SORD;KDSR;GFUS;AKR1C1;NSDHL;CBR4;DHRS4;DHRS9;BDH2;MDH1B;CRYL1;PHGDH;PGD;AKR1A1;HSD17B8;DHRS3
prerank,deubiquitinase activity (GO:0101005),0.4455589113611452,1.249741513230545,0.12659574468085105,0.7718889011960208,1.0,49/88,30.64%,USP24;USP2;OTUB1;USP50;MINDY4;USP40;UCHL3;USP48;USP45;OTUB2;USP34;USP11;TANK;USP7;USP33;USP36;USP13;USP19;USP35;PSMD14;OTUD5;OTULIN;YOD1;USP32;USP10;USP46;USP1;UCHL5;ZRANB1;MPND;OTUD6B;UCHL1;BRCC3;USP5;USP47;DESI2;CYLD;USP4;USP49;USP14;MYSM1;USP21;USP16;USP22;USP37;USP30;OTUD3;USP26;COPS5
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.5483383501050632,1.2493829169766248,0.20754716981132076,0.7671683205046984,1.0,9/18,25.12%,GAS6;NOL3;CD27;SERPINB9;PRDX3;BIRC5;BIRC3;DPEP1;XIAP
prerank,phosphoric ester hydrolase activity (GO:0042578),-0.34114247887440535,-1.2487640613460977,0.10743801652892562,0.5286541734143786,1.0,10/49,7.56%,ATP1A2;PPP1CB;DUSP16;PTPRO;DUSP10;PXYLP1;SAMHD1;PLCXD3;DUSP3;ACP2
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),0.5730260632572746,1.2442400592739047,0.2037533512064343,0.7808209682965267,1.0,2/15,8.46%,CMKLR1;ACKR4
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),0.5100820871274723,1.2435613468139244,0.18159203980099503,0.7773184049203613,1.0,4/28,8.42%,GRIK4;GABRA3;CHRNB2;CHRNA5
prerank,poly-pyrimidine tract binding (GO:0008187),0.5224043895547212,1.241726948527831,0.20149253731343283,0.7784916543246125,1.0,10/23,14.11%,HNRNPH1;PABPC1;SSB;DAZAP1;DIS3L2;PATL1;KHDRBS1;PTBP1;HNRNPC;U2AF2
prerank,potassium ion antiporter activity (GO:0022821),0.5678617616383432,1.241043421377949,0.201949860724234,0.7752783998503134,1.0,4/15,6.93%,SLC24A3;SLC9A8;SLC9A4;SLC9A1
prerank,flavin adenine dinucleotide binding (GO:0050660),0.4609035817136786,1.2388326549308581,0.1705685618729097,0.7776283435330352,1.0,11/53,11.53%,MICAL2;ACOXL;AOX1;XDH;ACOX3;NOX4;QSOX1;MTRR;ETFDH;ETFA;AIFM1
prerank,E-box binding (GO:0070888),-0.36369639823429567,-1.2376393799741088,0.12422360248447205,0.5423380352787442,1.0,4/34,4.52%,TCF4;ZEB1;AHR;MITF
prerank,sequence-specific DNA binding (GO:0043565),0.411929122915205,1.2375684588494953,0.012,0.7767139242868412,1.0,114/590,15.98%,TBX15;FOXP2;ESR1;SIX1;FOXP1;KLF12;HOXA5;NFIX;ZNF423;FOXD1;NFIB;TCF7L2;RARB;ELF4;VSX1;HOXB6;PRRX2;JDP2;GLI2;PRDM5;GLIS2;LHX9;CUX1;NFAT5;HDAC4;ELF1;RXRA;ONECUT2;MEOX2;HES5;KLF5;SIX4;TCF7L1;ZNF250;ATF4;NR2F1;TCFL5;GMEB1;FOXC2;RXRB;LBX2;SAFB;SMAD4;NFE2L2;BHLHE40;PKNOX2;MEF2B;RFX7;E2F3;PBX1;MEIS3;TBX21;SOX9;HOXA9;HOXA6;SMG6;MAEL;IKZF3;RARA;FOXJ3;ESRRB;TFE3;FOXK1;ZNF76;NFATC1;FOXL1;RFX2;SLTM;ZIC1;MBNL2;RORA;FOXA1;SMG1;ZBTB2;UBP1;CSRNP1;PRDM4;SREBF1;RUNX2;KDM2A;ABL1;ZIC4;RFX5;POU6F1;CHTOP;TERT;HSF4;TELO2;NEUROD2;KDM5B;SRF;NR1D2;HEY1;GLIS1;TEN1;LONP1;FBXL19;MEF2D;HOXB4;ZNF740;MEF2A;NFATC3;HOXA4;ERF;ZNF148;CPSF4;EN2;MAFG;MBD1;GRHL1;FOXO3;NKX6-2;NFE2;CREB1
prerank,methylated histone binding (GO:0035064),0.45723614854265077,1.2372606668471995,0.1591928251121076,0.7722553887289841,1.0,25/62,25.67%,MORC3;PHF1;ING3;SGF29;MBTD1;PYGO1;ING5;PHF8;CBX2;KDM4A;WDR5;L3MBTL2;ING4;CBX5;THAP7;ZMYND11;CHD8;CDYL;BPTF;MPHOSPH8;KAT8;TAF1;ZCWPW2;ZMYND8;CHD1
prerank,insulin-like growth factor binding (GO:0005520),-0.45364304781013587,-1.236854565127625,0.19921875,0.5334209628107276,1.0,6/15,4.96%,IGF1R;INSR;IGFBP2;ITGA6;IGFBP3;ITGB4
prerank,translation initiation factor activity (GO:0003743),0.4802918972439226,1.2345915319397167,0.2134433962264151,0.7766330615025443,1.0,22/36,36.53%,EIF4A2;EIF4G2;EIF4G3;EIF4E3;EIF4A1;AGO2;EIF4G1;EIF2S2;EIF3D;EIF3A;EIF2A;EIF2S1;EIF4E;EIF3M;EIF3I;EIF3K;COPS5;EIF2D;EIF5B;EIF2B5;EIF1B;EIF3E
prerank,double-stranded DNA binding (GO:0003690),0.4110824365083959,1.2345277035058413,0.019,0.7711977451187705,1.0,119/531,20.20%,TBX15;ESR1;EGFR;SIX1;FOXP1;KLF12;HOXA5;NFIX;NFIB;RARB;ELF4;VSX1;HOXB6;PRRX2;JDP2;GLI2;GLIS2;LHX9;CUX1;NFAT5;ELF1;RXRA;ONECUT2;MEOX2;HES5;KLF5;SIX4;TCF7L1;ZNF250;ATF4;NR2F1;TCFL5;GMEB1;FOXC2;RXRB;PRKDC;LBX2;SAFB;BHLHE40;HMGB1;PKNOX2;MEF2B;RFX7;E2F3;PBX1;MEIS3;TBX21;SOX9;HOXA9;HOXA6;RARA;FOXJ3;ERCC5;ESRRB;TFE3;FOXK1;ZNF76;NFATC1;RFX2;PSIP1;RBBP8;ZIC1;MBNL2;FOXA1;ZBTB2;UBP1;PRDM4;SREBF1;RUNX2;ABL1;ZIC4;RFX5;POU6F1;WDR48;TDG;HSF4;NEUROD2;KDM5B;SRF;TDP1;NR1D2;HEY1;GLIS1;RAD50;MEF2D;HOXB4;ZNF740;NFATC3;HOXA4;CPSF4;EN2;MAFG;MBD1;GRHL1;FOXO3;NKX6-2;NFE2;CREB1;HOXA2;POLG2;NFKB2;KLF3;NR3C1;MEN1;HDGFL2;E2F1;ZMYND11;ZBTB32;ATF2;RAD51;KLF10;HOXB2;TEAD2;XRCC6;IRF3;NR3C2;NFATC4;ATF6;MAX
prerank,iron ion binding (GO:0005506),0.4577503872909211,1.2306541939229048,0.19457013574660634,0.7798474823138815,1.0,16/48,23.68%,AOX1;FTO;FXN;SCD5;PHF8;ABCE1;AGMO;ISCA2;ALKBH1;FECH;ALKBH8;DNAJC24;TET2;PHYH;ISCU;ALKBH3
prerank,cell-cell adhesion mediator activity (GO:0098632),-0.33731684465038947,-1.2302684605667193,0.12056737588652482,0.5376807464767012,1.0,14/42,10.11%,STXBP6;BSG;ESAM;LRRC4C;NTNG1;TMOD3;CNTN6;DSCAML1;CNTN4;BAIAP2;ROBO4;CD200;PDLIM5;NEXN
prerank,phospholipid transfer activity (GO:0120014),0.5301969276194969,1.2295861574490985,0.21510883482714468,0.7779936633574774,1.0,5/21,4.74%,TNFAIP8L3;PITPNC1;PRELID3B;PITPNA;PITPNM1
prerank,adrenergic receptor binding (GO:0031690),0.5504498587961273,1.227331180176873,0.22356091030789826,0.7807301192386111,1.0,3/16,7.83%,GNAS;NEDD4;DLG4
prerank,potassium:proton antiporter activity (GO:0015386),0.5993312003087164,1.2232999552155865,0.24633431085043989,0.7906672393355905,1.0,7/10,29.53%,SLC9A8;SLC9A4;SLC9A1;SLC9A5;SLC9A7;SLC9A6;SLC9A9
prerank,RNA polymerase binding (GO:0070063),0.5380792955754492,1.2229059882570443,0.21024258760107817,0.7864568346262039,1.0,7/18,20.51%,NEDD4;PKN2;ANP32B;CCNT2;PABPN1;STOM;PHRF1
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.4041240904591576,1.221779364977607,0.007,0.7850248887409753,1.0,126/731,13.91%,TBX15;FOXP2;PLAGL1;ESR1;SIX1;FOXP1;KLF12;ZBTB7C;PRRX1;ZFHX3;HOXA5;HIVEP3;PBX3;NFIX;HOXA3;ZNF423;FOXD1;NFIB;SKIL;TCF7L2;RARB;ELF4;HOXB6;MKX;SMAD9;NFIA;ZIM3;MUC1;ZFHX4;PRRX2;JDP2;GLI2;PRDM5;DMTF1;GLIS2;TWIST1;HOXC6;NFAT5;HDAC4;STAT5A;SIX5;ELF1;HOXB3;RXRA;ONECUT2;MEOX2;HES5;KLF5;SIX4;STAT3;ZBTB25;TCF7L1;ZNF250;ATF4;ZFP14;NR2F1;TCFL5;GMEB1;FOXC2;RXRB;SAFB;SMAD4;NFE2L2;BHLHE40;PKNOX2;MEF2B;ZNF471;RFX7;E2F3;PBX1;MEIS3;SKI;ZNF691;HEYL;TBX21;THRAP3;SOX9;HOXA9;HOXA6;IKZF3;NRIP1;RARA;NSD1;FOXJ3;ESRRB;TFE3;FOXK1;ZNF76;NFATC1;FOXL1;RFX2;ZIC1;RORA;FOXA1;ZBTB2;UBP1;PRDM4;SREBF1;EHF;RUNX2;ZNF260;ZIC4;RFX5;POU6F1;NFE2L1;NRF1;HSF4;MAZ;NEUROD2;FOXO6;FOXP4;SRF;NR1D2;HEY1;GLIS1;ZNF112;HDAC1;MEF2D;HOXB4;ZNF740;MYPOP;MEF2A;NACC1;RUNX1;NFATC3;HOXA4
prerank,histone deacetylase activity (GO:0004407),0.5231842406379673,1.2216081367442366,0.24069148936170212,0.78021023977008,1.0,9/19,25.75%,HDAC9;HDAC4;MIER2;HDAC1;SIRT2;HDAC6;MIER1;HDAC2;SUDS3
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.4038685315414628,1.2209426248381066,0.007,0.7772956569996009,1.0,138/732,15.98%,TBX15;FOXP2;PLAGL1;ESR1;SIX1;FOXP1;KLF12;ZBTB7C;PRRX1;ZFHX3;HOXA5;HIVEP3;PBX3;NFIX;HOXA3;ZNF423;FOXD1;NFIB;SKIL;TCF7L2;RARB;ELF4;HOXB6;MKX;SMAD9;NFIA;ZIM3;MUC1;ZFHX4;PRRX2;JDP2;GLI2;PRDM5;DMTF1;GLIS2;HOXC6;NFAT5;HDAC4;STAT5A;SIX5;ELF1;HOXB3;RXRA;ONECUT2;MEOX2;HES5;KLF5;SIX4;STAT3;ZBTB25;TCF7L1;ZNF250;ATF4;ZFP14;NR2F1;TCFL5;GMEB1;FOXC2;RXRB;SAFB;SMAD4;NFE2L2;BHLHE40;PKNOX2;MEF2B;ZNF471;RFX7;E2F3;PBX1;MEIS3;SKI;ZNF691;HEYL;TBX21;THRAP3;SOX9;HOXA9;HOXA6;IKZF3;NRIP1;RARA;NSD1;FOXJ3;ESRRB;TFE3;FOXK1;ZNF76;NFATC1;FOXL1;RFX2;ZIC1;RORA;FOXA1;ZBTB2;UBP1;PRDM4;SREBF1;EHF;RUNX2;ZNF260;ZIC4;RFX5;POU6F1;NFE2L1;NRF1;HSF4;MAZ;NEUROD2;FOXO6;FOXP4;SRF;NR1D2;HEY1;GLIS1;ZNF112;HDAC1;MEF2D;HOXB4;ZNF740;MYPOP;MEF2A;NACC1;RUNX1;NFATC3;HOXA4;ZNF148;EN2;VDR;ZKSCAN1;MAFG;PER1;GRHL1;FOXO3;HDAC6;FOXN3;NKX6-2;NFE2;CREB1
prerank,cytokine activity (GO:0005125),0.4213705022409812,1.2188866496731612,0.15816326530612246,0.7798557629655999,1.0,21/131,15.25%,GDF10;WNT9A;VEGFA;FGF2;IL33;INHBC;TGFB3;CCL13;SLURP1;CCL15;TGFB2;HMGB1;CXCL16;FAM3C;BMP4;CTF1;INHBA;NDP;BMP5;CLCF1;IL6
prerank,metal ion transmembrane transporter activity (GO:0046873),0.504154913086473,1.2182449753402773,0.21656050955414013,0.7769160680963526,1.0,5/27,4.08%,SLC23A1;SLC12A2;SLC9B2;SLC4A8;CNNM2
prerank,serine-type endopeptidase activity (GO:0004252),0.43813267280629464,1.2146838376084474,0.1652542372881356,0.7841009018594993,1.0,8/80,7.85%,PCSK5;F3;PRSS38;PRSS12;FAP;PRSS53;CLPP;MBTPS1
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),-0.43527486504670776,-1.2140842098645188,0.21235521235521235,0.5637364792055027,1.0,5/15,9.02%,SLC1A3;SLC25A13;SLC1A1;SLC1A2;SLC38A7
prerank,regulatory RNA binding (GO:0061980),0.4747637736257351,1.214020220587494,0.2062937062937063,0.7811123505237356,1.0,13/38,23.77%,ZC3H7A;PUM1;MATR3;HNRNPA2B1;RBM10;AGO1;AGO2;RBM4;ZC3H10;TUT7;ZNF346;HNRNPA1;YBX1
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.4014873417049223,1.212702138247509,0.017,0.7804710636751606,1.0,103/597,13.91%,TBX15;BNC2;ESR1;SIX1;FOXP1;KLF12;HOXA5;NFIX;NFIB;TCF7L2;RARB;ELF4;VSX1;HOXB6;SMAD6;PRRX2;JDP2;GLI2;PRDM5;DMTF1;GLIS2;LHX9;CUX1;NFAT5;HDAC4;ELF1;RXRA;ONECUT2;MEOX2;HES5;KLF5;SIX4;STAT3;TCF7L1;ZNF250;ATF4;MCMDC2;NR2F1;CHD3;TCFL5;GMEB1;FOXC2;RXRB;LBX2;PER3;SMAD4;NFE2L2;BHLHE40;HMGB1;PKNOX2;MEF2B;RFX7;E2F3;PBX1;MEIS3;TBX21;SOX9;HOXA9;HOXA6;MCM2;CENPC;RARA;FOXJ3;ESRRB;TFE3;FOXK1;ZNF76;CDC6;CARM1;NFATC1;RFX2;HNRNPL;ZIC1;MBNL2;FOXA1;ZBTB2;UBP1;PRDM4;SREBF1;RUNX2;ABL1;ZIC4;RFX5;POU6F1;HSF4;NEUROD2;KDM5B;SFPQ;SRF;NR1D2;HEY1;GLIS1;ZW10;MEF2D;CDC45;HSPD1;HOXB4;ZNF740;ARID4B;KMT2D;RUNX1;NFATC3;HOXA4
prerank,nuclear localization sequence binding (GO:0008139),0.5313985825623333,1.2119318470881786,0.217005076142132,0.7781900925177887,1.0,9/18,19.72%,IPO5;IPO4;KPNA2;TNPO2;KPNA3;POM121;TNPO1;KPNA4;NFKBIA
prerank,N-acyltransferase activity (GO:0016410),-0.36029931871146087,-1.2113103349182885,0.1695906432748538,0.5603017640216641,1.0,4/32,3.31%,CERS4;NMT2;TGM2;PLAAT3
prerank,MHC class II protein complex binding (GO:0023026),0.5943335461169899,1.2100435934422165,0.2590975254730713,0.7799837073589744,1.0,2/11,13.55%,ATP1B1;YWHAE
prerank,mRNA methyltransferase activity (GO:0008174),0.5872011361263448,1.2099775142222817,0.25140449438202245,0.7751308871637977,1.0,6/12,25.89%,TRMT61B;METTL16;TRMT61A;METTL8;METTL14;RNMT
prerank,phospholipase A2 activity (GO:0004623),0.5039018829504193,1.208788548892638,0.24688279301745636,0.7742364406333881,1.0,6/26,16.48%,PLA2G4F;PLA2G4A;PLA2G5;PLA2G12A;PNPLA3;PLA2G15
prerank,lipoprotein particle receptor binding (GO:0070325),0.4946199706986094,1.2079817455683632,0.2524390243902439,0.771914485634373,1.0,9/27,20.47%,LRP1;APBB3;LRPAP1;AP2A1;ANKRA2;CLTC;APBB1;DNAJA1;CLU
prerank,histone methyltransferase binding (GO:1990226),0.5899381351475499,1.2056841419949833,0.2633802816901408,0.7752592382966942,1.0,5/11,20.93%,CBX1;PHF1;PRDM4;LCOR;NOP56
prerank,SH3 domain binding (GO:0017124),0.4437833541321643,1.2051136034384167,0.19196428571428573,0.7726700465798133,1.0,16/62,12.56%,ADAM9;DPYSL3;MAPK15;AFAP1L1;CD3E;SOCS7;DNM2;ABI1;CBL;ZNF106;SYNJ1;WIPF1;ABL1;SHANK1;REPS1;KHDRBS1
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),0.5950520422622965,1.2048080922461328,0.2558139534883721,0.7687524038643346,1.0,2/10,1.18%,SLCO3A1;SLCO2A1
prerank,retinoic acid binding (GO:0001972),-0.4623711993775902,-1.2041831157448233,0.23255813953488372,0.5662814251059798,1.0,2/12,2.50%,NR2F2;CYP26B1
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",0.5460087324433758,1.2035144536535352,0.23392612859097128,0.763450019023117,1.0,8/16,25.07%,ATP6V1C2;TCIRG1;ATP6V0A1;ATP6V0D1;ATP6V1B2;ATP6V1C1;ATP6V0E1;ATP6V0B
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",0.5460087324433758,1.2035144536535352,0.23392612859097128,0.763450019023117,1.0,8/16,25.07%,ATP6V1C2;TCIRG1;ATP6V0A1;ATP6V0D1;ATP6V1B2;ATP6V1C1;ATP6V0E1;ATP6V0B
prerank,endoribonuclease activity (GO:0004521),0.47992495626859477,1.2034146332151672,0.24378698224852072,0.7590724567548468,1.0,12/32,21.19%,ERN2;SMG6;ZC3H12D;AGO1;ZC3H12C;AGO2;YBEY;LACTB2;SND1;KHNYN;NOB1;ENDOV
prerank,vitamin D receptor binding (GO:0042809),0.5511890195657844,1.2023762031835092,0.2459016393442623,0.7579245254149702,1.0,5/14,17.98%,RXRA;THRAP3;MED13;MED14;MED12
prerank,glutamate receptor binding (GO:0035254),0.5369443386285588,1.2006363810069045,0.2622739018087855,0.7590769409409361,1.0,7/17,19.83%,GNAS;DLG4;NSF;SHANK1;SQSTM1;HIP1;HOMER2
prerank,low-density lipoprotein particle binding (GO:0030169),0.5413094571737304,1.1995334739507757,0.2623169107856192,0.7583902454498885,1.0,1/16,0.08%,THBS1
prerank,voltage-gated sodium channel activity (GO:0005248),0.5138213960273847,1.198575512154455,0.22952853598014888,0.7572134177529117,1.0,3/22,6.62%,CACNA1G;HCN4;SCN11A
prerank,RNA binding (GO:0003723),0.39518712832332875,1.1975779182229638,0.002,0.7560448849317978,1.0,492/1321,27.93%,SRSF6;STRBP;C1D;LRP1;RRBP1;RPSA;COL14A1;DDX5;P4HB;HOXB6;HELB;SERPINH1;FNDC3B;YBX3;DDX17;HNRNPH1;RCC1L;PPP1CC;ERI3;TCF20;RDX;GNL3;AHNAK;PNISR;KHDC4;LUC7L2;ANXA7;SRSF1;PABPC1;NOL3;ARC;SAMD4A;SRSF5;SIDT2;CLK3;ARCN1;TSR1;HDLBP;RBFOX2;MBNL1;EIF4A2;IPO5;GCN1;RBM39;ZRANB2;BAZ2A;ANXA2;DUSP11;STAT3;KCTD12;ZC3H7A;ZCCHC24;TRIM28;RAE1;CELF4;RBM42;SPATS2L;RRS1;DYNC1H1;VCP;CHD3;SRSF2;CASC3;EIF4G2;SREK1;ATXN2L;TENT4B;KMT2C;GOLGB1;SNRNP70;RTCA;CCAR2;NFX1;PRKDC;RRP7A;SAFB;SSB;FAM98A;PUM1;MRPS35;MRPS28;HMGB1;DAP3;GNL2;PRKRA;TENT5A;MTHFSD;MATR3;PRPF40B;ABCF1;FUS;PPP1R8;CKAP4;HNRNPA2B1;CS;HNRNPDL;LAS1L;EIF4G3;ELP5;THRAP3;FBRSL1;TES;EWSR1;RBM47;HUWE1;SMG6;PURG;SRSF11;GDI2;PA2G4;ACO1;CHERP;RBBP6;TRNAU1AP;HARS2;CELF3;LUC7L;GSPT1;EMG1;RBM45;NOA1;LUC7L3;ZC3H12D;SLTM;UBAP2L;HNRNPL;RAVER2;HNRNPH2;PSIP1;SRFBP1;MBNL2;RBM28;ALG13;R3HDM2;SF3B2;SF3B1;PRRC2C;RBM25;PKN2;ZNF106;ILF3;ZCCHC9;PCBP4;MYEF2;SF3A1;PNN;TBRG4;NXF1;PDIA3;ZC3H11A;SMG1;RBM10;LARP1B;WDR3;BZW1;FAM98B;DAZAP1;RBM26;GTF2F1;SRRM1;U2AF1;AGO1;RBM6;NVL;ZC3H15;MRPL39;KPNA2;YARS1;CHTOP;RBM5;TERT;TRMT1;NUFIP2;ARF1;MAZ;PABPN1;TAF15;MSI2;FAM120A;SFPQ;ZC3H12C;DGCR8;FUBP1;METTL16;DALRD3;PRRC2A;USO1;DARS2;SRF;RCC2;ESF1;DDX50;CRNKL1;PATL1;EIF4A1;NOSIP;EZR;LONP1;MRPS14;RRP12;SNUPN;KHDRBS1;CSNK1E;AGO2;PSMA6;EIF4G1;CCDC59;HSPD1;DHX29;HNRNPM;ADD1;PCBP2;DIDO1;LSM2;ALKBH1;PTBP1;YWHAE;RALY;HMGN2;MANF;RBM4;NOLC1;SUGP2;HNRNPC;SUPV3L1;ETF1;TIAL1;UTP14A;CLTC;FAM133B;USP36;U2AF2;DCAF13;SRPK1;ZCCHC7;HEXIM1;ARHGEF1;G3BP2;ELP1;FNDC3A;PRR3;LACTB2;SND1;EIF2S2;CPSF4;HNRNPK;HEATR6;FLNB;YTHDC1;RTCB;XRN1;CMSS1;NCBP3;SARNP;DDX19A;LRRC59;NOC4L;IREB2;MRTO4;THOC2;DDX56;SRSF3;RPP40;FYTTD1;ISY1;UBAP2;PPAN;N4BP1;PCF11;BYSL;ZC3H10;PARP1;EIF3D;AATF;UBC;RPS27A;TUT7;ELAC2;TSN;YARS2;EIF3A;SUMO1;RC3H2;NCBP1;MRPL45;SSRP1;ADAT1;XPOT;SLC4A1AP;SPTBN1;RPP14;SNRPA;BOP1;TUFM;SECISBP2;ACIN1;EPRS1;SRSF7;SRSF10;KHNYN;TRMT6;ALKBH8;COA6;CPSF7;TFB2M;AQR;CPSF6;U2SURP;RBM22;TOP3B;NCBP2;USP10;SPATS2;TNPO1;SARS1;SARS2;FASTKD3;ZCCHC17;POLR1G;CAST;SEC23IP;PEBP1;DRG2;SAFB2;SYNCRIP;PTCD3;UCHL5;CAVIN1;CLUH;CCT4;XRCC6;LARP7;GANAB;ZNF346;CSTF2;AKAP8;TRA2B;CCT6A;RPL7A;RAMAC;TRIP6;EIF2AK4;NOC2L;MTREX;HNRNPH3;DNAJC21;UNK;DARS1;PARP12;RTRAF;CALR;MRPL12;PYM1;CIRBP;EIF2A;EIF2S1;TRA2A;RCAN3;AFF2;ZCCHC8;NOP56;ABT1;CSTF2T;DHX8;PPP1R10;ENDOV;DDX49;FBL;SBDS;CHD2;SAP18;WDR36;PSMD4;ATXN2;SCAF4;HNRNPA3;SNRPB;MRPS24;HNRNPA1;FXR2;UPF1;SRSF4;POLR2B;SHFL;DNAJC2;MRPS21;TASOR;DHX16;NGDN;MCAT;MRPS26;FAM50A;SUMO2;NSUN6;UNC50;TOP1;SLC3A2;RSRC2;PRDX1;DHX32;EIF4B;SRP72;PUS1;DCP1A;TCP1;NIFK;PRMT1;RBM19;FKBP4;BCLAF1;PPIG;WDR46;SF3B6;R3HDM1;WDR75;ZC3H14;HNRNPU;YBX1;RPP21;DUS3L;SMC1A;RPS9;SF1;TBL3;BUD23;MRPL37;KRI1;STAU1;METAP2;ZFR;GTPBP4;PABPC4;PHF6;RPS27L;CDK13;SUGP1;UPF3B;MTO1;RBM3;HDAC2;C1QBP;SNRNP35;DDX39B;UTP11;SLC25A11;TUBB4B;RTF1;FAM120C;NOP58;METTL14;PUS10;PSMC1;CARS1;DDX20;RNMT;MRPL13;TOE1;ANKHD1;NAA15;TPR;YY1;EIF1AX;SEC61B;DDX41;DKC1;SRBD1;RIDA;MAK16;EIF4E;POP5;UBTF;FCF1;SLC25A5;PSMA1;XPO5;NOP53;MEX3B;SRRT;TNRC6A;TRMT1L;RPL41;MRPL4;GPATCH1;SON;FXR1;CCDC47;GPATCH8;LSM5;YTHDF1;RBM27;ZC3H18;RPL30
prerank,tRNA methyltransferase activity (GO:0008175),0.5375993453509588,1.1968046455140948,0.2591093117408907,0.7537689539177459,1.0,5/16,17.87%,TARBP1;TYW3;THUMPD3;TRMT44;ALKBH8
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.4101817106399563,1.1963048019512,0.13557594291539246,0.7509835425579523,1.0,30/173,14.55%,FOXP2;PLAGL1;FOXP1;KLF12;ZFHX3;SKIL;JDP2;PRDM5;DEAF1;HES5;ZBTB25;NR2F1;TCFL5;ZNF25;NFX1;BHLHE40;SKI;HEYL;TBX21;FOXK1;ZBTB2;ZFP90;POU6F1;FOXP4;HEY1;MYPOP;NACC1;NFATC3;ERF;ZNF148
prerank,G protein-coupled amine receptor activity (GO:0008227),-0.3851401784652725,-1.1934787000690132,0.19469026548672566,0.5601006605081413,1.0,12/22,33.10%,HTR2C;HTR4;CHRM3;HTR2B;CHRM2;CHRM1;HRH1;HTR1B;HTR1F;HTR1A;HRH3;HTR1D
prerank,G protein-coupled serotonin receptor activity (GO:0004993),-0.3851401784652725,-1.1934787000690132,0.19469026548672566,0.5601006605081413,1.0,12/22,33.10%,HTR2C;HTR4;CHRM3;HTR2B;CHRM2;CHRM1;HRH1;HTR1B;HTR1F;HTR1A;HRH3;HTR1D
prerank,serotonin receptor activity (GO:0099589),-0.3851401784652725,-1.1934787000690132,0.19469026548672566,0.5601006605081413,1.0,12/22,33.10%,HTR2C;HTR4;CHRM3;HTR2B;CHRM2;CHRM1;HRH1;HTR1B;HTR1F;HTR1A;HRH3;HTR1D
prerank,Toll-like receptor binding (GO:0035325),-0.46183899497284786,-1.1933157510751269,0.22826086956521738,0.5506996793903033,1.0,6/11,29.66%,TOLLIP;UNC93B1;MYD88;CD36;TLR6;TLR2
prerank,myosin II binding (GO:0045159),0.5916253566300976,1.193234861295489,0.2582972582972583,0.7569966260385003,1.0,3/10,12.58%,GSN;LLGL1;STXBP5
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.4003986108494058,1.1925805800610976,0.10261569416498995,0.7547671213776352,1.0,58/254,20.04%,PLAGL1;ESR1;SIX1;PRRX1;HOXA5;NFIB;ELF4;NFIA;GLIS2;NFAT5;ELF1;HOXB3;ONECUT2;MEOX2;KLF5;STAT3;ATF4;GMEB1;FOXC2;RXRB;SMAD4;MEF2B;E2F3;MEIS3;MDM4;SOX9;FOXJ3;ESRRB;ZNF76;NFATC1;FOXA1;UBP1;PRDM4;EHF;RFX5;NRF1;SRF;ZNF112;MEF2A;RUNX1;NFATC3;TFDP1;GRHL1;FOXO3;CREB1;PRDM2;NFKB2;NR3C1;RFXANK;E4F1;ATF2;KLF10;HOXB2;FOSL2;IRF3;VEZF1;TCF3;ATF6
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),0.5891186356170686,1.1918846533145957,0.28023598820059,0.7526101991657951,1.0,4/10,12.08%,RIOX2;KDM2A;PHF8;KDM4A
prerank,transcription coregulator binding (GO:0001221),0.4497817527004246,1.1863103766882712,0.22857142857142856,0.7665726120038583,1.0,17/50,20.17%,ESR1;CIT;PHF1;PER3;SMAD4;EHMT1;RORA;CCNT2;TERT;MED25;USP11;PER1;HDAC6;LCOR;THAP7;TEAD2;CHD6
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.3913462087509722,1.1841465654956898,0.011,0.7696521965477515,1.0,138/831,13.91%,TBX15;FOXP2;PLAGL1;ESR1;SIX1;FOXP1;KLF12;ZBTB7C;PRRX1;ZFHX3;HOXA5;HIVEP3;PBX3;NFIX;HOXA3;ZNF423;FOXD1;NFIB;SKIL;TCF7L2;RARB;TWIST2;ELF4;HOXB6;MKX;SMAD9;NFIA;ZIM3;MUC1;ZFHX4;PRRX2;JDP2;GLI2;PRDM5;DMTF1;GLIS2;TWIST1;HOXC6;DEAF1;LHX9;CUX1;NFAT5;HDAC4;STAT5A;SIX5;ELF1;HOXB3;RXRA;ONECUT2;MEOX2;HES5;KLF5;SIX4;STAT3;ZBTB25;TCF7L1;ZNF250;ATF4;ZFP14;NR2F1;TCFL5;GMEB1;FOXC2;ZNF25;RXRB;NFX1;NFXL1;SAFB;SMAD4;NFE2L2;BHLHE40;PKNOX2;MEF2B;ZNF471;RFX7;E2F3;PBX1;MEIS3;SKI;ZNF691;HEYL;TBX21;THRAP3;SOX9;HOXA9;HOXA6;PURG;IKZF3;NRIP1;RARA;NSD1;FOXJ3;ESRRB;TFE3;FOXK1;ZNF76;NFATC1;FOXL1;RFX2;ZIC1;RORA;FOXA1;ZBTB2;UBP1;ZFP90;PRDM4;SREBF1;EHF;RUNX2;ZNF260;FOXM1;ZIC4;RFX5;POU6F1;NFE2L1;NRF1;HSF4;MAZ;NEUROD2;FOXO6;FOXP4;SRF;NR1D2;HEY1;GLIS1;ZNF112;HDAC1;MEF2D;HOXB4;ZNF740;MYPOP;NPAS1;MEF2A;NACC1;RUNX1;NFATC3;ZBTB9;HOXA4
prerank,protein serine/threonine kinase activity (GO:0004674),0.39599457711700775,1.1838145125703547,0.08508508508508508,0.7663022137305747,1.0,125/335,24.82%,EGFR;PRKCD;CIT;ULK2;CLK1;MARK1;PRKCE;ACVR1B;MAPK15;CAMKK1;CLK3;CSNK1D;CAMK2D;MAP3K5;CSNK2A2;CSNK2A1;LIMK2;FASTK;PRKCA;DYRK4;NRBP2;ACVR1;BRD4;ILK;NEK7;PRKDC;ERN2;TGFBR2;TLK1;STK39;BCR;IRAK3;CDK10;RAF1;RPS6KA4;PAK4;AKT2;KALRN;CDK12;PKN2;PAK2;MAPK8;SMG1;CSNK1G1;CHUK;RIOK1;RIPK3;ALPK1;IRAK1;MAP4K5;MAP3K12;ATM;BMPR1A;CHEK2;MAPK12;PDPK1;GRK6;NRBP1;UHMK1;CSNK1E;TGFBR1;CLK4;STK19;MAP3K10;DMPK;MARK4;WNK1;SRPK1;SQSTM1;BRD2;LATS2;CAMK4;CDC42BPB;TLK2;TRIO;TP53RK;STK16;MKNK2;SIK2;DAPK3;ARAF;BCKDK;VRK2;CLK2;CDK20;MAST2;CDKL2;AKT1;HIPK2;CDK2;IKBKE;STK35;CDK5;EIF2AK4;SGK3;MAPK9;PRKACA;VRK3;MOK;NEK4;LRRK2;CSNK1G3;MAST4;CAMK1;CDKL3;STK38;EIF2AK3;MAP3K14;PRKCI;TOP1;FAM20A;PDIK1L;NEK8;HIPK4;PLK4;TAOK3;RPS6KA2;RPS6KB1;TAF1;TBK1;ROCK1;PINK1;LMTK2;CDK13;TAOK2
prerank,voltage-gated potassium channel activity (GO:0005249),0.4281616067753987,1.1836093221465134,0.19368879216539717,0.7626057935917211,1.0,9/80,9.13%,KCNJ2;KCNJ15;KCNB1;HCN4;KCNN1;KCNE5;KCNIP2;KCND1;KCNK6
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.3999584791539602,1.1827662861171717,0.12550607287449392,0.7612255631351996,1.0,35/181,14.16%,ID2;PRRX1;ZFPM2;TCF7L2;LDB2;LDB1;MDFIC;NCOR2;HDAC4;RXRA;BAZ2A;STAT3;ANXA4;ATF4;BCAS3;TACC2;DACT1;NFE2L2;BHLHE40;JUP;NRIP1;CDK5RAP3;NFATC1;WWP2;RBBP8;MIER2;ATN1;RNF25;COMMD7;TAF6;HDAC1;PSMA6;BBS5;MEF2A;PIAS4
prerank,cGMP binding (GO:0030553),0.5728988628431099,1.1810493574361096,0.27887323943661974,0.7630119006014995,1.0,1/11,0.87%,PDE11A
prerank,nuclease activity (GO:0004518),0.44805368109269533,1.1807765650940554,0.23542600896860988,0.7595636702922642,1.0,15/52,18.11%,N4BP2;RNASE7;ERN2;RNASE3;ERCC5;RNASE6;OGG1;WRN;DIS3L2;REXO1;SND1;N4BP1;AEN;DIS3;DFFB
prerank,ion channel activity (GO:0005216),0.43052289577118236,1.1805198728318596,0.21566523605150215,0.7561320492926483,1.0,11/80,8.86%,PIEZO2;GRIK4;GRIN3A;TRPV3;CHRNB2;CALHM6;TMC8;CALHM5;TRPM7;CHRNA5;TRPM4
prerank,GTP binding (GO:0005525),0.4073922946696692,1.1795660388530502,0.16177957532861476,0.75514349323748,1.0,28/172,11.33%,RHOJ;RHOBTB1;RHOQ;MRAS;TUBG2;RND3;GNL3;ATL2;TSR1;RAB2A;DNM2;GNL1;RAB21;ATL3;GNL2;RABL6;RAB8A;RHOT2;ARF4;GBP6;NOA1;RHOA;RHOT1;RRAD;PIP4K2B;ARFIP2;RAB38;ARF1
prerank,poly(U) RNA binding (GO:0008266),0.5106904969524568,1.1788262451088685,0.251604621309371,0.7532520592141159,1.0,8/20,13.79%,HNRNPH1;PABPC1;SSB;DAZAP1;DIS3L2;PATL1;KHDRBS1;HNRNPC
prerank,omega peptidase activity (GO:0008242),0.4183887566349804,1.1764194382170228,0.20569620253164558,0.7569160327018494,1.0,49/89,30.64%,USP24;USP2;OTUB1;USP50;USP40;UCHL3;USP48;USP45;OTUB2;USP34;USP11;TANK;USP7;USP33;USP36;USP13;USP19;USP35;PSMD14;OTUD5;OTULIN;YOD1;USP32;USP10;USP46;USP1;UCHL5;ZRANB1;MPND;OTUD6B;UCHL1;BRCC3;USP5;USP47;DESI2;CYLD;USP4;USP49;USP14;MYSM1;USP21;USP16;USP22;USP37;USP30;OTUD3;ASRGL1;USP26;COPS5
prerank,secondary active transmembrane transporter activity (GO:0015291),0.44449775612616166,1.1759989955658525,0.24188129899216126,0.7542021821597602,1.0,9/51,12.45%,SLC4A4;SLC5A6;SLCO3A1;SLCO2A1;MCU;SLC28A2;CLCN4;SLC25A3;SLC35E1
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),-0.3746374340276992,-1.1748205169003572,0.22685185185185186,0.5825006009704888,1.0,8/22,21.99%,DUSP16;DUSP10;DUSP3;MTMR3;DUSP6;DUSP15;DUSP4;CDKN3
prerank,kinase binding (GO:0019900),0.39378684885673426,1.1746550783564405,0.056,0.7543061357441327,1.0,110/434,20.23%,ESR1;EGFR;PKD1;PRKCD;SLC12A7;RHOBTB1;CIT;SLC12A2;TCF7L2;TTC28;GSN;SRCIN1;CNTLN;TIAM1;DLG2;GHR;RND3;PPP1CC;SHC1;SPRED2;STRADA;CARD16;STAT3;CD3E;CSPG4;NISCH;ATF4;TAX1BP1;NBEA;AP2A1;CALM2;MAVS;DVL1;TOM1L1;ILK;PRAM1;ADAM10;ANKRA2;ANK2;IRAK3;SKI;LLGL1;SLC12A4;DLG4;TRIM27;FZD5;LAPTM4B;RBBP6;CDC6;CDK5RAP3;DGKQ;DLG1;TSKS;RHOA;DCTN2;NSF;PAK2;CDC25B;FOXM1;IRAK1;MAP3K12;TELO2;AXIN1;CHEK2;RCC2;CHP1;PTPN2;AP2A2;MAPRE3;SNAP91;CASP1;WNK1;UBQLN1;CLTC;SQSTM1;ACSL3;PRDX3;RHOB;CAMK2N1;PER1;STX1A;STUB1;IQGAP1;FOXO3;GSKIP;PIP5K1A;PARP1;TPRKB;CDC25A;CALM3;UFL1;NR3C1;PRKAG1;TRIM6;VRK2;CNOT9;SUFU;RB1CC1;LRRC14;ATF2;CRK;CKS1B;PEBP1;PTPN23;WWC2;PRKAB1;TRIP6;MAP2K3;MAPKAP1;DCTN1
prerank,GTPase activity (GO:0003924),0.4021758738886904,1.1724548496377072,0.15501519756838905,0.7572836630434193,1.0,47/192,21.87%,GNAS;RHOJ;RHOBTB1;RHOQ;MRAS;RND3;ATL2;GNG8;TSR1;RAB2A;RAB43;RAB24;DNM2;GNL1;RAB21;ATL3;GNL2;RAB8A;RHOT2;TBC1D24;GBP6;GSPT1;RHOA;RHOT1;RAB38;RAB11B;ARL2;GNAO1;RAB23;RHOB;GNA11;RAB3B;RASL12;GPN3;NKIRAS1;EFL1;RAB5B;DRG2;RHEB;ENTPD7;GNB1;RAB4A;ATL1;LRRK2;RAB1A;RAB18;MFN1
prerank,calcium ion binding (GO:0005509),0.3942030752649057,1.1712789604852116,0.09018036072144289,0.7570663493952708,1.0,58/323,16.03%,THBS1;SLIT3;SLIT2;SMOC2;SLIT1;CDH11;LRP1;GSN;PLA2G4F;ACER3;PLA2G4A;COLEC11;SYT8;DMP1;COMP;CALML4;CRACR2A;ANXA7;NOL3;SPARC;ANXA2;ANXA4;C2CD5;PITPNM1;DSG3;CALM2;THBS3;S100A10;TKT;ARSA;KCNIP2;S100B;TRPM4;STIM1;PGS1;CALU;ANXA1;PLA2G5;RCN1;HSPA5;AOC3;CHP1;MICU2;LETM1;LRP2;S100A1;DCHS1;NUCB1;SRR;MICU1;SCIN;CALB2;NCS1;PKD2L1;IQGAP1;TCHH;PLSCR3;GALNT3
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),0.5044267417353478,1.1697080529388806,0.2870493991989319,0.7577622334786532,1.0,2/19,5.17%,GRIK4;GABRA3
prerank,core promoter sequence-specific DNA binding (GO:0001046),0.457484510669255,1.1690764653331713,0.2548076923076923,0.755938132608634,1.0,15/35,27.07%,FOXP1;BAZ2A;AGO1;HDAC1;AGO2;NR3C1;KLF10;TAF1C;TBP;FOS;TAF1;TP53;SMARCA4;H3-3A;UBTF
prerank,nuclear receptor binding (GO:0016922),0.40239232455872725,1.1672868856537346,0.20920502092050208,0.7576647699968155,1.0,29/111,20.36%,ESR1;FOXP1;TCF7L2;DDX5;NCOR2;JMJD1C;RXRA;BAZ2A;BCAS3;TACC2;THRAP3;JUP;NRIP1;NSD1;MED13;RNF14;MED25;TGFB1I1;DCAF13;MMS19;DNAAF4;MED14;LCOR;HMGA1;MED12;CCDC62;BRD8;TRIP6;CALR
prerank,lipoprotein particle binding (GO:0071813),0.5000551253141651,1.1664423382989775,0.26390685640362227,0.7564546149741497,1.0,1/20,0.08%,THBS1
prerank,cysteine-type peptidase activity (GO:0008234),0.420803542360782,1.1661835031754557,0.24212812160694897,0.753401249405361,1.0,37/73,30.40%,USP24;USP2;USP50;CAPN2;USP40;PDIA3;USP48;USP34;USP11;USP7;CASP1;USP33;USP36;USP13;USP35;OTULIN;USP10;USP46;USP1;CTSZ;UCHL1;USP5;CTSB;USP47;CTSK;CTSO;USP49;USP14;USP21;USP16;USP37;USP30;ATG4A;CASP2;BLMH;CASP6;USP26
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.5108277485433665,1.165960210324,0.27989821882951654,0.7501477879815586,1.0,15/20,34.79%,OTUB1;USP50;SENP5;USP7;OTUD5;YOD1;SENP1;USP47;DESI2;SENP3;USP21;COPS5;USP9X;COPS2;USP25
prerank,lipase activator activity (GO:0060229),-0.4584109902216994,-1.1651832769962644,0.25391849529780564,0.5949341931673215,1.0,1/10,0.73%,ARHGAP6
prerank,mRNA binding (GO:0003729),0.39099498151612677,1.164232860018257,0.14814814814814814,0.7519917369119892,1.0,94/249,25.08%,SRSF6;DDX5;YBX3;GNL3;LUC7L2;SRSF1;PABPC1;ARC;SAMD4A;SRSF5;HDLBP;RBFOX2;CELF4;EIF4G2;SNRNP70;SSB;PUM1;CRYZ;PPP1R8;HNRNPA2B1;EIF4G3;RBM47;ACO1;CELF3;LUC7L;LUC7L3;ZC3H12D;HNRNPL;SF3B1;RBM25;PCBP4;MYEF2;ZC3H11A;DAZAP1;AUH;RBM5;ZC3H12C;FUBP1;EIF4A1;MARF1;KHDRBS1;AGO2;EIF4G1;HNRNPM;PCBP2;PTBP1;RBM4;HNRNPC;ETF1;G3BP2;EIF2S2;HNRNPK;YTHDC1;NCBP3;IREB2;THOC2;FYTTD1;N4BP1;PCF11;EIF3D;EIF3A;RC3H2;NCBP1;SLC4A1AP;SHMT2;SECISBP2;KHNYN;AQR;CPSF6;NCBP2;SHMT1;SYNCRIP;CLUH;CSTF2;TRA2B;UNK;CALR;CIRBP;EIF2A;CSTF2T;FXR2;SRSF4;SHFL;RNF20;DCP1A;SF3B6;HNRNPU;SF1;TP53;RBM24;PABPC4;UPF3B;C1QBP;SNRNP35
prerank,phospholipase activity (GO:0004620),0.425139189682908,1.1640024661034396,0.23314917127071824,0.748866055023122,1.0,15/67,20.25%,MGLL;PLCE1;PLA2G4F;PLA2G4A;SMPD4;SMPDL3A;PDIA3;ABHD6;PLA2G12A;PNPLA3;GDPD3;PLA2G15;PNPLA7;SEC23IP;PLCB2
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.530359101264723,1.1637342475701224,0.29347826086956524,0.7458944524374258,1.0,6/14,21.74%,RSAD1;ACO1;ETFDH;ISCA2;IREB2;ISCU
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),0.4907999341268384,1.1631258365802517,0.28735632183908044,0.7439787389958997,1.0,9/22,25.07%,ATP6V1C2;TCIRG1;ATP6V0A1;ATP6V0D1;ATP6V1B2;ATP6V1E1;ATP6V1C1;ATP6V0E1;ATP6V0B
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.5329643493850873,1.1592606387977058,0.31107954545454547,0.7528120474846773,1.0,4/14,21.78%,AK5;DTYMK;AK1;NME3
prerank,zinc ion transmembrane transporter activity (GO:0005385),0.4997075279052174,1.158390614287702,0.2952503209242619,0.7516106688645402,1.0,5/20,9.85%,SLC39A14;SLC39A11;SLC39A7;SLC30A5;SLC39A13
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),-0.3993950204212076,-1.1549684933186777,0.25,0.6087504156368259,1.0,3/18,1.02%,TGFBR3;ENG;LTBP1
prerank,ionotropic glutamate receptor activity (GO:0004970),0.5178596069980983,1.1542973653442585,0.2924281984334204,0.7606843385554354,1.0,2/17,2.49%,GRIK4;GRIN3A
prerank,growth factor activity (GO:0008083),0.4173307570010875,1.152162460518326,0.255047821466525,0.7637617600799066,1.0,5/74,2.08%,PGF;VEGFA;FGF2;OSGIN2;FGF17
prerank,heparan sulfate sulfotransferase activity (GO:0034483),-0.42818817097682466,-1.1514472760385852,0.3108108108108108,0.6073627033420471,1.0,5/15,9.31%,HS3ST3A1;NDST3;NDST4;NDST1;HS6ST3
prerank,DNA-binding transcription factor binding (GO:0140297),0.38960249441315187,1.1503121559521303,0.18346774193548387,0.7661583068106033,1.0,58/189,25.08%,ID2;PRRX1;ZFPM2;TCF7L2;LDB2;LDB1;PRDM5;TWIST1;TLE2;HDAC9;HDAC4;STAT3;ATF4;TLE6;DACT1;NFE2L2;BHLHE40;HMGB1;SKI;DGKQ;NFATC1;WWP2;TLE3;RBBP8;MIER2;ATN1;SRF;HDAC1;MEF2D;BBS5;MEF2A;MAP3K10;PIAS4;PSMC5;CRTC2;CREB1;CREBBP;RBL2;MTA3;CBX5;DAPK3;HCFC1;ATF2;HIPK2;TCF3;NOC2L;MAD2L2;MIER1;TBP;TXLNG;FOS;TAF1;TP53;CHD4;CRTC1;NCOR1;HDAC2;BBS7
prerank,protein kinase C activity (GO:0004697),0.5297800063612397,1.150238161887162,0.3181818181818182,0.7625670965252033,1.0,4/14,9.99%,PRKCD;PRKCE;PRKCA;SMG1
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),0.47785940578705943,1.14944753635481,0.2905982905982906,0.7612057516607094,1.0,4/26,2.98%,SLC5A6;SLC16A9;SLC16A1;SLC26A6
prerank,sodium channel regulator activity (GO:0017080),0.45661121527294724,1.1490130941055463,0.2825322391559203,0.7589213403949977,1.0,6/37,7.38%,FGF13;FXYD5;NEDD4;PTPN3;CAMK2D;SNTA1
prerank,NADP binding (GO:0050661),0.4719238335058716,1.1485010788662702,0.30666666666666664,0.7568669480519503,1.0,8/32,16.23%,ME1;GMDS;CRYZ;MTRR;CBR4;NNT;CAT;PGD
prerank,filamin binding (GO:0031005),-0.4444484977276293,-1.1469330377775966,0.2819548872180451,0.6079881150359941,1.0,6/11,13.26%,NEBL;SYNPO2;RFLNA;CEACAM1;FBLIM1;RFLNB
prerank,N-methyltransferase activity (GO:0008170),0.5029992649304916,1.1442653563102465,0.3166458072590738,0.7663739259049235,1.0,10/20,29.91%,PEMT;NNMT;TRMT1;HNMT;GNMT;TFB2M;PRMT1;RNMT;TRMT1L;METTL15
prerank,phospholipase inhibitor activity (GO:0004859),0.5727247505131137,1.1438257997353385,0.314410480349345,0.7639399031373983,1.0,3/10,9.69%,ANXA2;ANXA4;ANXA1
prerank,carbohydrate kinase activity (GO:0019200),-0.4471467053431719,-1.1437943643979558,0.2881944444444444,0.6058604785005193,1.0,5/11,21.65%,HK2;GALK2;FGGY;XYLB;KHK
prerank,neurexin family protein binding (GO:0042043),0.5585482312879537,1.1393141769289719,0.3181818181818182,0.7750434191861372,1.0,4/10,17.29%,CEL;SYTL5;NLGN1;SYTL4
prerank,alpha-actinin binding (GO:0051393),0.4751505057279093,1.138446006375874,0.32697201017811706,0.7742106889764846,1.0,4/24,8.22%,CACNA1C;PDLIM7;RARA;PALLD
prerank,DNA replication origin binding (GO:0003688),0.47722645913377343,1.1357397790709114,0.306282722513089,0.7792770810449173,1.0,8/23,20.42%,MCMDC2;MCM2;CDC6;CDC45;HSPD1;MCM4;ORC2;KAT7
prerank,hexose transmembrane transporter activity (GO:0015149),-0.4357149451194066,-1.1340364518817478,0.3435374149659864,0.619898073473574,1.0,5/12,25.55%,SLC2A1;SLC5A3;SLC2A4;SLC2A3;MFSD4A
prerank,acid-thiol ligase activity (GO:0016878),-0.42645935620452335,-1.1328272130238781,0.3155893536121673,0.6137507418906973,1.0,3/13,5.77%,ACSS3;ACSL1;ACSS2
prerank,solute:proton symporter activity (GO:0015295),0.512685788408195,1.1321417700453422,0.3195739014647137,0.7870719861361449,1.0,5/16,17.10%,SLC2A13;SLC2A9;SLC25A3;SLC17A5;SLC2A10
prerank,FAD binding (GO:0071949),0.4722063986838426,1.129993782715862,0.30407911001236093,0.7901667695266433,1.0,8/24,21.85%,MICAL2;QSOX1;MTRR;AIFM1;AGPS;DAO;MTHFR;CRY2
prerank,phosphatidate phosphatase activity (GO:0008195),0.5347556526241084,1.1288235963809528,0.32348993288590605,0.7903331089843367,1.0,3/13,6.18%,PLPP3;PLPP5;PLPP1
prerank,copper ion binding (GO:0005507),-0.31704412207702315,-1.1279321754217755,0.2708333333333333,0.6155569383675445,1.0,11/42,18.03%,PAM;MOXD1;SOD3;LACC1;LOXL3;SUMF1;CUTA;SNCA;S100A13;ATP13A2;MT3
prerank,poly-purine tract binding (GO:0070717),-0.3488185224946468,-1.123485865670824,0.29081632653061223,0.6172164583366263,1.0,9/27,14.43%,RBPMS;RBMS1;RBMS3;ELAVL4;DDX3X;ATXN1;MCRS1;PABPC4L;KHDRBS2
prerank,calcium-dependent phospholipid binding (GO:0005544),0.4234411305049371,1.1231037026900472,0.31014823261117447,0.805120293947986,1.0,6/49,4.37%,PLA2G4F;PLA2G4A;SYT8;ANXA2;ANXA4;C2CD5
prerank,hydro-lyase activity (GO:0016836),0.4300191959741854,1.1220584936291886,0.3099885189437428,0.8046720712245072,1.0,14/41,24.87%,EHHADH;ECHDC2;GMDS;ACO1;AUH;IREB2;ENO2;L3HYPDH;CDYL;UROS;ECHDC1;HADHA;PCBD2;ENO4
prerank,Lys48-specific deubiquitinase activity (GO:1990380),0.5290426454860916,1.121037119180853,0.3647711511789182,0.8041180644285143,1.0,6/14,22.24%,MINDY4;USP7;USP13;OTUD5;YOD1;DESI2
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),0.5370963973068076,1.1183141358713589,0.35382513661202186,0.8091873404728659,1.0,2/11,8.42%,CHRNB2;CHRNA5
prerank,guanyl ribonucleotide binding (GO:0032561),0.3840955622115045,1.116743244891425,0.25100806451612906,0.8105013894746436,1.0,29/196,11.33%,RHOJ;RHOBTB1;PDE11A;RHOQ;MRAS;TUBG2;RND3;GNL3;ATL2;TSR1;RAB2A;DNM2;GNL1;RAB21;ATL3;GNL2;RABL6;RAB8A;RHOT2;ARF4;GBP6;NOA1;RHOA;RHOT1;RRAD;PIP4K2B;ARFIP2;RAB38;ARF1
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),-0.4020299550633458,-1.1155077814185488,0.3235294117647059,0.6276019803041014,1.0,7/16,16.41%,SLC13A3;SLC25A13;SLC1A1;SLC38A7;SLC25A14;SLC13A5;SLC25A30
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.4049552323982382,1.1153595395984204,0.3236870310825295,0.8114645065326342,1.0,11/72,7.65%,KCNJ2;GSN;PLEKHA4;MARK1;VILL;ANXA2;SNX18;PFN2;FZD7;SLC9A1;FCHO2
prerank,metalloendopeptidase inhibitor activity (GO:0008191),0.5090355120048106,1.1150831439694693,0.32689655172413795,0.8086227515635337,1.0,3/14,2.67%,TIMP2;TIMP3;RARRES1
prerank,carboxylic acid binding (GO:0031406),0.446511470544754,1.1146927295747204,0.3267211201866978,0.8061963538044282,1.0,15/38,20.40%,GCLC;GRIN3A;SESN3;EPDR1;CASTOR2;AKR1C1;SESN2;SRR;SHMT2;GNMT;CAD;SHMT1;UBR2;PHYH;GLRB
prerank,lysine N-methyltransferase activity (GO:0016278),0.4821180682409123,1.1121615134668388,0.3383647798742138,0.810593323163646,1.0,9/20,26.50%,EEF1AKMT3;KMT5A;EHMT1;EEF1AKMT2;SETD4;SETD2;SMYD2;EHMT2;SETD7
prerank,NF-kappaB binding (GO:0051059),0.4636811583933913,1.10772135483278,0.35331632653061223,0.8208917440318545,1.0,6/24,12.75%,ANXA4;CDK5RAP3;RNF25;COMMD7;HDAC1;PSMA6
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),0.5213175004203481,1.1036148965339654,0.36363636363636365,0.8304617480033764,1.0,4/12,13.22%,JMJD1C;PHF8;KDM4A;HR
prerank,transforming growth factor beta receptor binding (GO:0005160),0.48626487546812264,1.1017679440877508,0.3592105263157895,0.8324840444058534,1.0,7/18,12.60%,INHBC;SMAD6;TGFB3;TGFB2;TGFBR2;SMAD7;TGFBR1
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.4196642779943191,1.0967251937510436,0.36624569460390355,0.8450300631103416,1.0,14/46,26.08%,EXT1;B3GNT7;OGT;MGAT4B;HEXA;B3GNT9;B4GAT1;B3GNT6;EXT2;GCNT7;B3GNT2;PIGQ;MGAT5;RFNG
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.389820689892028,1.0918739338622707,0.3358050847457627,0.8565410719774855,1.0,15/91,9.25%,KCNJ2;GSN;PLEKHA4;MARK1;VILL;ANXA2;SNX18;PFN2;FZD7;SLC9A1;GBF1;WIPI2;FCHO2;LAPTM4B;SH3PXD2B
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.40379114035452895,1.0908767000902782,0.34350282485875705,0.8559267088328093,1.0,21/54,26.34%,ACER3;HDAC9;HDAC4;SIRT5;PM20D2;NTAN1;MIER2;HDAC1;PIGL;NGLY1;SIRT2;HDAC6;NTAQ1;ASAH1;DARS1;HINT3;MIER1;VNN1;HDAC2;SUDS3;FAAH
prerank,metal ion binding (GO:0046872),0.3632860834300496,1.0887322044701895,0.2182182182182182,0.8591281329662719,1.0,82/477,16.03%,THBS1;SLIT3;SLIT2;SMOC2;SLIT1;CDH11;LRP1;EYA2;GSN;PLA2G4F;GCLC;ACER3;PLA2G4A;COLEC11;SYT8;MARK1;DMP1;COMP;CALML4;CRACR2A;ANXA7;NOL3;SPARC;MAP3K5;ANXA2;ANXA4;C2CD5;PITPNM1;DSG3;ADCY2;CALM2;THBS3;S100A10;ERN2;TKT;ARSA;KCNIP2;IRAK3;TRIM27;S100B;DCTPP1;TRPM4;STIM1;PGS1;CALU;ANXA1;WRN;HMGCL;PLA2G5;PPA2;SNN;RCN1;ABL1;DIS3L2;TDG;MAPK12;HSPA5;CLYBL;AOC3;MTHFD2;CHP1;MICU2;LETM1;LRP2;S100A1;DCHS1;PI4K2A;NUCB1;TRIM26;SRR;SRPK1;MICU1;SCIN;CALB2;NCS1;PKD2L1;IQGAP1;TCHH;HACL1;CDC42BPB;PLSCR3;GALNT3
prerank,cytochrome-c oxidase activity (GO:0004129),-0.3952726996609377,-1.0885760512514868,0.32706766917293234,0.6824189470560957,1.0,6/15,24.19%,COX8A;COX4I1;COX10;COX5B;NDUFA4L2;NDUFA4
prerank,protein phosphatase binding (GO:0019903),0.382041799670816,1.0871955588974065,0.3267838676318511,0.8604993465514996,1.0,41/117,24.97%,EGFR;GRIN3A;PPP1R3C;ANAPC5;PPP1R9B;MAP3K5;STAT3;VCP;ADCY8;SLC9A1;STRN4;JUP;DLG4;PPP6R1;PPP6R3;PPP1R3F;GTF2F1;SHOC2;SOD1;ANAPC4;TRAF3;ARPP19;IQGAP1;ERBB2;KCNN4;CDC27;IKBKE;ATP2B4;AKAP11;VRK3;MAP2K7;JAK1;EIF2AK3;PPP1R3B;BOD1L1;PXN;TP53;SNX3;BAD;TBK1;AP3B1
prerank,protein homodimerization activity (GO:0042803),0.3609658563681225,1.0857293233021474,0.203,0.8614389405146693,1.0,158/589,22.79%,PRPS2;SLIT2;FOXP2;LRP6;EXT1;MGLL;PRMT8;VEGFA;ABCD3;SRGAP2;NPR3;ECE1;NTRK1;GHR;LDB1;PEX7;AOX1;PSMD7;GALE;CAMK2D;GOLGA5;FAP;MAP3K5;SNX2;TGFB2;STAT3;XDH;MID1;NECTIN3;PEX11A;HM13;TMEM266;STARD3NL;ADCY8;ACVR1;CPQ;S100A10;SMAD4;NAA60;ADAM10;KLHL7;BHLHE40;TKT;PRKRA;FGFR1;IRAK3;JUP;MUC13;TRIM27;XPNPEP1;IKZF3;S100B;NFS1;ERCC5;NOG;TIMM9;EEA1;ST3GAL2;SNX1;FGFR2;WRN;SLC39A13;PIP4K2B;MYOM3;ATIC;CHUK;CCDC66;IRAK1;MAP3K12;TDG;TERT;BCL2L2;NRF1;BMPR1A;AXIN1;CHEK2;SNX9;SFPQ;DGCR8;DARS2;SRF;MID2;NRBP1;TENM1;CIDEA;STK25;S100A1;ADD1;PAFAH1B2;ERP29;ALDH3A2;SRM;MAP3K10;UBA5;NDP;SUPV3L1;GUCY2D;SRR;CARNMT1;DCLRE1B;HPS4;CAT;GRHL1;STUB1;CRYL1;WDR54;GSTZ1;NECTIN1;IDE;FECH;HIP1;YARS2;ACP3;SHMT2;DNTTIP1;HMOX1;EPRS1;DAPK3;COQ9;GLB1;TRIM6;KIF20B;CNOT9;SHMT1;AOC1;AKT1;GDNF;ACSL6;EXT2;PAFAH1B3;PHETA2;SARS1;MLXIPL;IRF3;TCF3;DPY30;APPL2;APPL1;MTMR1;CHMP4A;CHMP4B;KYAT1;TPD52;PDCD6IP;FBLN5;LRRK2;PANK3;FXR2;SMIM1;STARD3;ABCD1;TRIM8;ASMT;ABCG2;KMT2A;SLC11A1;TSC2;TMEM192
prerank,acetyltransferase activity (GO:0016407),0.439289495459305,1.0831384133885384,0.36496350364963503,0.8662421778024734,1.0,12/31,26.59%,SAT2;KAT6B;NAA16;ACAT1;PAFAH1B2;CREBBP;PAFAH1B3;ELP3;KAT8;KAT2B;NAA15;ESCO1
prerank,telomeric DNA binding (GO:0042162),0.4329308523305907,1.0826749363039803,0.3647342995169082,0.8641429672838237,1.0,11/32,22.90%,HNRNPA2B1;SMG6;WRN;SMG1;TERT;TELO2;TEN1;RAD50;XRCC6;UPF1;UPF3A
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),0.43172866456039627,1.0801783899549644,0.38259833134684146,0.8681789271060334,1.0,10/32,23.68%,FTO;RIOX2;KDM2A;PHF8;KDM4A;ALKBH1;HSPBAP1;TET2;PHYH;ALKBH3
prerank,Hsp70 protein binding (GO:0030544),0.44122624151842804,1.0780943461958061,0.3774271844660194,0.8710185956394606,1.0,15/31,30.98%,SPN;DNAJB14;HIKESHI;PPEF2;STUB1;DNAJC18;DNAJA1;DNAJC2;RNF207;DNAJB12;PPID;ERN1;DNAJB1;PRKN;GPR37
prerank,CoA-ligase activity (GO:0016405),-0.3919560622020277,-1.0763423738014006,0.36329588014981273,0.7041525264322954,1.0,3/14,5.77%,ACSS3;ACSL1;ACSS2
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.4268283427183141,1.0759893094701494,0.3847953216374269,0.873867628725848,1.0,15/34,31.18%,EEF1AKMT3;KMT5A;EHMT1;EEF1AKMT2;SETDB1;SETD4;MEN1;SUV39H1;SETD2;SMYD2;EHMT2;SETD7;NSD3;TTLL12;EEF2KMT
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),0.5322112235616101,1.0750769522308774,0.37677053824362605,0.8729319844564992,1.0,3/10,12.36%,PIK3C2B;ATM;PIK3CB
prerank,G protein-coupled photoreceptor activity (GO:0008020),0.5052668829528988,1.0738815567361808,0.3873239436619718,0.8732053551317271,1.0,5/12,27.17%,OPN1MW;OPN1MW3;OPN3;RRH;GPR52
prerank,disordered domain specific binding (GO:0097718),0.4594635912964217,1.072851009511592,0.39158163265306123,0.8729632348403839,1.0,7/23,19.35%,HSPA2;CALM2;BCL2L2;CLTC;CALM3;DFFB;TEAD2
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.36128135101735026,1.0723125936478526,0.32222222222222224,0.8708973858974357,1.0,25/188,9.84%,BNC2;SIX1;TCF7L2;VSX1;SMAD6;PRDM5;DMTF1;GLIS2;HDAC4;RXRA;STAT3;ATF4;CHD3;FOXC2;PER3;SMAD4;NFE2L2;HMGB1;PBX1;TBX21;TFE3;FOXK1;CARM1;HNRNPL;FOXA1
prerank,ADP binding (GO:0043531),0.44086428615855855,1.0718572838631681,0.37358490566037733,0.8687707731262844,1.0,2/25,1.56%,ME1;GCLC
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),0.49787566506822534,1.0713723598139344,0.4056987788331072,0.8666863314372975,1.0,5/13,27.51%,TARBP1;TRMT1;THUMPD3;METTL1;TRMT1L
prerank,NADPH binding (GO:0070402),0.5076802147576001,1.06969383880588,0.3915989159891599,0.8681317436319869,1.0,3/13,10.36%,CRYZ;MTRR;CBR4
prerank,voltage-gated calcium channel activity (GO:0005245),0.42134868628460964,1.0686145978198998,0.39227166276346603,0.8677330767295787,1.0,6/37,11.23%,CACNA1G;CACNA1C;CACHD1;CATSPER3;ITGAV;CACNA2D2
prerank,3'-5' exonuclease activity (GO:0008408),0.4114327079880391,1.0681044616031323,0.38351648351648354,0.8658884344956936,1.0,10/45,17.06%,REV3L;ERI3;REXO2;RAD1;WRN;DIS3L2;RAD50;EXOSC4;CNOT8;DIS3
prerank,phosphatase binding (GO:0019902),0.37638723021470144,1.0648033181977508,0.384297520661157,0.8725298581041782,1.0,39/105,24.97%,EGFR;PPP1R3C;ANAPC5;MAP3K5;STAT3;SFI1;VCP;JUP;DLG4;TRPC4AP;PPP6R1;DLG1;PPP6R3;PPP1R3F;GTF2F1;SHOC2;ANAPC4;TRAF3;WNK1;IQGAP1;ERBB2;KCNN4;CNST;MAST2;CDC27;IKBKE;RCAN3;VRK3;MAP2K7;CRY2;JAK1;EIF2AK3;TSC2;PXN;TP53;SNX3;BAD;TBK1;AP3B1
prerank,sialyltransferase activity (GO:0008373),0.4571175667541931,1.0644700889300591,0.40981432360742703,0.8700720954225531,1.0,4/20,8.59%,ST3GAL4;ST8SIA2;ST6GALNAC5;ST3GAL2
prerank,magnesium ion binding (GO:0000287),0.3690528866426927,1.0638040753880647,0.3748712667353244,0.8686311981032899,1.0,41/135,27.61%,EYA2;GCLC;MARK1;MAP3K5;ADCY2;ERN2;TKT;IRAK3;DCTPP1;WRN;HMGCL;PPA2;ABL1;DIS3L2;TDG;MAPK12;CLYBL;MTHFD2;PI4K2A;SRR;SRPK1;HACL1;CDC42BPB;PLSCR3;XYLT2;SIK2;PPA1;MAST2;RHEB;ENDOV;MAP2K7;LRRK2;STK38;PINK1;NUDT18;STK3;NIM1K;ERN1;NEK6;ADPRS;ABL2
prerank,transition metal ion binding (GO:0046914),0.3530520975370384,1.063738040567006,0.324,0.8653431289469632,1.0,113/397,24.39%,ADAMTS3;ME1;ZFPM2;TIMP2;ACER3;ECE1;SEC24D;GLI2;ADAM30;PAPPA;AOX1;SEC23A;HDAC4;RXRA;SORD;TRIM28;ADCY2;CHD3;ADA;GLO1;SIRT5;SCD5;SKI;MDM4;B4GALT1;TES;XPNPEP1;NSD1;S100B;TIMM9;EEA1;PPM1M;SMPDL3A;SLC30A5;WRN;HMGCL;KDM2A;ABL1;PHF8;TAB2;ABCE1;KDM5B;AGMO;RNF2;SOD1;AOC3;KDM4A;CHORDC1;FBXL19;SEC24C;SEC24B;QPCTL;ISCA2;MMP16;USP33;UBA5;PIAS4;RNF11;LACTB2;LNPEP;MBD1;SIRT2;GALNT1;PLSCR3;IDE;GALNT3;ZFPL1;MPPED2;KDM5C;PLA2G15;KMT2B;XYLT2;DPF3;PRDM2;SHMT2;SEC24A;EPRS1;ALKBH8;COA6;SUV39H2;CAD;SHMT1;ZMYND11;RNF7;AOC1;ZBTB32;NPEPPS;MYCBP2;TK1;LVRN;DNAJC24;TET2;CALR;IKZF4;ZDHHC20;ZKSCAN5;NEK4;ISCU;TRIM8;LOXL2;KMT2A;GPC1;GALNT2;CYLD;B4GALT7;DPEP1;CZIB;PRIMPOL;ARG2;PHEX;TP53;RASSF1;CHD4
prerank,nucleotidase activity (GO:0008252),0.4808360965897684,1.0631244446651877,0.4007936507936508,0.8638339012630417,1.0,6/15,22.69%,NT5DC3;NT5C3B;BPNT1;ACP3;NT5C;NT5DC1
prerank,syntaxin binding (GO:0019905),0.39148876833463137,1.0628795135838927,0.3916849015317287,0.8611311063276818,1.0,16/61,17.80%,SYT8;UNC13B;PRRT2;VPS52;NSF;SCFD1;ABL1;TMED9;STXBP5;PTPN2;ABCA1;SNAP23;SCFD2;STX16;VPS11;NAPA
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.5155860547442133,1.0623568205563343,0.40233236151603496,0.8592190116380451,1.0,5/10,24.16%,NSD1;ASH1L;SETD5;SETD2;SMYD2
prerank,"DNA binding, bending (GO:0008301)",0.49926234487756327,1.0612944004814833,0.4175824175824176,0.8591162010425374,1.0,3/14,8.86%,FOXD1;HMGB1;FOXL1
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),-0.4178168726397218,-1.060998257654385,0.39285714285714285,0.7346333723066645,1.0,6/11,24.15%,PPP1R1A;PPP1R2;PPP1R14C;PPP1R11;PPP1R14A;PPP1R14B
prerank,transition metal ion transmembrane transporter activity (GO:0046915),0.4253019678209502,1.0608689852593993,0.4095808383233533,0.8569780155962389,1.0,6/30,11.18%,SLC39A14;SLC39A11;SLC39A7;SLC30A5;SLC39A13;TMEM165
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.3553030419854839,1.0598385369678534,0.3486973947895792,0.8567723766220405,1.0,95/269,27.27%,EGFR;SMAD6;PRR7;ACVR1B;FHIT;GLMN;UBE2B;SNCAIP;TRIM28;MID1;HM13;VCP;USP2;CASC3;TNFRSF1B;ANKRA2;OTUB1;SKI;FAF2;SLF2;FZD5;PA2G4;LAPTM4B;CDK5RAP3;ITCH;CUL4A;LTBR;UBE2C;AXIN1;CHEK2;SNX9;SMAD7;HSPA5;KDM4A;TRAF3;CUL1;HSPD1;TANK;MC4R;PCBP2;YWHAE;USP7;SLC22A18;PIAS4;SQSTM1;PSMD1;USP13;UBE2L6;PER1;ARRB1;STUB1;CKB;HDAC6;CXCR4;UBC;RPS27A;APBB1;SUMO1;YOD1;NPLOC4;BLZF1;DNAJA1;IKBKE;NFKBIA;SCAMP3;PSMA3;UCHL1;CALR;CLU;PRKACA;PRKAR2A;UBOX5;MUL1;SLF1;SMAD5;ABI2;JAK1;SUMO2;DERL1;RNF20;TCP1;DET1;CAMLG;TP53;PINK1;UBE2W;DAXX;SMC6;SHPRH;JKAMP;RIPK1;AMBRA1;SLC25A5;RALA;NEK6
prerank,heme binding (GO:0020037),0.38718096658439594,1.0584941502801937,0.36996735582154516,0.8576151553556707,1.0,14/65,14.93%,PTGIS;CYP19A1;CYP1B1;FLVCR1;HMOX2;NOX4;HEBP1;PTGES2;RSAD1;DGCR8;SUOX;CYP2U1;ABCB6;CAT
prerank,ubiquitin protein ligase binding (GO:0031625),0.3547330741123993,1.0581368167306802,0.3557114228456914,0.8554116987379337,1.0,91/254,27.27%,EGFR;SMAD6;ACVR1B;FHIT;GLMN;UBE2B;SNCAIP;TRIM28;MID1;HM13;VCP;USP2;CASC3;TNFRSF1B;ANKRA2;OTUB1;SKI;FAF2;SLF2;FZD5;PA2G4;LAPTM4B;CUL4A;LTBR;AXIN1;CHEK2;SNX9;SMAD7;HSPA5;KDM4A;TRAF3;CUL1;HSPD1;TANK;MC4R;PCBP2;YWHAE;USP7;SLC22A18;PIAS4;SQSTM1;PSMD1;USP13;UBE2L6;PER1;ARRB1;STUB1;CKB;HDAC6;CXCR4;UBC;RPS27A;APBB1;SUMO1;YOD1;NPLOC4;BLZF1;DNAJA1;IKBKE;NFKBIA;SCAMP3;PSMA3;UCHL1;CALR;CLU;PRKACA;PRKAR2A;UBOX5;MUL1;SLF1;SMAD5;ABI2;JAK1;SUMO2;DERL1;RNF20;TCP1;DET1;CAMLG;TP53;PINK1;UBE2W;DAXX;SMC6;SHPRH;JKAMP;RIPK1;AMBRA1;SLC25A5;RALA;NEK6
prerank,cholesterol transfer activity (GO:0120020),-0.3841508059933658,-1.0568008633183765,0.3700787401574803,0.7352742536365022,1.0,4/16,6.96%,PLTP;ABCG1;GRAMD1B;STARD4
prerank,H4 histone acetyltransferase activity (GO:0010485),0.5194727020529721,1.0564745683158645,0.4044943820224719,0.856943097231088,1.0,5/10,27.84%,NAA60;NAA40;ATF2;KAT8;USP22
prerank,nuclear receptor coactivator activity (GO:0030374),0.39126176598584184,1.0559283268684212,0.4137542277339346,0.8552938231485392,1.0,18/52,19.17%,FGF2;ZMIZ1;DCAF6;CCAR2;THRAP3;MED13;SRA1;ENY2;CARM1;SFR1;ZMIZ2;SLC30A9;MED14;HMGA1;MED12;CNOT9;CCDC62;BRD8
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.508052586268127,1.0543015929676047,0.4090267983074753,0.8568442760263095,1.0,1/11,2.89%,HCN4
prerank,cholesterol binding (GO:0015485),-0.2896692125912873,-1.0538530460409032,0.33070866141732286,0.7327886488095927,1.0,10/47,6.96%,OSBPL8;APOD;SIDT1;PTCH1;PROM1;ABCG1;GRAMD1B;NR1H3;OSBPL10;STARD4
prerank,myosin V binding (GO:0031489),0.48862099719136526,1.0526861446784053,0.4318181818181818,0.8581971675628992,1.0,4/15,15.40%,RAB8A;RAB3D;RAB11B;RAB3B
prerank,pyrophosphatase activity (GO:0016462),0.39600182410506274,1.0524889988279809,0.4139072847682119,0.8555166617144828,1.0,8/50,10.11%,ALPL;ENTPD2;PLPP5;ENTPD6;PLPP1;DCTPP1;DOLPP1;PPA2
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.4489883353495948,1.0517416755510252,0.40707964601769914,0.8545521726867749,1.0,8/22,20.47%,APBB3;LRPAP1;AP2A1;ANKRA2;CLTC;APBB1;DNAJA1;CLU
prerank,organic cation transmembrane transporter activity (GO:0015101),-0.37674198037145123,-1.0506958464916467,0.371900826446281,0.7316699225132713,1.0,5/16,26.49%,SLC44A1;SLC22A2;SLC22A4;SLC44A2;SLC29A4
prerank,potassium channel regulator activity (GO:0015459),-0.2918100859020446,-1.0504221026636742,0.4,0.7228099860911457,1.0,9/49,8.91%,NEDD4L;DPP10;KCNIP3;KCNIP4;KCNIP1;ABCC9;WNK2;SLC5A3;DPP6
prerank,signaling receptor complex adaptor activity (GO:0030159),0.41234251923085247,1.0499765769949136,0.4147465437788018,0.8563178152762334,1.0,18/38,26.23%,IRS1;GAB2;SHC1;CD3E;SH2B1;AXIN1;SHANK1;G3BP2;MMS19;SPAG9;TRAT1;NUP62;MAPK8IP3;LRRK2;DLG5;TRADD;PTPN11;NCK1
prerank,chemokine receptor activity (GO:0004950),0.4437174639134561,1.0477208538694287,0.4489544895448955,0.8596222043788369,1.0,2/24,8.46%,CMKLR1;ACKR4
prerank,gamma-tubulin binding (GO:0043015),0.452695181064956,1.0466612845867647,0.4069319640564827,0.8594820290110976,1.0,6/21,13.88%,TUBGCP3;BLOC1S2;NDRG1;GIT1;RAB11FIP5;MARK4
prerank,transmembrane receptor protein kinase activity (GO:0019199),0.3851049717501889,1.0463107023476654,0.425414364640884,0.8572544094943185,1.0,15/60,11.74%,EGFR;DDR2;NTRK3;NTRK1;ACVR1B;EPHB2;ACVR1;EPHB3;EPHB6;TGFBR2;FGFR1;ROR1;FGFR2;MUSK;DDR1
prerank,actin monomer binding (GO:0003785),0.44316433791246307,1.045470865393659,0.4230271668822768,0.856393702186733,1.0,6/22,13.37%,PRKCE;LIMA1;COBL;PFN2;ABL1;PFN4
prerank,zinc ion binding (GO:0008270),0.3489301444485739,1.0434921467897604,0.39056224899598396,0.8590494025348578,1.0,74/293,20.50%,ADAMTS3;ZFPM2;TIMP2;ACER3;ECE1;SEC24D;GLI2;ADAM30;PAPPA;SEC23A;HDAC4;RXRA;SORD;TRIM28;CHD3;ADA;GLO1;SIRT5;SKI;MDM4;TES;NSD1;S100B;TIMM9;EEA1;SMPDL3A;SLC30A5;KDM2A;PHF8;TAB2;KDM5B;RNF2;SOD1;KDM4A;CHORDC1;FBXL19;SEC24C;SEC24B;QPCTL;MMP16;USP33;UBA5;PIAS4;RNF11;LACTB2;LNPEP;MBD1;SIRT2;IDE;ZFPL1;KDM5C;PLA2G15;KMT2B;DPF3;PRDM2;SHMT2;SEC24A;EPRS1;ALKBH8;SUV39H2;CAD;SHMT1;ZMYND11;AOC1;ZBTB32;NPEPPS;MYCBP2;TK1;LVRN;DNAJC24;TET2;CALR;IKZF4;ZDHHC20
prerank,DNA polymerase binding (GO:0070182),0.4579770546338465,1.0433161087661618,0.43989431968295906,0.8563685501935329,1.0,9/18,30.44%,HMGB1;SMG6;LONP1;POLG2;CDT1;RAD51;SMARCA4;RTEL1;HSP90AA1
prerank,ribosome binding (GO:0043022),0.4005899163016448,1.0427657093311442,0.43615819209039547,0.8547071494998384,1.0,20/46,29.73%,RPSA;SEC61A1;NAA16;NCLN;ETF1;EIF6;EFL1;PYM1;EIF2A;EIF2S1;SBDS;SHFL;SRP72;C1QBP;NAA15;SEC61B;CCDC47;YTHDF1;IGHMBP2;ERI1
prerank,chloride channel activity (GO:0005254),0.3874343236660005,1.0416593612350644,0.41325966850828727,0.8548535467190893,1.0,4/59,5.17%,SLC26A7;CLIC3;CLIC4;GABRA3
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.47197746638718197,1.0401673522656607,0.4195323246217332,0.8558390152946768,1.0,4/15,8.51%,SOCS7;SOCS4;SOCS6;SOCS2
prerank,nucleoside-triphosphatase activity (GO:0017111),0.35156760209344257,1.0396378879179793,0.39457831325301207,0.8543024452324849,1.0,58/248,21.99%,GNAS;RHOJ;RHOBTB1;RHOQ;MRAS;RND3;ATL2;GNG8;TSR1;RAB2A;RAB43;CHD1L;RAB24;VCP;CHD3;MYO1E;DNM2;GNL1;RAB21;ATL3;GNL2;RAB8A;RHOT2;TBC1D24;GBP6;GSPT1;RHOA;RHOT1;RAB38;DHX29;RAB11B;ARL2;ABCB6;VWA8;GNAO1;RAB23;RHOB;GNA11;RAB3B;RASL12;GPN3;KLC1;NKIRAS1;EFL1;RAB5B;KIF20B;DRG2;RHEB;ENTPD7;CLU;GNB1;RAB4A;ATL1;LRRK2;RAB1A;RAB18;MFN1;ABCD1
prerank,phosphatidylinositol kinase activity (GO:0052742),0.4744237472179101,1.0395181506701194,0.4306864064602961,0.851533257786477,1.0,5/15,16.06%,PIK3C2B;ATM;PIK3CB;PI4K2A;PI4KB
prerank,calcium channel activity (GO:0005262),0.37416751769448825,1.0387868674706693,0.4025695931477516,0.8505357205351242,1.0,13/84,11.23%,PKD1;CACNA1C;SLC24A3;SEC61A1;TRPV3;ANXA2;CACHD1;MCU;TRPM7;TRPM4;CATSPER3;ITGAV;CACNA2D2
prerank,single-stranded RNA binding (GO:0003727),0.40254655013200685,1.0385942532839452,0.42491268917345754,0.8480143778434025,1.0,19/43,29.21%,STRBP;SRA1;ILF3;AGO1;LONP1;AGO2;PTBP1;U2AF2;LACTB2;AQR;ENDOV;HNRNPA1;EIF4B;PUS1;HNRNPU;ZFR;FXR1;EIF4H;DDX11
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),0.4077397668285953,1.0362647328445,0.42857142857142855,0.8519937545861688,1.0,15/38,29.18%,PLEKHA4;PLA2G4A;WIPI2;SH3PXD2B;ZFYVE19;BBS5;HIP1;SNX13;RUFY4;DENND1A;SNX3;PARD3;ATG2B;PLEKHF1;ZFYVE1
prerank,lipid phosphatase activity (GO:0042577),0.48427416671029955,1.0359958623042478,0.44813829787234044,0.8496376625743914,1.0,2/14,6.18%,PLPP3;PLPP1
prerank,tumor necrosis factor receptor binding (GO:0005164),-0.4131675228083172,-1.0334538443553993,0.3781818181818182,0.7561365076996771,1.0,5/12,22.58%,STAT1;BABAM2;TRAP1;TRAF2;TRAF1
prerank,protein kinase binding (GO:0019901),0.3444790713364462,1.0331734316759391,0.3833833833833834,0.8543593982943144,1.0,116/479,21.31%,ESR1;IRS1;PKD1;PRKCD;SLC12A7;RHOBTB1;CIT;SLC12A2;ADAM9;TCF7L2;SRCIN1;CNTLN;GHR;PRR7;RND3;PPP1CC;SHC1;HDAC9;SPRED2;STAT3;CD3E;CSPG4;NISCH;ATF4;NBEA;AP2A1;CALM2;MAVS;DACT1;ACVR1;DVL1;PRKCSH;TOM1L1;ILK;NOX4;PRAM1;ADAM10;ANKRA2;ANK2;NBR1;IRAK3;SKI;LLGL1;SLC12A4;SOX9;TRIM27;RARA;FZD5;DACT3;RBBP6;CDK5RAP3;DLG1;TSKS;RHOA;DCTN2;NSF;PAK2;ITGAV;CDC25B;FOXM1;ABL1;IRAK1;MAP3K12;TELO2;AXIN1;CHEK2;RCC2;EZR;NELL1;KHDRBS1;PPEF2;PTPN2;AP2A2;MAPRE3;SNAP91;PICK1;WNK1;CLTC;SQSTM1;ACSL3;PRDX3;RHOB;CAMK2N1;IQGAP1;FOXO3;GSKIP;SPAG9;PARP1;TPRKB;CDC25A;CALM3;UFL1;NR3C1;PRKAG1;TRIM6;VRK2;SUFU;RB1CC1;ATF2;CRK;CKS1B;PEBP1;PTPN23;DUSP19;TCF3;PRKAB1;MAP2K3;APPL1;MAPKAP1;DCTN1;MAD2L2;PRKACA;PRKAR2A;BANK1;MAP2K7;MAPK8IP3
prerank,Hsp90 protein binding (GO:0051879),0.41510514738446586,1.0325100907322509,0.4365175332527207,0.8531162949095206,1.0,15/33,27.83%,SLC12A2;CSNK2A1;TELO2;CHORDC1;PPEF2;PTGES3L;STUB1;USP19;HDAC6;NR3C1;TSC2;UNC45A;PPID;ERN1;HSF1
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.5036315879874107,1.0301725349036441,0.45504840940525587,0.8564775415458667,1.0,3/11,11.62%,NAA60;NAA40;NAA16
prerank,receptor tyrosine kinase binding (GO:0030971),0.38850615973723623,1.0298469452757217,0.43991179713340683,0.8543310794252179,1.0,11/56,14.32%,IRS1;GAS6;DOCK4;GAB2;SHC1;PITPNM1;CBL;ANGPT4;SH2B1;PTPN2;SQSTM1
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.3803766554223826,1.0283686552732136,0.457174638487208,0.8554819627138898,1.0,15/60,12.40%,EGFR;DDR2;CRIM1;NTRK3;NTRK1;IGF2R;EPHB2;EPHB3;EPHB6;FGFR1;ROR1;FGFR2;MUSK;DDR1;NRP1
prerank,dynactin binding (GO:0034452),-0.4031434228068843,-1.0278864974280488,0.39932885906040266,0.760892003279495,1.0,2/12,10.14%,BICDL1;SNX6
prerank,anion transmembrane transporter activity (GO:0008509),-0.38416789735801027,-1.0277601114086374,0.40823970037453183,0.7516228290998134,1.0,3/12,4.15%,SLCO2B1;SLC22A6;SLC39A8
prerank,high voltage-gated calcium channel activity (GO:0008331),0.5079836436274452,1.0272407224044087,0.47198879551820727,0.8555218176739575,1.0,1/10,0.48%,CACNA1C
prerank,ligand-gated anion channel activity (GO:0099095),-0.3628378499711885,-1.0270306544932881,0.41732283464566927,0.7440299997821367,1.0,7/17,14.72%,GLRA2;GABRB1;GABRB3;GABRB2;GABRA5;GLRA1;CFTR
prerank,potassium channel activity (GO:0005267),0.36430884222269805,1.0270280290115172,0.44337606837606836,0.853097162686981,1.0,8/89,9.13%,KCNK5;GRIK4;KCNB1;HCN4;KCNN1;KCNE5;KCND1;KCNK6
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.342956831291288,1.0265424010591362,0.414,0.8514884850193607,1.0,119/431,23.81%,PRPS2;RHOJ;RHOBTB1;ABCD3;N4BP2;RHOQ;MARK1;MRAS;TUBG2;RND3;GNL3;ACVR1B;ATL2;HSPA2;TSR1;SMC4;RAB2A;MAP3K5;TNK1;DNM2;ACVR1;GNL1;RAB21;ATL3;ERN2;GNL2;TLK1;RABL6;RAB8A;ABCF1;IRAK3;RHOT2;ARF4;RPS6KA4;AK6;GBP6;AKT2;NOA1;RHOA;RHOT1;RRAD;HSPA14;PIP4K2B;PEX1;ARFIP2;RAB38;ABL1;NVL;MAP4K5;TDG;ABCE1;ABCB8;BMPR1A;ARF1;HSPA5;DARS2;LONP1;UHMK1;TGFBR1;PSMA6;EIF4G1;LIG4;RAB11B;ARL2;ABCA1;PI4K2A;DMPK;MARK4;WNK1;SRR;ABCB6;SRPK1;CLP1;TBCK;RHOB;RASL12;LATS2;HACL1;CDC42BPB;TLK2;IDE;HASPIN;YARS2;PGK1;MKNK2;SIK2;PRKAG1;DAPK3;BCKDK;CAD;PEX6;MAST2;AKT1;CHD8;RAD51;SARS2;DRG2;ABCF3;RHEB;MTREX;RAB4A;ATL1;LRRK2;PANK3;ANXA6;ABCD1;STK38;TUBB6;PRKCI;TOP1;PPIP5K1;CARS2;RAB1B;PYGL;ARF5;HNRNPU;SYN3;NRAS;KRAS
prerank,chemokine activity (GO:0008009),0.4189849255983727,1.0240669010458585,0.46878824969400246,0.855471545263317,1.0,3/31,7.21%,CCL13;CCL15;CXCL16
prerank,anion channel activity (GO:0005253),0.3773807995107672,1.022929832400547,0.4439608269858542,0.8555690252668288,1.0,5/61,5.40%,SLC26A7;CLIC3;CLIC4;GABRA3;LRRC8D
prerank,TBP-class protein binding (GO:0017025),0.4401574409622545,1.0228119293778126,0.4485387547649301,0.8529528178732848,1.0,1/21,0.26%,ESR1
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.42449149378802564,1.022711259257616,0.46886912325285895,0.8503071015228968,1.0,8/24,24.12%,CAMKK1;CAMK2D;PHKA1;EEF2K;CAMK4;MKNK2;CAMK1;PHKA2
prerank,metalloaminopeptidase activity (GO:0070006),0.464125109871,1.0217827449504855,0.4555112881806109,0.850028677409738,1.0,7/16,21.26%,MMP14;XPNPEP1;MMP16;LNPEP;NPEPPS;LVRN;RNPEPL1
prerank,transcription cis-regulatory region binding (GO:0000976),0.3383990361284328,1.0197400328017927,0.44344344344344344,0.8526801766153488,1.0,82/406,20.20%,PLAGL1;BNC2;SIX1;FOXP1;TCF7L2;TWIST2;VSX1;SMAD6;PRDM5;DMTF1;GLIS2;TWIST1;DEAF1;LHX9;CUX1;HDAC4;RXRA;STAT3;ATF4;CHD3;FOXC2;ZNF25;RXRB;NFX1;NFXL1;PER3;SMAD4;NFE2L2;HMGB1;E2F3;PBX1;TBX21;SOX9;PURG;RARA;ESRRB;TFE3;FOXK1;CARM1;HNRNPL;RORA;FOXA1;ZFP90;SREBF1;FOXM1;AGO1;RFX5;SFPQ;LONP1;HDAC1;AGO2;MEF2D;ARID4B;KMT2D;NPAS1;MEF2A;RUNX1;ZBTB9;TFDP1;PER1;GRHL1;FOXO3;FOXN3;NFE2;RBL2;PRDM2;NFYA;NR3C1;RFXANK;E4F1;MEN1;HMGA1;E2F1;SUV39H2;ATF2;KLF10;FOSL2;XRCC6;VEZF1;TCF3;ATF6;MAX
prerank,DNA secondary structure binding (GO:0000217),0.4131886428540743,1.0197049277226593,0.4368932038834951,0.8498977529180586,1.0,9/31,22.60%,HMGB1;ERCC5;RBBP8;WRN;ABL1;MEN1;HMGA1;XRCC3;KMT2A
prerank,receptor ligand activity (GO:0048018),0.34588432251745266,1.0172329135741436,0.4593781344032096,0.853570266401949,1.0,21/245,7.25%,PGF;GDF10;WNT9A;VEGFA;GAS6;FGF2;OSGIN2;IL33;FGF17;INHBC;INSL6;TGFB3;SLURP1;LRPAP1;CCL15;TGFB2;SEMA3E;HMGB1;JAG1;SEMA4B;FAM3C
prerank,DNA binding (GO:0003677),0.33898545071264746,1.0163170434726505,0.429,0.8531843863744742,1.0,154/694,20.49%,FOXP2;PLAGL1;EGFR;SIX1;KLF12;HOXA5;C1D;ZNF423;FOXD1;NFIB;TCF7L2;RARB;COLEC11;GLI2;PRDM5;CUX1;HDAC4;TOPORS;RXRA;MEOX2;STAT3;TCF7L1;ATF4;TRIM28;MCMDC2;MPG;NR2F1;CHD3;TCFL5;PHF1;FOXC2;PRKDC;SAFB;SMAD4;NFE2L2;HMGB1;EZH1;E2F3;PBX1;TSHZ2;MEIS3;TBX21;THRAP3;SOX9;HUWE1;MAEL;MCM2;CENPC;IKZF3;MBD6;FOXJ3;ERCC5;ESRRB;ZNF76;HMGN1;FOXL1;RFX2;SLTM;PSIP1;RBBP8;ERCC4;RAD1;RORA;OGG1;ILF3;WRN;FOXA1;CSRNP1;SREBF1;EHF;ABL1;ZIC4;RBM6;SPTY2D1;RFX5;POU6F1;WDR48;TDG;RBM5;TERT;KDM5B;AIFM1;SFPQ;SDE2;FUBP1;TAF6;PMS2;CCDC25;TDP1;ERCC3;RAD50;LONP1;KHDRBS1;CDC45;HSPD1;LIG4;PCBP2;KMT2D;MEF2A;ERCC2;SUPV3L1;TRIM26;ERF;DEDD;MSH4;DCLRE1B;RNF11;ZNF148;VDR;SNAPC4;XRN1;MBD1;GRHL1;FOXO3;NKX6-2;NFE2;ZFPL1;CREBBP;MCM4;TSN;RC3H2;POLG2;PRDM2;NFYA;SMARCAD1;DNTTIP1;MEN1;HDGFL2;HMGA1;CDT1;E2F1;RYBP;ZMYND11;ZBTB32;ZMYM3;CHD8;RAD51;HOXB2;MLXIPL;SAFB2;QRICH1;GTF3C1;XRCC6;IRF3;GTF3C4;CBFB;TCF3;APLP2;ATF6;TWNK;MAX;BPTF;CALR;FANCG
prerank,G protein-coupled receptor binding (GO:0001664),0.354219060705596,1.0160739650318966,0.4567901234567901,0.8509442538839392,1.0,5/132,1.91%,MYOC;GNAS;LRP6;WNT9A;PROK2
prerank,ligand-gated ion channel activity (GO:0015276),0.4147919795069797,1.01594572032125,0.45280764635603343,0.8485467483947511,1.0,4/30,8.42%,GRIK4;GRIN3A;CHRNB2;CHRNA5
prerank,ligand-gated channel activity (GO:0022834),0.41672801409651994,1.0128683184470246,0.4519230769230769,0.8538701558392563,1.0,4/29,8.42%,GRIK4;GRIN3A;CHRNB2;CHRNA5
prerank,pseudouridine synthase activity (GO:0009982),0.4696424191634989,1.009701900019391,0.47375886524822697,0.8595993937271399,1.0,8/13,34.69%,RPUSD1;PUS3;TRUB1;PUS1;PUS10;DKC1;PUS7;PUS7L
prerank,phospholipase activator activity (GO:0016004),-0.3992731327068465,-1.009639407175913,0.4533333333333333,0.7789568398375404,1.0,1/10,0.73%,ARHGAP6
prerank,platelet-derived growth factor receptor binding (GO:0005161),-0.3892227004704252,-1.0087553978566954,0.40562248995983935,0.7719528756278405,1.0,5/13,8.05%,IL1R1;PDGFD;PDGFRB;PDGFRA;PDGFC
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",0.40184811715470437,1.007207388233368,0.46987951807228917,0.8633664016502228,1.0,11/35,27.90%,FTO;MTFMT;PTRH2;ALKBH1;TYW3;ELAC2;DUS1L;DUS3L;TARS2;PUS10;DTWD1
prerank,exoribonuclease activity (GO:0004532),-0.3864939872293671,-1.0060025367293635,0.45357142857142857,0.7698697273462154,1.0,5/12,18.55%,EXOSC8;ZC3H12A;EXOSC1;EXOSC9;EXOSC10
prerank,5'-nucleotidase activity (GO:0008253),0.46493723523937136,1.005951910315869,0.4583333333333333,0.8640257522923555,1.0,5/13,22.69%,NT5DC3;NT5C3B;ACP3;NT5C;NT5DC1
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.4396053688434142,1.0056287631682286,0.4749661705006766,0.8619246908749588,1.0,4/18,21.84%,AKR1C1;DHRS9;HSD17B8;HSD3B7
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),-0.39038270626426913,-1.003804242136526,0.4212328767123288,0.7662457754396086,1.0,4/11,18.42%,KCND3;KCNJ3;KCNJ8;KCNQ1
prerank,ubiquitin-protein transferase activity (GO:0004842),0.33336722450843825,1.0022544748128273,0.5075075075075075,0.8677597656259204,1.0,106/346,26.17%,WWP1;RNF144A;SH3RF3;NEDD4;FBXO10;FBXW8;TOPORS;COP1;UBE2B;TRIM28;UBR4;RNF182;DTX3;LRSAM1;UBE2R2;ERCC8;NFX1;UBE3C;RNF115;TRIM41;HUWE1;TRIM27;SYVN1;CBL;RBBP6;WWP2;SHARPIN;ITCH;CUL4A;FBXO25;RNF114;UBR5;RNF25;UBE2C;FBXO22;RNF14;FBXO3;RNF2;ANAPC4;MYLIP;TRAF3;CUL1;RNF38;DTX2;LTN1;RNF103-CHMP3;TRIM26;FBXL14;RNF11;RING1;UBE2L6;FBXO17;STUB1;RNF214;TRAF3IP2;RNF121;RC3H2;BIRC6;TRIM13;VPS11;GID4;TRIM6;HECTD1;UHRF2;RNF7;FBXW2;UBR2;RNF141;MYCBP2;NEURL1B;NEURL3;UBE2G2;RMND5B;TRAIP;TRIM47;SMURF2;TRIM43;MUL1;SH3RF1;RNF4;KCTD13;BIRC3;AREL1;TTC3;RNF20;RNF216;ZFP91;RNF146;FBXO11;UBE2Z;TAF1;FBXO9;RNF122;AMFR;IRF2BPL;RCHY1;RNF138;RNFT1;XIAP;KCMF1;UBE2W;UBR3;RNF111;SHPRH;RNF126;RNF166
prerank,growth factor receptor binding (GO:0070851),0.3566814491206126,1.0017353693618822,0.5042016806722689,0.8662855899936467,1.0,10/95,8.78%,PGF;VEGFA;FGF2;FGF17;SHC1;GLMN;SNX2;AGR2;ARF4;SNX1
prerank,fibroblast growth factor receptor binding (GO:0005104),0.4360208922221771,1.0006461962685633,0.4872773536895674,0.8662420659579343,1.0,2/21,2.08%,FGF2;FGF17
prerank,DNA polymerase activity (GO:0034061),0.4276396771612865,0.9996051436830653,0.4813863928112965,0.8660861628940902,1.0,8/22,26.26%,REV3L;POLE2;TERT;POLB;REV1;PRIMPOL;POLD1;POLG
prerank,retinoid X receptor binding (GO:0046965),0.48079387005116153,0.9975014175025546,0.4985632183908046,0.8687803985420163,1.0,5/11,17.75%,NRIP1;NSD1;MED25;VDR;HMGA1
prerank,ubiquitin protein ligase activity (GO:0061630),0.33388418807747294,0.9963391962812567,0.5190763052208835,0.8688795069892812,1.0,70/228,26.17%,WWP1;RNF144A;SH3RF3;NEDD4;TOPORS;COP1;UBR4;DTX3;LRSAM1;NFX1;UBE3C;RNF115;TRIM41;HUWE1;TRIM27;SYVN1;CBL;RBBP6;WWP2;ITCH;RNF114;UBR5;RNF25;RNF14;RNF2;MYLIP;RNF38;DTX2;LTN1;TRIM26;RNF11;RING1;FBXO17;STUB1;TRAF3IP2;RNF121;RC3H2;TRIM13;VPS11;UBE4A;GID4;TRIM6;HECTD1;UHRF2;RNF7;UBR2;MYCBP2;NEURL1B;NEURL3;UBOX5;SMURF2;TRIM43;MUL1;SH3RF1;BIRC3;AREL1;RNF216;RNF122;AMFR;IRF2BPL;RCHY1;RNF138;RNFT1;XIAP;KCMF1;UBR3;RNF111;SHPRH;RNF126;RNF166
prerank,nucleosomal DNA binding (GO:0031492),0.42499031704619544,0.9933203174358838,0.48378728923476005,0.8737914086621505,1.0,12/21,32.02%,SMARCC2;RCC1;HDAC1;HNRNPC;CHD4;SMARCA4;HDAC2;H3-3A;SMARCD2;SMARCC1;MBD3;GATAD2B
prerank,basic amino acid transmembrane transporter activity (GO:0015174),-0.36832914723784055,-0.9929573309543904,0.45901639344262296,0.7861327847164168,1.0,6/13,21.75%,SLC38A5;SLC7A1;SLC38A7;SLC25A29;SLC3A1;SLC7A3
prerank,Notch binding (GO:0005112),0.4181362305183905,0.9917565704528243,0.49222797927461137,0.8750302948257166,1.0,3/22,6.52%,CCN3;NCOR2;JAG1
prerank,chemokine receptor binding (GO:0042379),0.39824349496631173,0.9896554019435837,0.49642857142857144,0.8776579514530641,1.0,4/35,9.82%,CCL13;CCL15;CXCL16;ITCH
prerank,single-stranded DNA binding (GO:0003697),0.35014928895126063,0.9884500704993705,0.4968152866242038,0.8778252042608204,1.0,43/93,32.96%,MCMDC2;HMGB1;MCM2;ERCC5;RBBP8;ERCC4;WDR48;FUBP1;PMS2;TDP1;LONP1;CDC45;HSPD1;PCBP2;MCM4;RAD51;TWNK;CRY2;HNRNPA1;TOP1;NUP35;HNRNPU;TOP3A;RNF138;RTF1;SMC6;POLR2H;MCM7;FBH1;SWSAP1;IGHMBP2;HMCES;DDX11;RAD52;CTC1;SSBP1;TDP2;MSH2;BLM;ERCC1;RAD23B;RPA3;PURA
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.331803403085606,0.9883707643851743,0.5441767068273092,0.8752189098549498,1.0,70/232,26.17%,WWP1;RNF144A;SH3RF3;NEDD4;TOPORS;COP1;UBR4;DTX3;LRSAM1;NFX1;UBE3C;RNF115;TRIM41;HUWE1;TRIM27;SYVN1;CBL;RBBP6;WWP2;ITCH;RNF114;UBR5;RNF25;RNF14;RNF2;MYLIP;RNF38;DTX2;LTN1;TRIM26;PIAS4;RNF11;RING1;FBXO17;STUB1;TRAF3IP2;RNF121;RC3H2;UFL1;TRIM13;VPS11;GID4;TRIM6;HECTD1;UHRF2;RNF7;UBR2;MYCBP2;NEURL1B;NEURL3;SMURF2;TRIM43;MUL1;SH3RF1;BIRC3;AREL1;RNF216;RNF122;AMFR;IRF2BPL;RCHY1;RNF138;RNFT1;XIAP;KCMF1;UBR3;RNF111;SHPRH;RNF126;RNF166
prerank,general transcription initiation factor binding (GO:0140296),0.4087361046101892,0.9879288695838297,0.5048661800486618,0.8734699174354802,1.0,8/25,25.77%,ESR1;TAF13;PSMC5;THAP7;YEATS2;TBP;TAF1;PSMC1
prerank,endopeptidase regulator activity (GO:0061135),-0.2750352773658869,-0.9875847593206488,0.5067567567567568,0.7901957443013958,1.0,8/40,12.01%,ITIH2;TFPI;PROS1;SERPIND1;PSME3;PSME1;A2M;SPINT2
prerank,chemokine binding (GO:0019956),0.4001475433669084,0.9860856185188708,0.5084134615384616,0.8753405726235968,1.0,7/30,21.40%,FGF2;HMGB1;ACKR4;ITGAV;CXCR4;PLP2;ACKR3
prerank,hormone receptor binding (GO:0051427),0.46330880616665043,0.9848630759534973,0.4787379972565158,0.8757748774605603,1.0,4/14,25.21%,SOCS2;VIP;JAK1;TYK2
prerank,phosphatidylcholine transporter activity (GO:0008525),0.4412825553410489,0.9829348493970025,0.48700410396716826,0.8778377528038972,1.0,6/17,13.70%,PITPNC1;PITPNA;PITPNM1;ATP8B2;PCTP;ABCA1
prerank,phosphatidylinositol binding (GO:0035091),0.3460064744281628,0.9813780284333866,0.5382978723404256,0.8790699175117037,1.0,31/91,23.50%,TNFAIP8L3;PITPNC1;SNX2;PITPNA;PITPNM1;BCAS3;MYO1E;GPAA1;GAP43;FCHO2;EEA1;SNX24;SNX1;SNX9;SNAP91;MITD1;SCIN;HIP1;SNX13;DENND1B;C2CD2L;ZFYVE16;AIDA;APPL2;APPL1;SNX11;RUBCN;DENND1A;MTM1;SNX4;DPEP1
prerank,semaphorin receptor activity (GO:0017154),0.47728681627547187,0.9805553078545379,0.4942528735632184,0.8783552330662328,1.0,1/11,0.51%,PLXNA4
prerank,sterol binding (GO:0032934),-0.26374015857094235,-0.9804311760340475,0.5392156862745098,0.799978497472493,1.0,11/56,6.96%,OSBPL8;APOD;SIDT1;PTCH1;PROM1;ABCG1;GRAMD1B;NR1H3;OSBPL10;INSIG2;STARD4
prerank,potassium ion leak channel activity (GO:0022841),0.44674945323613313,0.9795265878336782,0.49658002735978113,0.8781221251981298,1.0,1/15,0.40%,KCNK5
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.393156084209127,0.9772088376765476,0.5141104294478528,0.8810357217356674,1.0,14/31,31.48%,UBE2B;UBE2R2;UBE2C;UBE2L6;BIRC6;UBE2G2;UBE2Z;TAF1;UBE2W;UBE2Q2;UBE2H;UBE2S;UBE2A;UBE2N
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",0.46626291803311265,0.9765682049265698,0.5054794520547945,0.8798688575367227,1.0,5/12,22.06%,B3GNT7;B3GNT9;B4GAT1;B3GNT6;B3GNT2
prerank,phosphoric diester hydrolase activity (GO:0008081),0.38312813989252514,0.975264295695402,0.5136741973840666,0.8804505048824032,1.0,9/35,16.32%,PLCE1;PDE11A;SMPD4;SMPDL3A;PDIA3;PLCXD2;ENPP6;MPPED2;GDPD3
prerank,phosphatidylinositol phosphate binding (GO:1901981),0.3429183913212581,0.9749884809308084,0.532563025210084,0.8784444545744795,1.0,29/100,22.41%,CYTH3;ARAP1;PLEKHA4;PLA2G4A;GAB2;GAP43;GBF1;WIPI2;LAPTM4B;SNX24;OGT;DAPP1;SH3PXD2B;ARFIP2;ZFYVE19;OSBP;BBS5;IQGAP1;HIP1;SNX13;GOLPH3;DENND1B;AKT1;ZFYVE16;MAPKAP1;SNX11;RUFY4;RUBCN;DENND1A
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.36026513263119314,0.9692831841339542,0.5334075723830735,0.889655822481293,1.0,7/55,8.20%,PKD1;SLC24A3;SEC61A1;TRPV3;ANXA2;MCU;TRPM7
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.37171119178392537,0.968985888998764,0.5393518518518519,0.8875854984586209,1.0,15/49,21.58%,VCP;FAAP20;SHARPIN;TAB2;UBQLN1;SQSTM1;HDAC6;ATRIP;UBL7;ZFAND2B;IKBKE;ZRANB1;BRCC3;OPTN;PSMD4
prerank,leucine zipper domain binding (GO:0043522),0.47412677969040634,0.9655223326969802,0.5260930888575458,0.8931548162325735,1.0,4/10,17.85%,ATF4;ERC1;AATF;DAPK3
prerank,tRNA-specific ribonuclease activity (GO:0004549),0.44253184577134397,0.9630130603439646,0.5321229050279329,0.8964799288824518,1.0,7/14,30.83%,RPP40;ELAC2;RPP14;TSEN34;RPP21;POP5;PRORP
prerank,Tat protein binding (GO:0030957),0.47007665337184756,0.9608063219596701,0.5275035260930888,0.8990513167905155,1.0,4/10,25.18%,MDFIC;DNAJA1;SMARCA4;CTDP1
prerank,N-acetyltransferase activity (GO:0008080),0.4212575320523266,0.9600985254352475,0.5485122897800776,0.8980939507363737,1.0,3/19,9.48%,NAT1;ATAT1;SAT2
prerank,sterol transfer activity (GO:0120015),-0.34701353427947385,-0.9590641399891052,0.49173553719008267,0.8457446668044268,1.0,4/17,6.96%,PLTP;ABCG1;GRAMD1B;STARD4
prerank,four-way junction DNA binding (GO:0000400),0.429360418053257,0.9587807675123434,0.5405405405405406,0.8985826727679226,1.0,8/17,31.68%,HMGB1;WRN;ABL1;MEN1;XRCC3;YY1;MSH2;BLM
prerank,mannosyltransferase activity (GO:0000030),-0.3194258604727471,-0.9587607296503592,0.5024154589371981,0.8370996628503591,1.0,2/21,1.25%,TMTC2;TMTC4
prerank,protein phosphatase 1 binding (GO:0008157),0.4112366123403387,0.9584999467867394,0.5179760319573902,0.8965347436168034,1.0,4/21,11.39%,PPP1R3C;PPP1R9B;PPP1R3F;SHOC2
prerank,5'-3' RNA polymerase activity (GO:0034062),0.3991063571426612,0.956100904021859,0.5412054120541205,0.8995010256986151,1.0,11/27,22.05%,POLR3H;TERT;CRCP;POLR2F;MED21;POLR3K;TENT2;MED20;POLR1D;POLR1C;POLR2B
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",-0.3944291712785298,-0.9557002479819736,0.49158249158249157,0.8353264601483569,1.0,3/10,10.17%,ADARB2;LACC1;GDA
prerank,aminopeptidase activity (GO:0004177),0.3975792678460363,0.9556368077916289,0.5397590361445783,0.8979698559970168,1.0,10/26,24.44%,MMP14;XPNPEP1;MMP16;LNPEP;LAP3;NPEPPS;LVRN;RNPEPL1;METAP1D;METAP2
prerank,telomerase RNA binding (GO:0070034),0.4039929092433861,0.9532397113186405,0.5408163265306123,0.9008024135718042,1.0,8/22,26.90%,TENT4B;SMG6;TERT;HNRNPC;XRN1;SNRPB;HNRNPU;DKC1
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.4032047942976811,0.9510021393127992,0.5425950196592398,0.9035829320821025,1.0,7/24,22.65%,AK5;AK3;IP6K1;DTYMK;AK1;NME3;PPIP5K1
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",0.45730648145356684,0.9506160334599785,0.5646551724137931,0.9018369894958035,1.0,4/10,27.44%,DPYSL3;CAD;DPEP1;OPLAH
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.3764141277118857,0.9488257211786709,0.5615942028985508,0.9030505521528528,1.0,15/34,31.48%,UBE2B;UBE2R2;UBE2C;UBE2L6;BIRC6;UBE2G2;UBE2Z;TAF1;UBE2W;UFC1;UBE2Q2;UBE2H;UBE2S;UBE2A;UBE2N
prerank,O-methyltransferase activity (GO:0008171),0.4764076375609865,0.9440487343350005,0.5679190751445087,0.9117069322794797,1.0,1/10,2.38%,LRTOMT
prerank,leak channel activity (GO:0022840),0.41546271821641234,0.9439404332119355,0.544973544973545,0.9092774856441305,1.0,1/18,0.40%,KCNK5
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.3294932243662903,0.9437984495563991,0.6041025641025641,0.9069373906687851,1.0,36/147,17.19%,PLCE1;ARHGEF28;CYTH3;TIAM1;FARP1;DOCK4;RCC1L;ANKRD27;VAV2;FGD6;RABGEF1;RAB3GAP1;DENND6A;EPS8L1;LAMTOR1;RASGEF1B;RIC1;BCR;DOCK5;MON1A;KALRN;RGP1;MADD;RCC1;IQSEC2;GAPVD1;WDR41;NUCB1;PREB;HPS4;FARP2;AKAP13;SOS1;EEF1B2;DIS3;NGEF
prerank,transaminase activity (GO:0008483),0.4610915043597466,0.9428979242852747,0.5693430656934306,0.90631025097742,1.0,3/11,21.05%,AGXT2;PSAT1;BCAT1
prerank,sequence-specific mRNA binding (GO:1990825),0.471238665599071,0.9405033181355043,0.579250720461095,0.9092678062494767,1.0,6/10,34.59%,SSB;ETF1;SHFL;RBM24;DHFR;DHX9
prerank,thyroid hormone receptor binding (GO:0046966),0.37829136437596694,0.9402276235456495,0.5693069306930693,0.9072659818020931,1.0,9/28,25.92%,JMJD1C;THRAP3;NSD1;MED13;MED12;BRD8;TRIP6;NCOR1;MED24
prerank,nucleotidyltransferase activity (GO:0016779),0.40508547207214884,0.9393083551894736,0.534640522875817,0.906697589486367,1.0,6/19,21.06%,PAPSS2;TENT4B;TERT;TUT7;REV1;TENT2
prerank,cadherin binding (GO:0045296),0.3167530195495454,0.9380280263336668,0.6806806806806807,0.906886890861161,1.0,64/315,15.79%,EGFR;CDH11;CTNND2;MPP7;FXYD5;FMNL2;CTTN;EHD1;RDX;AHNAK;PDXDC1;STX5;SCYL1;LIMA1;CSNK1D;HDLBP;GCN1;SNX2;ANXA2;ERC1;BAG3;ARGLU1;EIF4G2;ATXN2L;ACVR1;EPS8L1;ABI1;KLC2;GIPC1;JUP;TES;NDRG1;PAK4;CBL;DLG1;SNX1;PKN2;PAK2;ANXA1;ATIC;BZW1;ARFIP2;CKAP5;ZC3H15;SNX9;HSPA5;USO1;EZR;EEF1G;PARVA;DHX29;GAPVD1;ADD1;DCHS1;RAB11B;MPRIP;YWHAE;SND1;HNRNPK;FLNB;TBC1D10A;LRRC59;IQGAP1;UBAP2
prerank,kinase activity (GO:0016301),0.3263861153700861,0.9358216290990518,0.5849056603773585,0.9092551607386896,1.0,31/109,20.13%,PAPSS2;MAPK15;PIK3C2B;NADK;SCYL3;CSNK2A1;SHPK;STK39;HYKK;TRRAP;FCSK;DGKQ;ETNK1;PKN2;PANK4;ABL1;IRAK1;DCAKD;IP6K1;PIK3CB;ADPGK;CKB;CHKB;COQ8B;PI4KB;PGK1;BCKDK;AKT1;RFK;CDK5;SEPHS2
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),0.4631715387964261,0.9340333913528025,0.569164265129683,0.9105880229834784,1.0,8/10,26.40%,EHMT1;ASH1L;SETD5;SETDB1;SUV39H2;SUV39H1;SETDB2;EHMT2
prerank,ATP binding (GO:0005524),0.3139868487621738,0.9339269657502405,0.6649899396378269,0.9081623411324554,1.0,64/266,18.96%,PRPS2;ABCD3;N4BP2;MARK1;ACVR1B;HSPA2;SMC4;MAP3K5;TNK1;ACVR1;ERN2;TLK1;ABCF1;IRAK3;RPS6KA4;AK6;AKT2;HSPA14;PIP4K2B;PEX1;ABL1;NVL;MAP4K5;TDG;ABCE1;ABCB8;BMPR1A;HSPA5;DARS2;LONP1;UHMK1;TGFBR1;EIF4G1;LIG4;ABCA1;PI4K2A;DMPK;MARK4;WNK1;SRR;ABCB6;SRPK1;CLP1;TBCK;LATS2;HACL1;CDC42BPB;TLK2;IDE;HASPIN;YARS2;PGK1;MKNK2;SIK2;PRKAG1;DAPK3;BCKDK;CAD;PEX6;MAST2;AKT1;CHD8;RAD51;SARS2
prerank,snRNA binding (GO:0017069),0.3548611608439631,0.9312692959155248,0.5685164212910532,0.9114607111164127,1.0,15/42,29.40%,SNRNP70;CCNT2;LSM2;HEXIM1;SNRPA;RBM22;NCBP2;LARP7;SNRPB2;HNRNPU;SNRNP35;DDX39B;TOE1;CDK9;MEPCE
prerank,glutathione transferase activity (GO:0004364),0.396019616995402,0.9304117293532155,0.5594493116395495,0.9108199273552908,1.0,4/23,16.00%,GSTT1;GSTM5;GSTZ1;PTGES
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",0.39815935103179756,0.9300513979655093,0.5670498084291188,0.90898511289063,1.0,4/21,4.85%,PDE11A;PDE6C;PDE3A;PDE6A
prerank,antiporter activity (GO:0015297),0.4080947342812904,0.9292637223359742,0.5680628272251309,0.9081484852226598,1.0,7/20,25.24%,CLCN4;SLC35E1;TMEM241;SLC35C2;SLC35E2B;SLC35E2A;SLC25A11
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.45138340423419565,0.9262418651043349,0.5779036827195467,0.9121581139969243,1.0,6/11,31.13%,AKR1C1;AKR1A1;AKR1B10;RDH14;RDH13;ALDH3A1
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),0.44213142984050025,0.9260617553639118,0.5603328710124826,0.9099493590672227,1.0,3/12,12.36%,PIK3C2B;ATM;PIK3CB
prerank,death receptor activity (GO:0005035),-0.36220067514949394,-0.9258348943770703,0.5659722222222222,0.9036398420498754,1.0,5/11,18.12%,TNFRSF19;FAS;TNFRSF1A;TNFRSF11A;TNFRSF25
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.398812585365059,0.9256712564388362,0.5943517329910141,0.90826764816252,1.0,7/21,26.26%,REV3L;POLE2;POLB;REV1;PRIMPOL;POLD1;POLG
prerank,phosphatase inhibitor activity (GO:0019212),0.39773201190947344,0.9253099513553,0.5554123711340206,0.9065815630769395,1.0,11/20,27.66%,PPP1R9B;URI1;CABIN1;ARPP19;STYX;SAG;BOD1L1;LMTK2;ANP32E;MGAT5;PPME1
prerank,adenylate cyclase binding (GO:0008179),-0.3778303209066306,-0.925201257018802,0.54,0.895385022937221,1.0,3/10,5.06%,ADCY5;CAP2;AKAP6
prerank,hexosyltransferase activity (GO:0016758),0.3256741796348104,0.9239120272305148,0.6177083333333333,0.9070647457518928,1.0,32/101,29.48%,EXT1;CHPF2;POGLUT3;B3GNT7;POGLUT1;B4GALT1;B4GALT5;OGT;MGAT4B;FUT4;HEXA;B3GNT9;B4GAT1;B3GNT6;ALG1;TMTC1;EXT2;GCNT7;B4GALNT3;B3GNT2;PIGV;DPY19L2;B4GALT7;POMT1;ALG12;RFNG;PIGB;B3GAT3;ALG9;DPY19L4;B3GALNT2;HAS3
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),-0.38811190326511,-0.9214153286720121,0.5728476821192053,0.8955504575013044,1.0,6/10,17.63%,CXADR;CD200;PKP2;SIRPA;DSP;CD47
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.370001444113651,0.9195563243869425,0.5834348355663824,0.9138064399448432,1.0,14/29,33.67%,ACER3;GAA;GALC;HEXD;GANAB;PARG;GUSB;ADPRS;GANC;CTBS;MGAM;HPSE;GBA2;HYAL3
prerank,protein kinase regulator activity (GO:0019887),0.3258872860855067,0.9177860110846785,0.6277602523659306,0.9150658143246237,1.0,33/95,27.17%,FGF13;STRADA;CCNL2;KIDINS220;CCNL1;GMFB;MADD;CCNT2;PARVA;WNK1;CCNG2;CCNE2;HEXIM1;GSKIP;CDKN1C;PRKAG1;ELP4;DUSP19;PRKAR2A;ELP3;RPTOR;TAOK3;SMCR8;YWHAB;MAPK8IP1;QARS1;DAXX;CCNC;SOCS1;NCK1;WNT11;SH3BP5;CNPPD1
prerank,voltage-gated ion channel activity (GO:0005244),-0.33635330036219524,-0.9169747994144989,0.5555555555555556,0.8978329087058347,1.0,3/14,8.49%,CACNA1E;KCND2;ANO6
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),0.3863970776018234,0.9157583711346208,0.5699873896595208,0.9170139878034718,1.0,4/23,4.85%,PDE11A;PDE6C;PDE3A;PDE6A
prerank,peptide hormone receptor binding (GO:0051428),0.4484470858897954,0.9143949660680618,0.5958041958041959,0.9173895456742994,1.0,2/11,15.56%,VIP;PSMC5
prerank,adenyl ribonucleotide binding (GO:0032559),0.3063897517737102,0.9129921245743925,0.7158634538152611,0.9178959959065867,1.0,67/291,18.96%,PRPS2;ME1;ABCD3;N4BP2;GCLC;MARK1;ACVR1B;HSPA2;SMC4;MAP3K5;TNK1;ACVR1;ERN2;TLK1;ABCF1;IRAK3;RPS6KA4;AK6;AKT2;HSPA14;PIP4K2B;PEX1;ABL1;NVL;MAP4K5;TDG;ABCE1;ABCB8;BMPR1A;HSPA5;DARS2;LONP1;UHMK1;TGFBR1;EIF4G1;LIG4;ABCA1;PI4K2A;DMPK;MARK4;WNK1;SRR;ABCB6;SRPK1;CLP1;TBCK;LATS2;HACL1;CDC42BPB;TLK2;IDE;MPPED2;HASPIN;YARS2;PGK1;MKNK2;SIK2;PRKAG1;DAPK3;BCKDK;CAD;PEX6;MAST2;AKT1;CHD8;RAD51;SARS2
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),0.3958318397944725,0.9118956368487277,0.5989847715736041,0.9176906792978754,1.0,7/22,20.94%,FAAP20;TAB2;SQSTM1;ATRIP;IKBKE;ZRANB1;OPTN
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",0.35960464811100207,0.9100920930674473,0.6095808383233533,0.9189545438126335,1.0,6/34,9.17%,CYTH3;ARAP1;GAB2;GBF1;OGT;DAPP1
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.3668924261823076,0.908293677206271,0.6124567474048442,0.9202061194454718,1.0,7/33,17.06%,ERI3;REXO2;DIS3L2;XRN1;EXOSC4;CNOT8;DIS3
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.3623907738018376,0.9079603191847578,0.600715137067938,0.9184744004642197,1.0,6/35,14.23%,PKDCC;CLK1;TNK1;ABL1;SRMS;FRK
prerank,SUMO binding (GO:0032183),0.42364043574841376,0.9068063765443239,0.5972027972027972,0.9183205998297799,1.0,8/13,35.84%,TDG;USPL1;RNF4;SIMC1;RNF111;HERC2;USP25;CBX4
prerank,tau protein binding (GO:0048156),-0.2574318854192218,-0.9056074559477644,0.636986301369863,0.9164624038582451,1.0,4/40,2.53%,ROCK2;APOE;MAP2;PICALM
prerank,endopeptidase inhibitor activity (GO:0004866),0.32615042066456723,0.9056021298677436,0.640171858216971,0.9182423754170543,1.0,16/82,19.32%,SERPINH1;TIMP2;TIMP3;RARRES1;ANXA2;CARD16;SERPINF1;CST3;SERPINB9;SERPINE2;CRB2;RENBP;BIRC6;SERPING1;CAST;UCHL5
prerank,amino acid binding (GO:0016597),0.37158604419323127,0.9054526943891914,0.6137440758293838,0.9160987341627465,1.0,10/31,20.40%,GCLC;GRIN3A;DDAH1;CASTOR2;SRR;SHMT2;GNMT;CAD;SHMT1;GLRB
prerank,ATPase activator activity (GO:0001671),0.3936483704629702,0.905000820090097,0.6103404791929382,0.9145427815141591,1.0,2/20,5.10%,ATP1B1;DNAJA2
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),0.3989593493202233,0.9026044835109458,0.6069986541049798,0.917131138743218,1.0,4/18,8.51%,SOCS7;SOCS4;SOCS6;SOCS2
prerank,phosphatidylglycerol binding (GO:1901611),0.42405158414246064,0.9025594041694218,0.614950634696756,0.9147568462212523,1.0,5/13,23.38%,PITPNC1;PITPNA;GSDME;UQCC3;STOML2
prerank,nucleoside-diphosphatase activity (GO:0017110),0.4289603833876051,0.9009268301554744,0.597997138769671,0.9156504939893201,1.0,6/12,27.74%,ENTPD2;ENTPD6;ENTPD7;ENTPD5;NUDT18;CANT1
prerank,vinculin binding (GO:0017166),-0.36108698521700455,-0.9003085699508774,0.5664335664335665,0.9203238962195869,1.0,4/11,5.16%,UTRN;DAG1;CORO2B;SYNM
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),-0.35353193945567823,-0.8974348041934325,0.5704697986577181,0.9180939398279419,1.0,1/11,4.13%,NUDT4
prerank,sulfotransferase activity (GO:0008146),0.3579392609751496,0.8950201714486794,0.6227327690447401,0.9252651700677813,1.0,3/33,2.94%,SULT1C2;SULT1C4;CHST11
prerank,transmitter-gated ion channel activity (GO:0022824),0.3699452978740394,0.8942520473747391,0.6104060913705583,0.9242975778591953,1.0,2/29,5.17%,GRIK4;GABRA3
prerank,CCR chemokine receptor binding (GO:0048020),0.36819638831614276,0.8931973069228696,0.6162361623616236,0.9240196551839674,1.0,3/28,12.09%,CCL13;CCL15;DEFB1
prerank,protein kinase activator activity (GO:0030295),0.3303048448070769,0.8901830733248363,0.6499454743729552,0.9275268571598403,1.0,19/60,26.37%,GAS6;FGF13;STRADA;CALM2;ABI1;PAK2;MADD;WNK1;IQGAP1;CALM3;DBF4;DUSP19;FAM20A;RPTOR;STK3;DAXX;TAOK1;IGF2;WNT11
prerank,kinesin binding (GO:0019894),0.3720364230533779,0.8885128837320466,0.6349009900990099,0.9284997708706416,1.0,12/27,29.25%,KLC2;PLEKHM2;IFT88;SPAG9;KIF1B;ARHGEF10;MAPK8IP3;FAM83D;MAPK8IP1;NEK6;TTBK2;KIFAP3
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.41952386158208366,0.8883981196401971,0.6077586206896551,0.9263129690704016,1.0,2/11,15.18%,SLC25A25;SLC35B3
prerank,cytokine receptor binding (GO:0005126),0.3170682295312926,0.887611809374392,0.6855614973262032,0.925414786788853,1.0,5/83,4.20%,PGF;VEGFA;INHBC;SPRED2;TGFB2
prerank,ephrin receptor activity (GO:0005003),0.39575641387594357,0.8870736803105207,0.595360824742268,0.9216033397246671,1.0,3/17,5.81%,EPHB2;EPHB3;EPHB6
prerank,transmembrane-ephrin receptor activity (GO:0005005),0.39575641387594357,0.8870736803105207,0.595360824742268,0.9216033397246671,1.0,3/17,5.81%,EPHB2;EPHB3;EPHB6
prerank,protein tyrosine kinase activity (GO:0004713),0.3142938717164981,0.8867822814125568,0.697286012526096,0.9197368731689376,1.0,16/108,10.58%,EGFR;PKDCC;DDR2;CLK1;NTRK3;NTRK1;EPHB2;SCYL1;TNK1;EPHB3;EPHB6;FGFR1;ROR1;FGFR2;MUSK;ABL1
prerank,ATPase regulator activity (GO:0060590),0.3532803728072339,0.8861401697614949,0.6425233644859814,0.9186143759240766,1.0,15/38,31.19%,ATP1B1;BAG3;DNAJA2;SIL1;GRPEL1;DNAJA1;DNAJC24;DNAJC1;KATNB1;BAG1;TOR1AIP1;TOR1AIP2;DNAJB1;GRPEL2;HSPH1
prerank,deoxyribonuclease activity (GO:0004536),0.41003821274390634,0.8814798292267509,0.6194331983805668,0.9253725981081148,1.0,8/14,36.01%,ERCC5;ERCC4;DFFB;ZRANB3;DNASE1L2;MBD4;MRE11;APLF
prerank,endopeptidase activator activity (GO:0061133),-0.370528992994839,-0.8811630487584206,0.5894039735099338,0.9492754858241362,1.0,7/10,29.94%,PSME3;PSME1;APH1B;NLRC4;PSME2;APH1A;PSENEN
prerank,estrogen receptor binding (GO:0030331),0.35440560899402174,0.8808860558260867,0.6399506781750924,0.9240784450840565,1.0,8/32,18.78%,ESR1;NRIP1;NSD1;DCAF13;MMS19;DNAAF4;LCOR;CCDC62
prerank,triglyceride lipase activity (GO:0004806),0.382048949372088,0.8808314246730984,0.6426735218508998,0.9218161167235261,1.0,4/20,20.83%,CEL;PNPLA3;PLA2G15;DAGLB
prerank,galactosyltransferase activity (GO:0008378),0.43215735744974254,0.8789937634884359,0.6312849162011173,0.9229483534730366,1.0,4/11,23.30%,B4GALT1;B4GALT5;B3GNT6;B4GALT7
prerank,motor activity (GO:0003774),-0.2241981519898007,-0.8755225703535859,0.6941176470588235,0.9527420668951957,1.0,20/60,17.89%,STARD9;DYNC1I1;MYO6;KIF3C;MYL6;MYH9;KIF18A;KIFC3;KIF26A;KIFC2;KIF1A;KIF1C;KIF11;KIF5B;KIF26B;KIF15;KIF21B;DNAH3;GPR88;KIF27
prerank,1-phosphatidylinositol binding (GO:0005545),-0.31203070979850533,-0.8736227156085609,0.6228373702422145,0.9477419917066688,1.0,5/15,11.88%,EPB41;PICALM;ZFYVE9;SESTD1;SCARB1
prerank,delayed rectifier potassium channel activity (GO:0005251),0.3559054220511217,0.8726186370243652,0.6666666666666666,0.9325963042841259,1.0,3/32,12.84%,KCNB1;KCNE5;KCNG3
prerank,metallocarboxypeptidase activity (GO:0004181),-0.2786358651432457,-0.8719268935323156,0.6878306878306878,0.9421585770460765,1.0,3/26,3.51%,AEBP1;CPM;AGBL4
prerank,protein tyrosine phosphatase activity (GO:0004725),0.31624957664385267,0.8712126796396529,0.6907327586206896,0.9329142317426046,1.0,14/71,14.36%,EYA2;UBASH3B;PTPN3;PTPRS;PTPRF;PTP4A2;DUSP11;PTPRU;CDC14A;PTPN18;CDC25B;PTPDC1;PTPN2;DUSP18
prerank,GTPase activator activity (GO:0005096),0.2936107680517943,0.8710672113477966,0.8234704112337011,0.9307881369895178,1.0,74/313,17.28%,SGSM2;PLCE1;SRGAP2;ARHGEF28;CYTH3;ARFGAP1;ARFGAP3;ASAP3;TIAM1;ARAP1;FARP1;NPRL3;DOCK4;RCC1L;ANKRD27;VAV2;TBC1D8B;TBC1D2B;SIPA1L1;SEC23A;FGD6;ARHGAP17;RABGEF1;RAB3GAP1;DENND6A;EPS8L1;CDC42EP2;LAMTOR1;RASGEF1B;RIC1;ARFGAP2;BCR;DOCK5;LLGL1;MON1A;PGAM5;ADAP1;KALRN;RGPD1;RGP1;MADD;RCC1;ARHGAP20;EVI5L;ARHGAP8;IQSEC2;NRP1;STXBP5;TBC1D9B;ARHGAP44;OCRL;GAPVD1;TBC1D25;WDR41;NUCB1;PREB;RANBP2;HPS4;TBCK;FARP2;TBC1D10A;SIPA1L3;AKAP13;SOS1;ARRB1;IQGAP1;TBC1D17;TAGAP;TBCD;EEF1B2;NF1;DIS3;NGEF;FLCN
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),0.4091239174554324,0.8703983608431787,0.6497252747252747,0.929700471114029,1.0,9/14,33.90%,MTMR11;SYNJ1;MTMR10;MTMR1;MTM1;MTMR2;MTMR12;MTMR9;MTMR4
prerank,cAMP response element binding (GO:0035497),-0.3556437336570779,-0.8695871588811593,0.6459627329192547,0.9385141235962944,1.0,1/10,0.38%,CREB5
prerank,CoA hydrolase activity (GO:0016289),0.3925944144343188,0.8689700588386757,0.6378162450066578,0.9299458275664703,1.0,5/16,27.10%,ACOT11;ACOT13;ABCD1;ACOT8;HIBCH
prerank,carboxylic ester hydrolase activity (GO:0052689),0.31109331498801696,0.8687653489171763,0.7197452229299363,0.927985534682749,1.0,13/85,18.90%,MGLL;PLA2G4F;PLA2G4A;CEL;ABHD6;PTRH2;PAFAH1B2;PLA2G12A;PNPLA3;GDPD3;PLA2G15;PNPLA7;PAFAH1B3
prerank,phosphatidic acid binding (GO:0070300),0.38282137209012085,0.8680517333051451,0.6697127937336814,0.9268957743471523,1.0,3/19,4.74%,PITPNC1;MARK1;PITPNM1
prerank,pyridoxal phosphate binding (GO:0030170),0.38107465711974353,0.86556911753775,0.6481958762886598,0.929014617669769,1.0,5/20,19.03%,PYGB;SRR;SHMT2;SHMT1;PSAT1
prerank,acyl-CoA hydrolase activity (GO:0047617),0.38800245700417313,0.8643534341094103,0.6551264980026631,0.9290216433269457,1.0,4/17,24.66%,ACOT11;ACOT13;ABCD1;ACOT8
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),0.37145545079669856,0.8621491244227485,0.6542416452442159,0.9306233970917508,1.0,3/21,8.42%,DRD1;CHRNB2;CHRNA5
prerank,actinin binding (GO:0042805),0.3693948634451535,0.8615463743354714,0.668,0.929326164515027,1.0,4/21,15.51%,CACNA1C;RARA;CSRP3;PKD2L1
prerank,ribonuclease P RNA binding (GO:0033204),0.42554400378749757,0.8606535649207125,0.6461086637298091,0.9286273849966689,1.0,4/10,27.06%,RPP40;RPP14;RPP21;POP5
prerank,cytokine receptor activity (GO:0004896),0.3093931092771404,0.8598170234907737,0.7438894792773645,0.9278071191955544,1.0,8/83,8.46%,CMKLR1;F3;GHR;CNTFR;MPL;IL12RB2;IFNLR1;ACKR4
prerank,rRNA binding (GO:0019843),0.33206052312364787,0.8593971739789991,0.6789838337182448,0.926262561261406,1.0,15/42,29.73%,RCC1L;RRS1;EMG1;PPAN;PTCD3;CAVIN1;CIRBP;SBDS;GTF3A;MRPS18A;RPS9;NOP53;MRPL11;RPF2;ERI1
prerank,epidermal growth factor receptor binding (GO:0005154),0.3615071735965505,0.8591462426183399,0.698992443324937,0.9243989414421317,1.0,9/25,23.27%,SHC1;SNX2;AGR2;ARF4;SNX1;HIP1;CNOT9;ATXN2;SNX4
prerank,calcium-activated potassium channel activity (GO:0015269),0.41885120926834474,0.8590268757190712,0.645021645021645,0.9223548208111708,1.0,3/11,16.56%,KCNN1;PKD2L1;KCNN4
prerank,titin binding (GO:0031432),0.4064827198765606,0.8574473574786385,0.6375,0.9227711413787023,1.0,2/13,5.05%,CAMK2D;CALM2
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.33265736036548543,0.8574076474127824,0.64947245017585,0.9205764949042995,1.0,5/38,13.24%,SERPINH1;ANXA2;SERPINF1;SERPINB9;SERPINE2
prerank,GABA receptor binding (GO:0050811),-0.3368154491820038,-0.8571359642211556,0.6737588652482269,0.9580089913399673,1.0,4/11,16.55%,TRAK2;TRAK1;GABARAP;GABARAPL1
prerank,channel activity (GO:0015267),-0.24212995499665205,-0.8571094095792303,0.7430555555555556,0.9488381459717906,1.0,10/41,17.80%,BCL2;AQP11;TRPV2;CHRNB1;KCNK3;MCUB;TMEM120B;TRPV4;SLC14A1;TRPA1
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.31169278238502346,0.8567969508051365,0.7204301075268817,0.9194089922092614,1.0,24/69,27.38%,PLA2G4A;SOAT1;LPCAT4;LPCAT3;KAT6B;ZDHHC16;NAA16;HHAT;GLYAT;ZDHHC13;CREBBP;PLA2G15;LIPT1;ZDHHC20;ELP3;MCAT;KAT8;ZDHHC9;KAT2B;NMT1;CERS3;NAA15;ESCO1;SOAT2
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.3588268592618162,0.8540793522093348,0.6645807259073843,0.921934328994429,1.0,13/27,29.93%,POLR3H;CRCP;POLR2F;MED21;POLR3K;MED20;POLR1D;POLR1C;POLR2B;PRIMPOL;PRIM1;POLR2I;POLR2L
prerank,lipase activity (GO:0016298),0.33033118524279337,0.8534147179800702,0.694021101992966,0.9209373805253886,1.0,8/43,22.64%,MGLL;CEL;ABHD6;PNPLA3;PLA2G15;SEC23IP;DAGLB;ABHD12
prerank,metalloexopeptidase activity (GO:0008235),0.3200440475078216,0.8532961528902451,0.7066817667044167,0.918883591444723,1.0,18/51,24.74%,CPZ;CPQ;MMP14;XPNPEP1;AGBL5;AGBL3;MMP16;LNPEP;CPXM2;LAP3;NPEPPS;LVRN;CPB2;RNPEPL1;METAP1D;DPEP1;METAP2;VASH1
prerank,protein serine/threonine kinase activator activity (GO:0043539),0.34087272096282845,0.853259833788962,0.6828402366863905,0.9167178424938064,1.0,11/34,26.36%,STRADA;CALM2;CCNT2;IQGAP1;CALM3;DBF4;CKS1B;FAM20A;STK3;TAOK1;IGF2
prerank,GTPase regulator activity (GO:0030695),0.2872607813318622,0.8520931205147948,0.8180904522613065,0.91647057344398,1.0,46/212,16.38%,SLIT2;SGSM2;SRGAP2;ARFGAP1;ARFGAP3;ASAP3;ARAP1;NPRL3;TBC1D8B;GDI1;TBC1D2B;SIPA1L1;SEC23A;IPO5;ARHGAP17;RAB3GAP1;CDC42EP2;ARFGAP2;BCR;LLGL1;GPS1;PDE6D;PGAM5;ADAP1;RGPD1;ARHGAP20;EVI5L;ARHGAP8;NRP1;STXBP5;TBC1D9B;ARHGAP44;OCRL;TBC1D25;ARL2;PREB;RANBP2;TBCK;TBC1D10A;SIPA1L3;SOS1;ARRB1;IQGAP1;TBC1D17;TAGAP;TBCD
prerank,carboxy-lyase activity (GO:0016831),0.3640811958336361,0.8514241325606896,0.6734434561626429,0.9154322156168708,1.0,5/23,22.16%,GGCX;CSAD;AZIN1;ACOD1;ECHDC1
prerank,ribonuclease P activity (GO:0004526),0.4135521119698369,0.8508085760971427,0.6661786237188873,0.9143181630568731,1.0,5/11,30.83%,RPP40;RPP14;RPP21;POP5;PRORP
prerank,phosphatase activator activity (GO:0019211),0.3956229194037867,0.8494414469299758,0.6698240866035182,0.9143578449445959,1.0,4/14,16.85%,CALM2;GTF2F1;PPP2R5C;CALM3
prerank,SH2 domain binding (GO:0042169),0.33899193878315853,0.8489009987113764,0.6881720430107527,0.9131430548197792,1.0,5/31,14.32%,IRS1;SH3PXD2B;ABL1;KHDRBS1;SQSTM1
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.40571601891083536,0.8480770822247023,0.662873399715505,0.9123982999890582,1.0,2/12,6.77%,TENT4B;TENT5A
prerank,protein kinase A catalytic subunit binding (GO:0034236),-0.3133181793797046,-0.847534700540838,0.6759581881533101,0.9607848060030688,1.0,3/13,6.41%,RYR2;PRKAR2B;PRKAR1B
prerank,voltage-gated chloride channel activity (GO:0005247),-0.3487602975907912,-0.8465473677437284,0.6655948553054662,0.9535712665930681,1.0,2/10,8.49%,ANO1;ANO6
prerank,dipeptidyl-peptidase activity (GO:0008239),-0.3530478779157774,-0.8463205649563551,0.6395759717314488,0.9451647471051154,1.0,3/10,8.91%,DPP4;DPP10;DPP6
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",0.35828272695254865,0.8447171770565525,0.6733668341708543,0.9157099437761215,1.0,4/23,9.25%,PLEKHA4;GBF1;WIPI2;SH3PXD2B
prerank,water transmembrane transporter activity (GO:0005372),0.41020646189793464,0.8445359891343204,0.6623931623931624,0.9138627061111105,1.0,1/11,5.65%,SLC4A11
prerank,double-stranded RNA binding (GO:0003725),0.3055061473977604,0.8441464869479889,0.7389428263214671,0.9123564769966975,1.0,12/70,14.08%,STRBP;SIDT2;MBNL1;PRKRA;ILF3;AGO1;DGCR8;EIF4A1;AGO2;HSPD1;SUPV3L1;CLTC
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),0.41495945005333845,0.8437360696404517,0.6790830945558739,0.9086295438215198,1.0,6/11,31.19%,BAG3;SIL1;GRPEL1;BAG1;GRPEL2;HSPH1
prerank,adenyl nucleotide binding (GO:0030554),0.41495945005333845,0.8437360696404517,0.6790830945558739,0.9086295438215198,1.0,6/11,31.19%,BAG3;SIL1;GRPEL1;BAG1;GRPEL2;HSPH1
prerank,GDP binding (GO:0019003),0.3138865282827972,0.8407656140504041,0.7297592997811816,0.9113139831556495,1.0,22/63,32.20%,MRAS;RAB2A;RAB21;RAB8A;RAB11B;RAB3B;RASL12;RAB5B;RHEB;RAB4A;RAB18;NRAS;KRAS;RAB5A;DIRAS1;RALA;RAB5C;MIEF1;RAB27B;RAP2C;ARL3;RAB12
prerank,peptidase inhibitor activity (GO:0030414),0.3347612326907859,0.839520300465938,0.6932223543400713,0.9113575757305139,1.0,8/33,24.21%,GPC3;TIMP2;CST3;RENBP;CAST;UCHL5;SIMC1;USP14
prerank,muscle alpha-actinin binding (GO:0051371),0.38108783360046194,0.8371699073007463,0.6810810810810811,0.9129986998090251,1.0,3/15,15.51%,PDLIM7;PALLD;PKD2L1
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.33935380198949516,0.8357958315946364,0.6956521739130435,0.9131604027929167,1.0,2/29,3.41%,CIT;SPRED2
prerank,snoRNA binding (GO:0030515),0.3384680697231269,0.832305949966907,0.7216981132075472,0.9167228251450057,1.0,10/30,31.71%,TSR1;PRKDC;WDR3;BYSL;NOP56;TBL3;NOP58;DKC1;NOP10;NOP14
prerank,WW domain binding (GO:0050699),0.3430013545763584,0.8285228660765015,0.6970443349753694,0.9206383018011088,1.0,5/26,18.24%,PMEPA1;SCNN1A;NFE2;PRRG4;KIF20B
prerank,death domain binding (GO:0070513),-0.32905146492120224,-0.8277488148466615,0.659016393442623,0.9746516002062441,1.0,3/11,8.65%,BCL2;BCL2L1;DAPL1
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),0.3889551359353112,0.8265578192608095,0.6807909604519774,0.9215759829087742,1.0,4/13,17.91%,LPCAT1;GPAT4;PNPLA3;AGPAT5
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.2943774295333944,0.8229477366391279,0.7840172786177105,0.9250118092545331,1.0,15/74,16.06%,PAPSS2;PIK3C2B;NADK;SHPK;HYKK;FCSK;DGKQ;ETNK1;PANK4;DCAKD;PIK3CB;ADPGK;CLP1;CHKB;PI4KB
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),0.3467398456620959,0.8224829634014261,0.7116104868913857,0.9235933682096606,1.0,2/23,3.19%,PLCE1;EDNRA
prerank,glycine binding (GO:0016594),0.41019549245000514,0.822220981001694,0.703601108033241,0.9218812014520487,1.0,4/11,20.40%,GRIN3A;SRR;GNMT;GLRB
prerank,ephrin receptor binding (GO:0046875),0.3578706661382922,0.8222070110471925,0.7052767052767053,0.919768399154654,1.0,7/21,19.60%,EFNA5;SHC1;CBL;ABL1;EFNA1;CRK;ANKS1B
prerank,endodeoxyribonuclease activity (GO:0004520),0.35374416535598774,0.8198622187111329,0.6919060052219321,0.9213630268251168,1.0,11/20,36.81%,ERCC5;RBBP8;ERCC4;RAD50;ENDOV;ZRANB3;MBD4;ERCC1;MRE11;APLF;EXOG
prerank,peptide N-acetyltransferase activity (GO:0034212),0.4080469067219874,0.8193546215375411,0.7215189873417721,0.9200179288232944,1.0,5/10,33.33%,NAA60;NAA16;NAA15;NAA25;NAA20
prerank,monocarboxylic acid binding (GO:0033293),0.3595087266208312,0.8192420146782463,0.7117962466487936,0.9180613890727903,1.0,3/18,8.80%,RXRA;RARA;AKR1C1
prerank,GDP-dissociation inhibitor activity (GO:0005092),0.38035891078814543,0.8175763109840206,0.7072829131652661,0.9185065708112389,1.0,2/13,8.18%,GDI1;GDI2
prerank,UDP-galactosyltransferase activity (GO:0035250),0.4055208774655267,0.816392469473607,0.6937062937062937,0.9181913410240513,1.0,2/10,9.01%,B4GALT1;B4GALT5
prerank,voltage-gated cation channel activity (GO:0022843),0.2884732353539696,0.8139837542335944,0.7899786780383795,0.9196796479759669,1.0,11/97,12.84%,CACNA1C;KCNB1;GRIN3A;HCN4;CACHD1;KCNE5;KCND1;CATSPER3;ITGAV;CACNA2D2;KCNG3
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.2937888698945124,0.813843713145817,0.7719869706840391,0.9178108621189384,1.0,8/73,13.10%,GALR1;NPR3;FSHR;EDNRA;FPR3;GLP1R;F2R;MC4R
prerank,AMP binding (GO:0016208),-0.3301925682195552,-0.8123191395423643,0.7183098591549296,0.9962338956850334,1.0,3/11,8.80%,PRKAG2;ACSS2;PRKAG3
prerank,actin binding (GO:0003779),0.2734876929594082,0.8082869734865795,0.858739837398374,0.9241001888802254,1.0,26/170,13.37%,MICAL2;FXYD5;MAP1B;GSN;P4HB;PRKCE;RDX;PDLIM7;LIMA1;COBL;TNNT3;ADCY8;SPATA32;DMD;EPS8L1;PFN2;SLC6A2;GIPC1;ABL1;TLNRD1;EZR;BCL7B;CAP1;PARVA;ADD1;PFN4
prerank,active ion transmembrane transporter activity (GO:0022853),0.3158747146358807,0.8082628093969598,0.7446808510638298,0.9220408656785064,1.0,3/37,5.65%,SLCO3A1;SLCO2A1;SLC4A11
prerank,alpha-tubulin binding (GO:0043014),0.3244082488587478,0.8059463015331726,0.7601918465227818,0.9235714300019495,1.0,10/31,27.26%,TBCE;BEX4;SPAST;TRAPPC14;HDAC6;DIP2B;SETD2;TAOK1;DNAL1;EFHC1
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.3681255957957459,0.8057016955726951,0.7089655172413794,0.9218257978684788,1.0,4/14,26.01%,DHRS9;AKR1A1;DHRS3;RDH10
prerank,phospholipase binding (GO:0043274),-0.30615397400135813,-0.8052975906044496,0.7031802120141343,1.0,1.0,1/13,0.73%,ARHGAP6
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),0.3698646540976477,0.8051945763722321,0.7355704697986577,0.9205031958450087,1.0,10/16,33.90%,MTMR11;SYNJ1;MTMR10;MTMR1;MTM1;SACM1L;MTMR2;MTMR12;MTMR9;MTMR4
prerank,U6 snRNA binding (GO:0017070),0.3726791012945839,0.8049245250652477,0.7372654155495979,0.9188978423432782,1.0,5/14,25.10%,METTL16;LSM2;RBM22;LARP7;DDX39B
prerank,ubiquitin conjugating enzyme binding (GO:0031624),0.32761278713915265,0.7994902265789994,0.7571964956195244,0.9247487247272399,1.0,4/27,12.60%,RNF144A;DCUN1D5;RNF14;DCUN1D2
prerank,kinase activator activity (GO:0019209),0.3250839290205868,0.7993406763797516,0.7434052757793765,0.922884395892689,1.0,8/30,26.37%,FGF13;STRADA;MADD;WNK1;DUSP19;RPTOR;DAXX;WNT11
prerank,single-stranded DNA helicase activity (GO:0017116),0.3434130448333701,0.7963916775509509,0.7430830039525692,0.9252047566806856,1.0,2/19,7.92%,HELB;MCM2
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),-0.26306046999773586,-0.7960501751243688,0.7909090909090909,1.0,1.0,5/21,10.51%,CDK6;CDK14;CDK19;CDK15;CDK8
prerank,cyclin-dependent protein kinase activity (GO:0097472),-0.26306046999773586,-0.7960501751243688,0.7909090909090909,1.0,1.0,5/21,10.51%,CDK6;CDK14;CDK19;CDK15;CDK8
prerank,MAP-kinase scaffold activity (GO:0005078),0.38529730406570956,0.7911924831220578,0.743448275862069,0.9303191316680782,1.0,7/11,25.14%,AKAP13;IQGAP1;SPAG9;DUSP19;SH3RF1;MAPK8IP3;MAPK8IP1
prerank,protein kinase A regulatory subunit binding (GO:0034237),0.3380417628736594,0.7896247680098328,0.7327365728900256,0.9303115358565189,1.0,8/21,24.92%,PRRC1;EZR;AKAP9;GSKIP;AKAP8;PRKACA;ARFGEF2;ACBD3
prerank,microtubule motor activity (GO:0003777),-0.2080125527343331,-0.7862221628863577,0.8727272727272727,1.0,1.0,15/51,16.13%,STARD9;DYNC1I1;KIF3C;KIF18A;KIFC3;KIF26A;KIFC2;KIF1A;KIF1C;KIF11;KIF5B;KIF26B;KIF15;KIF21B;DNAH3
prerank,steroid hydroxylase activity (GO:0008395),-0.27809748657803085,-0.7856768744429368,0.7736625514403292,1.0,1.0,2/16,5.32%,CYP7B1;CYP27A1
prerank,PDZ domain binding (GO:0030165),0.2898638295245462,0.7843699298447256,0.806695464362851,0.9356856008862626,1.0,9/61,9.50%,CIT;CRIM1;DOCK4;SLC26A6;ERC1;KIDINS220;FZD7;DLG4;NSF
prerank,RNA stem-loop binding (GO:0035613),-0.3080400735653284,-0.7841723661583895,0.7344262295081967,0.9952231094277045,1.0,3/12,9.59%,MYH10;DDX3X;ZC3H12A
prerank,protein phosphatase regulator activity (GO:0019888),0.2945516770549049,0.7837927370571677,0.7924107142857143,0.9343861509012107,1.0,23/53,29.04%,PPP1R9B;CALM2;PPP6R1;PPP6R3;RCAN1;CABIN1;SHOC2;DMPK;PPP2R2D;ARPP19;PPP2R5C;CALM3;PPP6R2;SAG;RCAN3;PPP1R7;BOD1L1;LMTK2;MGAT5;PPP2R1A;PPME1;B3GAT3;PPP2R1B
prerank,poly(A)-specific ribonuclease activity (GO:0004535),-0.30203549282472,-0.7803363019777115,0.7571428571428571,0.9933982399146177,1.0,3/12,13.07%,CNOT1;NOCT;CNOT6L
prerank,purinergic nucleotide receptor activity (GO:0001614),-0.2844419124876508,-0.7784171134046712,0.7962264150943397,0.9881609584298744,1.0,11/15,42.17%,P2RY14;GPR34;P2RY1;P2RX7;P2RX5;P2RX3;GPR171;P2RX1;GPR87;P2RY13;P2RX6
prerank,neuropeptide hormone activity (GO:0005184),0.33353491077093567,0.7781955978107521,0.7554980595084088,0.9400004079426959,1.0,7/22,33.65%,VIP;AGRP;PENK;NMB;SPX;HCRT;NPFF
prerank,P-type ion transporter activity (GO:0015662),-0.29050584835544163,-0.777460910266564,0.7847222222222222,0.9812333502249224,1.0,2/12,8.72%,ATP2B1;ATP2A3
prerank,tau-protein kinase activity (GO:0050321),0.3360706992405187,0.7773541241362827,0.756687898089172,0.9390816909597085,1.0,7/20,28.20%,MARK1;MARK4;CDK5;ROCK1;TAOK2;TAOK1;TTBK2
prerank,phosphatase activity (GO:0016791),0.28301011998042624,0.7764335735866403,0.816017316017316,0.9382876949462035,1.0,8/73,8.39%,ALPL;PLPP3;PPP1CC;PLPP5;DUSP11;PLPP1;PGAM5;NANP
prerank,ubiquitin-dependent protein binding (GO:0140036),0.38279392259305745,0.7762135428145157,0.746705710102489,0.936518617258445,1.0,3/10,22.10%,FAAP20;IDE;DNAJC2
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),-0.20289664389531412,-0.7755849456494979,0.88,0.9757497351922955,1.0,17/57,24.70%,COX8A;NDUFC2;COX4I1;UQCR11;COX10;NDUFA13;NDUFB2;NDUFB7;COX5B;UQCRC1;NDUFS1;NDUFA4L2;NDUFA8;UQCRQ;NDUFS6;NDUFA4;CYB561D2
prerank,beta-tubulin binding (GO:0048487),0.308658347952663,0.7739632803353526,0.7722289890377588,0.93760066008663,1.0,4/31,9.94%,FGF13;BCAS3;SMC3;SPAST
prerank,carboxypeptidase activity (GO:0004180),-0.22384508188618163,-0.7694193096224053,0.8609271523178808,0.9773022708622305,1.0,3/35,3.51%,AEBP1;CPM;AGBL4
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.3093680074472549,0.7685724535589317,0.7865429234338747,0.9427464802622247,1.0,6/34,17.06%,ERI3;REXO2;DIS3L2;EXOSC4;CNOT8;DIS3
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),-0.25099687213572475,-0.7674475116326904,0.8486238532110092,0.9722659966158561,1.0,5/24,9.79%,OSBPL8;PLEKHA5;CERT1;SESTD1;LANCL2
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.35409974073734535,0.7654068688109891,0.7514044943820225,0.9448850599499538,1.0,2/12,15.18%,SLC25A25;SLC35B3
prerank,nucleotide diphosphatase activity (GO:0004551),-0.27663537436552194,-0.764838663323413,0.76171875,0.9682856452701452,1.0,5/14,19.19%,ENPP1;NUDT4;CILP;NUDT12;CILP2
prerank,peptidoglycan binding (GO:0042834),0.38198055716014384,0.7589963078407336,0.7905308464849354,0.9514021128943619,1.0,1/10,4.59%,RNASE7
prerank,calcium activated cation channel activity (GO:0005227),0.3386458112798545,0.7580541558351224,0.7839262187088274,0.9505662670830766,1.0,4/17,16.56%,KCNN1;TRPM4;PKD2L1;KCNN4
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),-0.2889072953064734,-0.7565025636752887,0.7900355871886121,0.9723952976234652,1.0,3/12,10.51%,CDK6;CDK19;CDK8
prerank,protein heterodimerization activity (GO:0046982),0.26029475447593653,0.7560920378316939,0.9092741935483871,0.9510183463190788,1.0,28/178,14.25%,EXT1;KCNB1;ATP1B1;P4HB;SNX2;CD3E;ATF4;ADCY8;BHLHE40;IRAK3;SMC3;SNX1;CHUK;IRAK1;RCC1;BCL2L2;NEUROD2;AOC3;TENM1;MICU2;HEXA;ADD1;PAFAH1B2;NPAS1;MEF2A;YWHAE;NOLC1;MICU1
prerank,neuropeptide receptor binding (GO:0071855),0.3474224222774056,0.7558557975514637,0.7664835164835165,0.9492760598223672,1.0,2/14,12.24%,SHANK1;AGRP
prerank,protein tyrosine kinase binding (GO:1990782),0.27767979194616016,0.7557173959351178,0.8358369098712446,0.947431336689201,1.0,12/71,14.32%,GAS6;DOCK4;PRR7;SHC1;PITPNM1;ACVR1;NOX4;CBL;ANGPT4;KHDRBS1;PTPN2;SQSTM1
prerank,exonuclease activity (GO:0004527),0.2879236529757105,0.7557051744362371,0.8316268486916951,0.9454236678927909,1.0,9/46,16.06%,REV3L;REXO2;RAD1;WRN;REXO1;RAD50;DCLRE1B;EXOSC4;AEN
prerank,tubulin binding (GO:0015631),0.25359712107510574,0.754627864998265,0.968937875751503,0.9447358086769146,1.0,67/295,22.74%,MAP7D3;FGF13;MAP1B;CFAP157;STMND1;KIF13A;TBCE;TTLL2;MID1;RAE1;TUBGCP3;BCAS3;DNM2;BLOC1S2;GPAA1;SYBU;ALMS1;NDRG1;BEX4;SMC3;AGBL5;TPGS1;SPAST;MTUS1;MACO1;EML3;CKAP5;CCDC66;GIT1;RAB11FIP5;RCC2;MID2;EZR;CHP1;TRAPPC14;MAPRE3;REEP3;MARK4;NDEL1;RMDN1;HDAC6;TBCD;VBP1;POLB;DIP2B;KIF20B;KATNA1;BIRC5;MAST2;KIF6;KIF1B;CDK5;DLGAP5;APPL1;DCTN1;CCDC61;STMN2;CLIP2;KIF21A;RITA1;CRIPT;SBDS;LRRK2;CDK5RAP2;SETD2;PEX14;CAPN6
prerank,phospholipase C activity (GO:0004629),0.31344296561098567,0.7522982421402846,0.7933168316831684,0.9456197434337941,1.0,2/25,3.19%,PLCE1;EDNRA
prerank,palmitoyltransferase activity (GO:0016409),-0.23271307901007005,-0.7510665172795271,0.8449197860962567,0.9726251197369897,1.0,13/28,28.06%,ZDHHC14;GLUL;ZDHHC18;ZDHHC3;ZDHHC2;ZDHHC23;ZDHHC12;ZDHHC21;ZDHHC7;ZDHHC6;GOLGA7B;ZDHHC24;ZDHHC22
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),0.34358115630014374,0.7504160291506181,0.7909215955983494,0.945938256691882,1.0,4/15,17.91%,LPCAT1;GPAT4;PNPLA3;AGPAT5
prerank,calcium:sodium antiporter activity (GO:0005432),0.3678860182933077,0.7492139388162844,0.7675753228120517,0.9453791640183461,1.0,1/10,1.39%,SLC24A3
prerank,extracellular ligand-gated ion channel activity (GO:0005230),0.36718668544450606,0.7480837691902855,0.7597597597597597,0.9448537433755205,1.0,1/10,5.17%,GABRA3
prerank,exopeptidase activity (GO:0008238),-0.2056576901376499,-0.7474662339018292,0.9428571428571428,0.9699673350229846,1.0,9/50,12.56%,DPP4;DPP10;CPM;ENPEP;TRHDE;ACE;DPP6;ACE2;GGH
prerank,microtubule binding (GO:0008017),0.2526755927142743,0.7462521639318129,0.9466800804828974,0.9451614436439707,1.0,51/222,22.74%,MAP7D3;FGF13;MAP1B;CFAP157;KIF13A;MID1;RAE1;CLIP4;TUBGCP3;DNM2;SYBU;ALMS1;NDRG1;STIM1;TPGS1;SPAST;MTUS1;MACO1;EML3;CKAP5;CCDC66;RCC2;MID2;EZR;CHP1;MAPRE3;REEP3;MARK4;NDEL1;RMDN1;HDAC6;POLB;KIF20B;KATNA1;BIRC5;MAST2;KIF6;KIF1B;CDK5;DLGAP5;DCTN1;CCDC61;CLIP2;KIF21A;CRIPT;SBDS;LRRK2;CDK5RAP2;CAMSAP3;PEX14;CAPN6
prerank,CXCR chemokine receptor binding (GO:0045236),0.3694382781402429,0.7455226078480929,0.7727910238429172,0.9440713886601306,1.0,2/11,10.98%,ITCH;YARS1
prerank,cardiolipin binding (GO:1901612),0.3689421464389089,0.7451923024014644,0.8008720930232558,0.9424509123790592,1.0,4/10,30.99%,GSDME;UQCC3;STOML2;PLEKHN1
prerank,NAD+ binding (GO:0070403),0.36197757912088946,0.7446245598585275,0.7821067821067821,0.9411600602351843,1.0,3/12,15.49%,SIRT5;SIRT2;CRYL1
prerank,histone acetyltransferase binding (GO:0035035),0.31091485740049507,0.7400833089693744,0.8125786163522013,0.944706700241077,1.0,7/21,24.29%,BCAS3;MEF2A;SIRT2;CITED2;KANSL1;GLI3;TP53
prerank,GABA-gated chloride ion channel activity (GO:0022851),-0.29147569307923743,-0.738777015703102,0.7704918032786885,0.9741088438338277,1.0,4/12,13.23%,GABRB1;GABRB3;GABRB2;GABRA5
prerank,glucose transmembrane transporter activity (GO:0005355),0.3321979562613949,0.7352842332443171,0.7867549668874172,0.9484837206325321,1.0,3/17,17.10%,SLC5A2;SLC2A2;SLC2A10
prerank,ribosomal small subunit binding (GO:0043024),-0.25737770555004574,-0.7321672745756058,0.8298755186721992,0.9754217556960542,1.0,2/17,5.11%,CPEB2;DDX3X
prerank,mRNA 3'-UTR binding (GO:0003730),0.2631204467285213,0.7321234773546441,0.88,0.9502153341222169,1.0,28/79,29.94%,DDX5;YBX3;PABPC1;PUM1;CRYZ;HNRNPA2B1;ILF3;PCBP4;DAZAP1;AUH;RBM4;HNRNPC;EXOSC4;SECISBP2;CIRBP;FXR2;RNF20;HNRNPU;TP53;RBM24;PABPC4;RPL41;CCT5;FXR1;LARP1;PUM2;ZFP36L1;KHSRP
prerank,alanine transmembrane transporter activity (GO:0022858),0.3481840960908218,0.7310708179240952,0.8019125683060109,0.9494895428752506,1.0,4/12,23.41%,SLC38A3;SLC1A4;SLC3A2;SLC36A1
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),0.34633739252938667,0.7288326934577317,0.8152173913043478,0.9500835170048381,1.0,4/13,15.88%,PIK3C2B;PIP4K2B;PIK3CB;PIP5K1A
prerank,retinoic acid receptor binding (GO:0042974),0.3213734814044891,0.7279038055622197,0.819672131147541,0.9491709587829572,1.0,5/17,17.75%,NRIP1;NSD1;MED25;VDR;HMGA1
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.28579420379450643,0.7260497145618837,0.8444976076555024,0.9493042816467206,1.0,4/33,12.60%,RNF144A;DCUN1D5;RNF14;DCUN1D2
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",0.3329826590395082,0.7223048342376474,0.8130968622100955,0.9517306403413849,1.0,2/14,11.53%,NOX4;AIFM1
prerank,syntaxin-1 binding (GO:0017075),0.30777905485249446,0.7204714017087408,0.8137755102040817,0.9518439192187114,1.0,4/22,12.58%,UNC13B;PRRT2;NSF;STXBP5
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),0.32902503006212935,0.7190485925862133,0.8265734265734266,0.9513710009538968,1.0,2/15,9.25%,PLA2G4A;SH3PXD2B
prerank,protein phosphatase 2A binding (GO:0051721),0.3036802134877368,0.7116686364858026,0.8463508322663252,0.95747950709972,1.0,3/23,7.41%,GRIN3A;ADCY8;STRN4
prerank,mRNA 5'-UTR binding (GO:0048027),-0.2333504016960089,-0.710366412024477,0.8826291079812206,0.9945978968925426,1.0,5/24,10.34%,RPS14;MYH10;DDX3X;RPL26;RPS7
prerank,GABA-A receptor activity (GO:0004890),-0.25297233554702936,-0.7103232593199349,0.848605577689243,0.9869371504792234,1.0,4/18,13.23%,GABRB1;GABRB3;GABRB2;GABRA5
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.2924775535134362,0.7066239898279079,0.837037037037037,0.9609874433054146,1.0,6/25,20.16%,PLEKHA4;GAB2;DAPP1;HIP1;AKT1;MAPKAP1
prerank,protein phosphatase activator activity (GO:0072542),0.33055321461022136,0.700995529108137,0.8277310924369747,0.96504504080564,1.0,3/13,16.85%,CALM2;PPP2R5C;CALM3
prerank,neuropeptide receptor activity (GO:0008188),0.28203908155891105,0.7003814208152002,0.8519417475728155,0.9637148065973555,1.0,1/29,1.82%,GALR1
prerank,pentosyltransferase activity (GO:0016763),0.2778923420836928,0.6975505950273083,0.8726415094339622,0.964845471658575,1.0,7/36,16.21%,PARP3;SIRT5;QPRT;UPP2;TNKS2;SIRT2;PARP1
prerank,fatty acid synthase activity (GO:0004312),0.34467944378918186,0.6972390826339304,0.8435277382645804,0.9631847087720414,1.0,4/10,27.15%,ELOVL5;CBR4;MCAT;ELOVL1
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",-0.2524336805851497,-0.6969413987464134,0.8695652173913043,0.9944908505775892,1.0,9/16,28.46%,CD38;MACROD2;SARM1;NEIL1;NEIL3;RPS3;OARD1;NEIL2;MACROD1
prerank,ATP hydrolysis activity (GO:0140603),0.26841397052876703,0.6955295789039169,0.8829663962920047,0.962861333531679,1.0,10/41,23.28%,CHD1L;VCP;CHD3;MYO1E;ABCB6;VWA8;KIF20B;CLU;ABCD1;ABCB10
prerank,translation elongation factor activity (GO:0003746),0.3156394938372461,0.6916738892998211,0.8552097428958051,0.9649399578983193,1.0,5/14,23.97%,EEF1B2;TUFM;EEFSEC;GTPBP2;EIF5A2
prerank,hormone activity (GO:0005179),0.25800810214561143,0.6890058009589484,0.9105145413870246,0.9656928694790683,1.0,5/54,13.02%,INSL6;EDN3;VIP;AGRP;INHBA
prerank,hexosaminidase activity (GO:0015929),-0.2636265841244445,-0.6885956293369776,0.8793103448275862,0.9953814634662301,1.0,3/12,16.11%,CEMIP;CEMIP2;HYAL2
prerank,Lys63-specific deubiquitinase activity (GO:0061578),0.33997241668091593,0.6858638819948649,0.8598540145985402,0.9668994995647514,1.0,4/10,23.22%,OTUD5;YOD1;DESI2;CYLD
prerank,amyloid-beta binding (GO:0001540),0.2470521628718392,0.6850191118591902,0.9095801937567277,0.9657765133760348,1.0,10/79,10.64%,LRP1;EPHB2;APBB3;LRPAP1;TGFB2;FZD5;IAPP;CST3;BACE1;COL25A1
prerank,proton transmembrane transporter activity (GO:0015078),0.26720912242366934,0.6835119768285426,0.8755868544600939,0.9653819534788813,1.0,5/39,13.38%,SLC4A11;SLC9A1;CLCN4;NNT;ATP6V1B2
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",-0.2418218070610643,-0.6828430589273844,0.8442622950819673,0.9933348121632884,1.0,1/16,1.69%,PIR
prerank,G protein-coupled receptor activity (GO:0004930),0.22923732190692303,0.6817860033867325,0.9779559118236473,0.9651232035604864,1.0,9/239,2.75%,CMKLR1;PDGFRL;GPR27;GALR1;NPR3;GNRHR;DRD1;FSHR;ADGRL2
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),0.3297231943065541,0.6811243399285057,0.8520055325034578,0.9638863977704639,1.0,5/11,27.36%,PPEF2;DUSP19;TCF3;STK38;MAP3K11
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.28107062706738584,0.6758124149574068,0.8659286592865929,0.9670467288463419,1.0,6/26,22.06%,CHPF2;B3GNT7;B3GNT9;B3GNT6;B4GALNT3;B3GNT2
prerank,FMN binding (GO:0010181),-0.2643566954230956,-0.670246826972597,0.8722627737226277,0.997345725589491,1.0,7/11,33.41%,NOS3;NOS1;PNPO;NDOR1;NOS2;POR;HAO1
prerank,adenylyltransferase activity (GO:0070566),0.28605326721315416,0.6668428762517122,0.8842652795838751,0.9734594917876473,1.0,9/21,33.09%,TENT4B;ABL1;NMNAT3;NMNAT2;TENT2;SELENOO;NMNAT1;PAPOLG;COASY
prerank,MAP kinase activity (GO:0004707),0.30479124257820706,0.6663602684579861,0.8616010854816825,0.9719765409142832,1.0,3/14,11.42%,MAPK15;MAPK8;MAPK12
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",0.32377158295983355,0.6660020780675351,0.869942196531792,0.9703470341547583,1.0,8/11,34.34%,PIGF;PTDSS1;PTDSS2;SGMS2;PIGN;GNPTAB;PIGO;SAMD8
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.2705561735312209,0.6639247795088385,0.9052369077306733,0.9701946554634426,1.0,7/28,27.06%,AGO2;RPP40;ELAC2;RPP14;ENDOV;RPP21;POP5
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),0.2881596263751835,0.6632236283281533,0.8934531450577664,0.9688573740518843,1.0,6/18,25.23%,ANXA2;PAK4;ANXA1;CNN3;BAIAP2L1;S100A11
prerank,ion channel inhibitor activity (GO:0008200),0.26331540011721216,0.6627977605052128,0.9038686987104337,0.9673466300805227,1.0,3/35,5.05%,NEDD4;CAMK2D;CALM2
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.25567143016447974,0.6625999466864247,0.9154929577464789,0.9656110955257593,1.0,6/42,14.28%,CCNL2;CCNL1;CCNT2;CCNG2;CCNE2;HEXIM1
prerank,acetylcholine receptor activity (GO:0015464),0.2841783590064693,0.6620183993925197,0.8858974358974359,0.9643003768029146,1.0,2/22,8.42%,CHRNB2;CHRNA5
prerank,acylglycerol O-acyltransferase activity (GO:0016411),0.28818529570893997,0.6567875794196201,0.8767833981841764,0.9670622723614068,1.0,5/20,17.91%,LPCAT1;GPAT4;PNPLA3;PLA2G15;AGPAT5
prerank,bHLH transcription factor binding (GO:0043425),0.28538044687440367,0.6533555214018213,0.8880503144654088,0.9681286404106415,1.0,5/19,19.78%,TWIST1;BHLHE40;MAP3K10;CREBBP;TCF3
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),0.30600929666185245,0.6482436425427119,0.8715083798882681,0.9705817719318577,1.0,4/12,24.95%,CASP1;BAD;RPS27L;BCL2L13
prerank,methyl-CpG binding (GO:0008327),-0.21419583170913584,-0.6469069842225967,0.9398148148148148,1.0,1.0,5/22,14.61%,MBD2;CXXC4;TET1;ERH;CXXC5
prerank,single-stranded telomeric DNA binding (GO:0043047),0.31208166530744363,0.6457014393692778,0.8783977110157367,0.970715483730765,1.0,3/11,21.87%,HNRNPA2B1;RAD50;HNRNPA1
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),0.3210593150566094,0.6452695446393791,0.8803418803418803,0.969191037588383,1.0,1/10,5.99%,NOX4
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.29500210132906934,0.6411442472580628,0.8929068150208623,0.9705969122858956,1.0,6/14,24.48%,ALDH1L2;MTHFD1;NOXRED1;MTHFR;PYCR1;CRYM
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.23793372684515882,0.640310962241029,0.946448087431694,0.9693630331868027,1.0,7/60,8.98%,PPP1CC;PPP1R3C;PHLPP2;CDC14A;PPM1H;PGAM5;PPM1M
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.2772001712385783,0.6393848305261921,0.9014084507042254,0.9681739370211838,1.0,2/21,8.42%,CHRNB2;CHRNA5
prerank,thioesterase binding (GO:0031996),-0.24971199144677808,-0.6301245759513071,0.8960573476702509,1.0,1.0,4/11,22.58%,ADRA2A;CDC42;TRAF2;TRAF1
prerank,protein phosphatase inhibitor activity (GO:0004864),0.25877626578842916,0.6263904327749776,0.9145299145299145,0.9762100289690254,1.0,10/26,29.27%,PPP1R9B;PPP1R8;CABIN1;ARPP19;SAG;BOD1L1;LMTK2;MGAT5;PPME1;PABIR1
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),-0.19106670658585154,-0.6231884091053016,0.9887640449438202,1.0,1.0,9/28,25.93%,STAT1;BABAM2;EDA;TRAP1;MYD88;TRAF2;TRAF1;FADD;FEM1B
prerank,GABA receptor activity (GO:0016917),-0.20507005588621052,-0.6226822356813864,0.9346938775510204,1.0,1.0,4/21,13.23%,GABRB1;GABRB3;GABRB2;GABRA5
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",0.2779763917505809,0.6220740210302941,0.9162234042553191,0.9774454074089931,1.0,8/17,35.47%,AKR1C1;BDH2;SRD5A3;MECR;DECR2;TM7SF2;TECR;BLVRA
prerank,glycerophospholipid flippase activity (GO:0140333),0.3038279165157753,0.620225294348953,0.9024024024024024,0.9768518885393305,1.0,2/11,9.18%,ATP8B2;ATP8A1
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),0.2935582193609598,0.6194026859307848,0.9173789173789174,0.9755403307133722,1.0,8/12,36.40%,HDAC1;TBP;FOS;TAF1;H3-3A;RELA;RUVBL2;POU2F1
prerank,mitogen-activated protein kinase binding (GO:0051019),0.2445070557182873,0.6185309711575002,0.9364508393285371,0.9742564417114955,1.0,4/29,10.58%,NBR1;CDK5RAP3;NFATC1;ABL1
prerank,MAP kinase kinase activity (GO:0004708),-0.23082937337613874,-0.6180307882366862,0.9601593625498008,1.0,1.0,2/15,6.05%,MAP2K6;PAK3
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),0.2557118846529296,0.6085049646472203,0.9376558603491272,0.9791963398461507,1.0,5/25,16.21%,PARP3;SIRT5;TNKS2;SIRT2;PARP1
prerank,chloride channel regulator activity (GO:0017081),0.28268401870243376,0.6015443507214543,0.9224489795918367,0.9816605205343675,1.0,5/14,26.58%,WNK1;STX1A;SGK3;VTI1B;SGK1
prerank,microtubule plus-end binding (GO:0051010),0.25831240864700067,0.5960305614189738,0.9371859296482412,0.9832522654805002,1.0,5/20,20.74%,CLIP4;STIM1;MAPRE3;DCTN1;CLIP2
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),0.2882770716785853,0.5918401466117543,0.9315263908701854,0.9838679382898444,1.0,3/10,25.57%,FAAP20;IDE;DAXX
prerank,peptidase activator activity (GO:0016504),0.2491090402066331,0.5896814501410949,0.9430463576158941,0.9831691861258225,1.0,4/22,16.37%,VCP;PCOLCE;TANK;PSMD14
prerank,ribosomal large subunit binding (GO:0043023),0.2810961139507984,0.5884711130795507,0.9290780141843972,0.981976849248094,1.0,4/11,24.94%,LTN1;EIF6;CPSF6;RBM3
prerank,MHC class I protein binding (GO:0042288),-0.22926737397200075,-0.5869450267477916,0.9548872180451128,1.0,1.0,13/13,77.10%,ATP5F1B;TAP1;CD8B;ATP5F1A;ABCB9;TUBB;PILRA;CD8A;TAPBP;TAP2;LILRB1;TUBB4B;DERL1
prerank,chloride channel inhibitor activity (GO:0019869),-0.23712859072613987,-0.5857960487855987,0.9238410596026491,1.0,1.0,3/10,14.72%,WNK2;WNK4;CFTR
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",-0.21200326448615733,-0.5691791447289977,0.9624060150375939,1.0,1.0,13/13,78.82%,DNA2;DNASE1L1;EXO1;FEN1;GEN1;DNASE1;DNASE1L3;DICER1;ZGRF1;FAN1;DNASE1L2;SLX4;ENDOV
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.2782606569001508,0.5664411301420305,0.9440654843110505,0.9915327916359782,1.0,2/11,22.12%,SLC25A47;SLC22A3
prerank,microtubule minus-end binding (GO:0051011),0.2567813337282687,0.5647078317607976,0.9446693657219973,0.9904611267025536,1.0,1/13,5.06%,TUBGCP3
prerank,C-C chemokine binding (GO:0019957),-0.18047671968095164,-0.5613540026295989,0.9761904761904762,1.0,1.0,3/22,12.05%,CCR9;CX3CR1;ZFP36
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),-0.16543600790248192,-0.5593584847238003,1.0,0.9877503310312441,1.0,33/34,72.69%,NDUFC2;NDUFA13;NDUFB2;NDUFB7;NDUFS1;NDUFA8;NDUFS6;NDUFA4;NDUFA2;NDUFA12;NDUFC1;NDUFB4;NDUFV1;NDUFS5;NDUFB8;NDUFS4;NDUFA5;NDUFA3;NDUFS2;NDUFS8;NDUFB5;NDUFB3;NDUFS3;NDUFB10;NDUFA10;NDUFA9;NDUFV3;NDUFA6;NDUFV2;NDUFB9;NDUFA7;NDUFA1;NDUFB6
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),-0.16543600790248192,-0.5593584847238003,1.0,0.9877503310312441,1.0,33/34,72.69%,NDUFC2;NDUFA13;NDUFB2;NDUFB7;NDUFS1;NDUFA8;NDUFS6;NDUFA4;NDUFA2;NDUFA12;NDUFC1;NDUFB4;NDUFV1;NDUFS5;NDUFB8;NDUFS4;NDUFA5;NDUFA3;NDUFS2;NDUFS8;NDUFB5;NDUFB3;NDUFS3;NDUFB10;NDUFA10;NDUFA9;NDUFV3;NDUFA6;NDUFV2;NDUFB9;NDUFA7;NDUFA1;NDUFB6
prerank,voltage-gated anion channel activity (GO:0008308),0.2510517428457195,0.5520937027850351,0.9578231292517007,0.9938974193174446,1.0,2/15,11.04%,CLCN4;VDAC2
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.2623447763957097,0.5423056929008445,0.9577464788732394,0.9959506795378158,1.0,1/11,8.40%,DDAH1
prerank,phosphate ion binding (GO:0042301),-0.22264693333838928,-0.5391520240267375,0.9753846153846154,0.9881553961619491,1.0,2/10,14.86%,PDE2A;ADSS1
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),0.24810150065703418,0.526130085901104,0.9634831460674157,0.999731536948899,1.0,3/13,24.14%,GABRA3;GLRB;GABRE
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),0.25050703781479566,0.5172169236610228,0.9562043795620438,1.0,1.0,7/10,41.88%,CASP1;CASP2;CASP6;CASP7;CASP8;CASP12;CFLAR
prerank,RNA methyltransferase activity (GO:0008173),0.219211300723006,0.5111077277717286,0.9806949806949807,1.0,1.0,6/19,35.07%,TYW3;FBL;METTL8;MEPCE;TGS1;MRM2
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),-0.19780828088237418,-0.5105833632960712,0.9903536977491961,0.9887945621309939,1.0,6/11,27.12%,NEIL1;NEIL3;RPS3;HMGA2;NEIL2;APEX1
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),0.22324253219962234,0.48598557103137774,0.9903448275862069,1.0,1.0,4/14,24.95%,CASP1;BAD;RPS27L;BCL2L13
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.19591846189711182,0.4770003784657233,0.99265605875153,1.0,1.0,11/28,30.96%,SBK2;AKT1;MAP2K3;PRKACA;MAP2K7;LRRK2;RPS6KA2;RPS6KB1;SGK1;MAP2K4;MAP2K5
prerank,5'-3' exonuclease activity (GO:0008409),0.19423612742023944,0.42221216252262805,0.9918809201623816,1.0,1.0,7/14,36.81%,DCLRE1B;XRN1;DXO;CPSF3;FAN1;MRE11;EXOG
prerank,neuropeptide binding (GO:0042923),0.18550773363436826,0.419271684991305,0.9921671018276762,1.0,1.0,4/18,31.90%,MC4R;NMUR1;GPR37;SSTR2
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.20160989582401317,0.4074803444432599,0.9942196531791907,1.0,1.0,2/10,23.43%,HEXIM1;KAT2B
prerank,C-C chemokine receptor activity (GO:0016493),0.17656898021616793,0.40415724162490235,0.9961439588688946,1.0,1.0,4/21,26.07%,ACKR4;CXCR4;ACKR3;CCRL2
prerank,death receptor binding (GO:0005123),0.17984463418454402,0.38887235042333196,0.9947643979057592,1.0,1.0,3/15,26.25%,MADD;BID;RIPK1
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),0.17695257483140664,0.37252370444843697,1.0,1.0,1.0,7/11,41.88%,CASP1;CASP2;CASP6;CASP7;CASP8;CASP12;CFLAR
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.172091053750783,0.34671420769320516,1.0,1.0,1.0,4/10,36.22%,DCLRE1B;POLD1;MGME1;TATDN1
prerank,MHC protein binding (GO:0042287),0.14236594306268094,0.32320211743987315,1.0,0.9998915595365254,1.0,5/20,34.29%,LAG3;DERL1;TUBB4B;LILRB1;TAP2
